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The fermentative synthesis of valuable 
compounds is a sustainable and feasible 
alternative to chemical synthesis or extraction 
(Vandamme 1992; Revuelta et al. 2016; 
Revuelta et al. 2017; Rosenberg et al. 2017a). 
The importance to find sustainable ways to 
produce valuable goods like vitamin B6 is 
demonstrated by the current investment of 
industry in more environment friendly 
production. DSM nutritional products, currently 
market leader in vitamin B6 production, is 
moving its chemical B6 synthesis plant to a new, 
more sustainable site in China, investing 
approximately US$ 100 million (Gray 2016). 
However, fermentative production of many 
substances is hindered by host-heterologous 
interactions or the malicious effects of 
overexpression of pathways. To circumvent 
these problems, the regulation of the pathways 
of interest (POIs) and the regulatory cross-talk 
with the remaining metabolism must be 
understood. Many groups are characterizing the 
regulation of all known metabolic pathways and 
this growing knowledge is going to help to 
generate strains able to produce valuable 
substances. Furthermore, alternative synthesis 
pathways are present for many products as 
summarized in a recent review and in the 
discussion of this work (Dairi et al. 2011). These 
routes offer opportunities for the failing 
approaches to fermentatively produce valuable 
goods. The growing knowledge of genomic 
sequences from all branches of life is generating 
an even greater knowledge about the different 
variants of metabolic pathways and alternative 
routes for synthesis of valuable substances 
(Dairi et al. 2011). Although a plethora of 
different genomic sequences is already known, 
most of them are barely characterized. The 
functions of single genes and the existence of 
many pathways in these uncharacterized 
genomes can be inferred by homology from 
model organisms, which are far better 
characterized, but the exact metabolic impact 
remains unknown until experimental 
characterization has been achieved. This is 
because simple presence of the genes and 
enzymes comprising a pathway are not enough 
to state that the pathway actually exists or at 
least does the job it does in other organisms, 
which has been exemplified in Escherichia coli, 
where despite the presence of the conserved 
pathway, an alternative route dominates 
thiamine synthesis (Bazurto et al. 2016). In 
addition, promiscuous enzyme activities make 
the metabolic makeup of uncharacterized 
organisms even less predictable (Khersonsky, 
Tawfik 2010). Therefore, the characterization 
and harnessing of alternative pathways is key to 
improve fermentative production of valuable 
goods. As part of the effort to improve an 
existing vitamin B6 production strain, this work 
is proposing and applies a feasible, ubiquitously 
applicable approach to achieve this via 
heterologous reverse engineering of alternative 
pathways. 
1.1. Bacillus subtilis 
B. subtilis is a Gram-positive, rod-shaped, non-
pathogenic bacterium, which has for decades 
served as a model organism in basic research 
and has been used in many applications for 
biotechnological production of valuable goods. 
Extensive knowledge about physiology, 
nutritional requirements and methods for 
genetic manipulation make this organism an 
ideal platform for genetic engineering. 
Furthermore, compared to other organisms, the 
functions and cross-relation of the encoded 
proteins are well understood and some groups 
are on the way to establish B. subtilis strains 
with a minimal gene set in which all genes are 
essential and have dedicated functions (Juhas et 
al. 2014). Most of the information concerning 
B. subtilis can be accessed through the 
comprehensive and convenient database 
SubtiWiki (Michna et al. 2016).  
Many biotechnological applications used 
B. subtilis as a platform. Those applications 
include production of vaccines, riboflavin, 
terpenoids, and antibiotics  (Craig et al. 1949; 
Hao et al. 2013; Rosales-Mendoza, Angulo 2015; 
Guan et al. 2015; Ozturk et al. 2016). 
Furthermore, B. subtilis has been engineered to 
produce vitamin B6 with intermediate success 
(Pflug, Lingens 1978; Commichau et al. 2014; 
Commichau et al. 2015a). 
1.2. Vitamin B6 
Vitamin B6 is the designation for the six 
compounds (so called vitamers) pyridoxamine 
(PM), pyridoxine (PN), pyridoxal (PL) and their 
respective 5’-phoshate esters (hereafter called 
phosphate) pyridoxamine phosphate (PMP), 




phosphate (PLP) (Mukherjee et al. 2011; 
Rosenberg et al. 2017a). PLP is the essential and 
metabolically active form of vitamin B6 and is 
required for approximately 4% of all known 
enzymatic reactions, most of which are part of 
amino acid metabolism (Percudani, Peracchi 
2003, 2009). A list of 67 known or predicted 
vitamin B6-dependent proteins in B. subtilis has 
recently been published (Rosenberg et al. 
2017b). The enzymes and complexes requiring 
PLP are catalyzing amination, deamination, 
transamination, racemization, α, β and γ-
elimination and replacement as well as 
decarboxylation by the common mechanism of 
aldimine formation and deprotonation of the α 
carbon under inclusion of an electron donor 
(Eliot, Kirsch 2004). In addition to the aldehyde 
group of PLP, the phosphate group can act as a 
proton donor e.g. in the glycogen phosphorylase 
reaction (Palm et al. 1990; Schneider et al. 
2000). It has also been reported that PMP acts as 
a cofactor and substrate for transamination and 
deoxygenation in deoxy sugar reactions (Romo, 
Liu 2011). In addition to its function as a 
cofactor, there is evidence that vitamin B6 is 
also an antioxidant due to its redox quencher 
ability (Bilski et al. 2000). 
1.2.1. Vitamin B6 biosynthesis 
Vitamin B6 is biosynthesized by many bacteria, 
archaebacteria, fungi and plants, but animals 
and thus humans lack biosynthetic pathways 
and have to ingest it with their diet 
(Mittenhuber 2001; Tanaka et al. 2005; 
Fitzpatrick et al. 2007; Mukherjee et al. 2011; 
Rosenberg et al. 2017a). Two non-homologous 
biosynthesis pathways have been described for 
the synthesis of PLP (Figure 1).
 
Figure 1: Vitamin B6 biosynthesis 
pathways. The DXP-dependent 
pathway synthesizes PLP in a seven-
step semi-enzymatic process, while the 
DXP-independent pathway comprises 
only one step. E4P, erythrose-4-
phosphate; PE, 4-phphoerythronate; 
HPAKB, 3-hydroxy-4-phospho-α-
ketobutyrate; 4HTP, 4-hydroxy-L-
threonine phosphate; AOPB, 2-amino-
3-oxo-4-phosphohydroxybutyrate; 
APA, 1-amino-3-phosphohydroxy-
acetone; R5P, ribulose-5-phosphate; 
G3P, glyceraldehyde-3-phosphate; PLP, 
pyridoxal phosphate; DXP, 1-
deoxyxylulose-5-phosphate; Pyr, 
pyruvate; PNP, pyridoxine phosphate; 
PLP; pyridoxal phosphate; amino acids 




The evolutionary ancient DXP- independent and 
the newer, albeit earlier described DXP-
dependent pathway (Fitzpatrick et al. 2007; 
Mukherjee et al. 2011; Rosenberg et al. 2017a).  
The DXP-dependent pathway was found in E. 
coli and other γ-proteobacteria and a very 
similar pathway in α-proteobacteria. Here, the 
name giving compound 1-deoxy-D-xylulose-5-
phosphate (DXP) together with 1-amino-3-
phosphohydroxy acetone (APA) are substrates 
for the synthesis of PNP by activity of the PNP 
synthase PdxJ (Cane et al. 1999). Subsequently, 
PNP oxidase PdxH forms PLP, producing 
hydrogen peroxide as a byproduct (Zhao, 
Winkler 1995). The precursor DXP is formed by 
Dxs and is essential also due to involvement in 
isoprenoid and thiamine synthesis in most 
organisms (Kuzuyama et al. 2000; Cane et al. 
2001). APA is the product of a four-enzyme 
pathway starting with erythrose-4-phosphate 
(E4P), which is dehydrated by E4P 
dehydrogenase Epd (Zhao et al. 1995; Boschi-
Muller et al. 1997). 4-Phoshoerythronate (PE) 
dehydrogenases PdxB and PdxR (in γ and α-
proteobacteria, respectively) form 3-hydroxy-4-
phospho-α-ketobutyrate (HPAKB), which is 
subsequently aminated by 3-phosphoserine 
aminotransferase SerC yielding 4-hydroxy-L-
threonine phosphate (4HTP) (Drewke et al. 
1996; Rudolph et al. 2010; Tazoe et al. 2006). 
Dehydratase PdxA then forms 2-amino-3-oxo-4-
phosphohydroxybutyrate (AOPB), which is non-
enzymatically decarboxylated to APA (Cane et 
al. 1998; Cane et al. 1999; Laber et al. 1999; 
Sivaraman et al. 2003).  
The DXP-independent pathway is present more 
organisms including species of bacteria, 
archaea, fungi and plants and consist of only two 
enzymes, PdxS and PdxT (or PDX1 and PDX2 in 
plants and fungi), which form a hetero-24-mer, 
which catalyzes the formation of PLP from 
glyceraldehyde-3-phosphate (G3P) or 
dihydroxyacetone phosphate (DHAP) and 
ribulose-5-phosphate (R5P) or ribose-5-
phosphate (Ri5P) (Ehrenshaft et al. 1999; 
Ehrenshaft, Daub 2001; Belitsky 2004b; Burns 
et al. 2005; Raschle et al. 2005; Strohmeier et al. 
2006). PdxST can use either two combinations 
of the four substrates due to an intrinsic sugar 
isomerase activity, thus the complex unifies 
triose isomerase, pentose isomerase and imine 
formation activity to synthesize PLP directly 
(Burns et al. 2005).  
It is an interesting fact that PLP synthesis has 
been evolved twice using completely unrelated 
enzymes and several publications have 
discussed this fact. An ancestor of α and γ-
proteobacteria seemingly has lost the ability to 
synthesize vitamin B6, possibly during 
adaptation to a niche providing this cofactor 
(Mittenhuber 2001; Tanaka et al. 2005). The 
DXP-dependent pathway then evolved from 
existing enzymatic functions from 
thiamine/isoprenoid (Dxs), serine (SerC) and 
vitamin B6 salvage (PdxH) pathways and α and 
γ-proteobacteria filled the last missing step with 
the novel PE dehydrogenase function of PdxR 
and PdxB, respectively. The two enzymes are 
not homologous but carry out the same function, 
demonstrating the plasticity of bacterial 
genomes.  
1.2.2. Regulation of vitamin B6 
metabolism 
The vitamer PLP is highly reactive and can be 
toxic to cells, as demonstrated later in this work. 
Therefore, accumulation of free PLP is most 
likely circumvented by vitamin B6 producers by 
feedback inhibition, export or catabolism 
(Mukherjee et al. 2011; Rosenberg et al. 2017a). 
Only little is known about the regulation of 
vitamin B6 synthesis and metabolism. The DXP-
dependent pathway has been shown to be 
feedback inhibited. PdxH is inhibited by PLP and 
can be acetylated leading to modulation of its 
activity and Dxs is inhibited by products of the 
isoprenoid synthesis pathway (Zhao, Winkler 
1995; Banerjee et al. 2013; Kudoh et al. 2017; Gu 
et al. 2017a). In several Gram-positive 
organisms, the regulator PdxRreg (not the 
enzyme from α-proteobacteria) has been shown 
to inhibit transcription of pdxST in presence and 
activate it in absence of PLP (Bramucci et al. 
2011; Jochmann et al. 2011; Belitsky 2014; Liao 
et al. 2015; Tramonti et al. 2015; Suvorova, 
Rodionov 2016). A regulator of the B6 salvage 
enzymes has been found in Salmonella 
typhimurium (Tramonti et al. 2017). However, 
similar mechanisms remain to be found in B. 
subtilis. Furthermore, the activator of the γ-
aminobutyric acid (GABA) utilization gabTD 
operon GabR has been shown to be active only 




enzymes are only transcribed when enough 
cofactor for GABA transaminase GabT is present 
together with the substrate (Belitsky 2004a; Wu 
et al. 2017). 
Exporters for vitamin B6 have not been 
identified to date, although importers have been 
shown to exist in fungi and plants (described in 
more detail in the discussion) (Stolz, Vielreicher 
2003; Stolz et al. 2005; Szydlowski et al. 2013; 
Kato et al. 2015). In order to be exported, the 
vitamers would have to be dephosphorylated 
according to the current model (Yamada et al. 
1977; Yamada, Furukawa 1981). A PLP 
phosphatase has been found in Sinorhizobium 
meliloti, which is most likely involved in the 
export of PLP (Tazoe et al. 2005).  
Furthermore, cells have been shown to contain 
very low amounts of free PLP, but rather bind 
the reactive cofactor to carriers (Fu et al. 2001). 
Much about these so called channeling 
mechanism remains unknown, but it has been 
shown that PdxH contains a PLP binding site in 
addition to its active site, proposing a ‘parking 
position’ for PLP until it is transferred to an 
enzyme utilizing it (Yang, Schirch 2000; Di Salvo 
et al. 2011). A similar mechanism has been 
proposed for PdxK, the PL kinase from E. coli, 
which is also feedback inhibited by PLP 
remaining bound to PdxK after phosphorylation 
(Ghatge et al. 2012; Di Salvo et al. 2015). In B. 
subtilis, PLP release has been shown to be 
facilitated in presence of a PLP-dependent 
enzyme, the aminotransferase BacF (Moccand et 
al. 2011). This way PLP would be prohibited 
from going into solution in the first place. 
Recently, a novel and highly conserved protein 
has been shown to be involved in B6 
homeostasis. E. coli lacking YggS show a 
disturbed coenzyme A (CoA) metabolism and 
are vulnerable to PN, showing a curious growth 
phenotype in presence of this vitamer, allowing 
growth only in presence of intermediate 
concentrations and not above or under certain 
thresholds (Ito et al. 2013; Prunetti et al. 2016). 
Interestingly, some of the phenotypes can be 
rescued by external addition of amino acids, 
showing a connection to PLP-dependent 
pathways. It will be very interesting to further 
investigate this protein, which has a homolog in 
B. subtilis, called YlmE (Knockout and 
overexpression construct BP995 and pBP626, 
respectively, were constructed by the author 
and are available but not further mentioned in 
this work). 
1.3. Approaches for fermentative 
vitamin B6 production 
Vitamin B6 is currently being produced in large 
scale chemical synthesis utilizing expensive and 
toxic substrates and technically challenging 
chemical processes (Eggersdorfer et al. 2012). 
The state of the art Diels-Alder approach was 
invented in the 1960´s and uses substrates 
including toxic acetic anhydride, ammonia, 
formic acid and very expensive ethoxyoxazoles 
(Eggersdorfer et al. 2012). Several attempts to 
produce vitamin B6 by fermentation have been 
made in the meantime but were not considered 
competitive with the Diels-Alder approach as 
reviewed recently (Rosenberg et al. 2017a). 
Thereby it was tried to isolate natural 
overproducers, overexpress the endogenous 
pathways, single or several genes, or to 
overexpress the heterologous pathways. In the 
60´s and 70´s of the last century, isolated strains 
of the genera Bacillus, Klebsiella, Kluyveromyces, 
Saccharomyces, Achromobacter, Pichia, Vibrio 
and Flavobacterium were tested for vitamin B6 
production and it was found that P. 
guilliermondii NK-2 was able to produce up to 
25 mg l-1 vitamin B6 within several days of 
fermentation in a complex medium with 
addition of a detergent (Scherr, Rafelson 1962; 
Pardini, Argoudelis 1968; Ishida, Shimura 1970; 
Suzue, Haruna 1970a, 1970b; Tani et al. 1972; 
Nishio et al. 1973; Pflug, Lingens 1978). Thirty 
years later, the first genetically engineered 
strains were tested. The overexpression of the 
heterologous PdxST complex in E. coli yielded 
approximately 60 mg l-1 within two days, while 
overexpression of the endogenous pathway 
with Epd, PdxJ and Dxs was more successful 
with about 78 mg l-1 within 31 hours (Yocum et 
al. 2004; Hoshino et al. 2006b). S. meliloti was 
shown to be a natural overproducer of vitamin 
B6 and strain IFO14782 already produced 
103 mg l-1 within 168 hours without further 
optimization (Hoshino et al. 2006a). 
Overexpression of the endogenous phosphatase 
PdxP and PdxJ from E. coli lead to improved 
production of 149 mg l-1 within 216 hours 
(Nagahashi et al. 2008). Further improvement 
by isolation of mutants and overexpression of 




lead to a titer of 1.3 g l-1 within 168 hours 
(Hoshino et al. 2006a; Hoshino et al. 2006c). 
Also B. subtilis was engineered to overexpress 
the complete DXP-dependent pathway with 
enzymes from E. coli (Epd) and S. meliloti (PdxR, 
SerC, PdxA, PdxJ) in two genomic cassettes 
(Figure 2, Commichau et al. 2014). This strain 
reached 41 mg l-1 within 72 hours of 
fermentation (Commichau et al. 2014). Most 
recently, a strain was engineered to convert the 
intermediate 4HT to PN by overexpression of 
PdxA from E. coli and PdxJ from S. meliloti, which 
reached a titer of 65 mg l-1 within 72 hours 
(Commichau et al. 2015a). 
 
Figure 2: Scheme showing the two genetic 
constructs used by Commichau et al. 2014. 
Synthetic construct (SC) 1 encodes PdxJ and PdxA 
from S. meliloti (blue) under control of two 
constitutive promoters (PE4 and 5) and the 
spectinomycin resistance gene spc. SC2 encodes 
SerC and PdxR from S. meliloti and Epd from E. coli 
(green) under control of a constitutive promoter 
and the chloramphenicol resistance gene cat. SC1 
and SC2 were integrated into the amyE and sacB 
loci of B. subtilis SP1 by homologous 
recombination, respectively. Red hexagons depict 
terminators. 
The reasons for the inability to reach 
considerably higher titers that 1 g l-1 are widely 
unknown. It is however known that vitamin B6 
is required in very low concentrations of 
approximately 0.1 µM for growth of B. subtilis. It 
was furthermore described above, that vitamin 
B6 metabolism is strictly regulated (by mostly 
unknown mechanisms) and that only a small 
fraction of the cofactor is present as free PLP, 
due to its reactivity (Fu et al. 2001). 1 g l-1 PLP, 
which is equivalent to 4 mM, is at minimum 
400.000x higher than the physiological 
concentration of this cofactor. The 
hypothetically required titer to compete with 
chemical production of 10 g l-1 would equal 
4.000.000x this concentration, suggesting that 
the bacteria will have to adapt or will need to be 
engineered to withstand such high amounts of 
vitamin B6 in addition to the ability to produce 
such amounts (Rosenberg et al. 2017a). It was 
previously determined that B. subtilis could 
withstand up to 2 g l-1 PL and up to 40 g l-1 of PN 
externally added to the medium (Commichau et 
al. 2014). However, it was reported that the 
recombinant DXP-dependent pathway 
expressed in B. subtilis was genetically instable 
and fractions of the fermentation population 
inactivated it by mutation despite a much lower 
titer of PN produced in the experiment 
(Commichau et al. 2014). In part, this fact might 
be due to the toxicity of intermediates, which 
have also been shown to be toxic to the host 
cells. 4HTP, the product of SerC in the DXP-
dependent pathway has a detrimental effect on 
growth of B. subtilis and strains grown in 
presence of toxic concentrations develop 
resistance by mutation of the branched-chain 
amino acid transporter encoding gene bcaP and 
mutations leading to the deregulation of the 
threonine synthesis operon, indicating 
interference with threonine metabolism 
(Commichau et al. 2015a; Rosenberg et al. 
2016). It was furthermore observed that B. 
subtilis strains overexpressing the DXP-
dependent pathway accumulated intermediates 
of the aromatic amino acid synthesis pathway, 
indicating even more unknown cross-talk with 
the host metabolism (Fabian Commichau, 
personal communication). The brute force 
overexpression of the unregulated heterologous 
pathway in B. subtilis might lead to inefficient 
catalysis and accumulation of intermediates, 
which might lead to toxic effects in the host and 
therefore limited yield and inactivation of the 
pathway as described above (Rosenberg et al. 
2017a). 
The story of vitamin B6 production is in part like 
that of vitamin B2 riboflavin. B2 is today 
produced by fermentation using different 
organisms, including B. subtilis, but was until the 
90´s chemically produced using toxic and 
expensive agents like barbiturate and xylidine, 
which is why fermentation was chosen to be 
more feasible (Revuelta et al. 2016; Revuelta et 
al. 2017). Possibly, this work helps to establish a 
successful and competitive fermentative 





Figure 3: Scheme of the regulation of central metabolism in B. subtilis. (A) CCR and (B) nitrogen utilization. Glc, 
glucose; G6P, glucose-6-phosphate; FBP, fructose-1,6-bisphosphate; PEP, phosphoenolpyruvate; TCA, citric 
acid cycle; amino acids are three-letter code. 
1.4. Regulation of central 
metabolism in B. subtilis 
The overexpression of heterologous pathways 
can be detrimental for the host as mentioned 
above. The interferences causing this effect can 
be related to central metabolism and the 
following section will summarize some relevant 
mechanisms from B. subtilis (Figure 3). 
1.4.1. Carbon catabolite repression 
B. subtilis prefers glucose as primary carbon (C) 
and energy source and when several sugars are 
present, glucose is consumed before all others. 
This preference for glucose is conveyed mainly 
by three proteins, catabolite control protein A 
CcpA, PtsH and the bifunctional kinase and 
phosphorylase HPrK (Görke, Stülke 2008; Fujita 
2009). PtsH has a phosphorylation site at S46, 
which can be phosphorylated by activity of 
HPrK and serves as a switch. When S46 is 
phosphorylated, PtsH can interact with the 
regulator CcpA and the complex can bind to 
conserved catabolite responsive elements (cre) 
repressing catabolic enzymes (Henkin et al. 
1991; Deutscher et al. 1995; Jones et al. 1997). 
However, HPrK is only active when fructose-1,6-
bisphosphate (FBP) is present, which is an 
intermediate of glycolysis and whose 
abundance is proportional to glycolytic activity, 
ensuring CCR is only triggered, when glucose is 
abundant (Deutscher et al. 1995; Galinier et al. 
1998; Jault et al. 2000). Interestingly, HPrK also 
dephosphorylates S46, when high 
concentrations of inorganic phosphate (Pi) 
and/or low concentrations of FBP are present, 
which is why it is considered a bifunctional 
protein (Mijakovic et al. 2002). Furthermore, 
FBP and glucose-6-phosphate (G6P) enhance 
the interaction between CcpA and 
phosphorylated PtsH, facilitating this regulatory 
connection (Seidel et al. 2005; Schumacher et al. 
2007). The target cre elements are often located 
in the promoter regions or the 3’-regions of 
target genes and lead to a transcriptional 
roadblock for RNA polymerase. Targets of the 
CcpA PtsH complex are uptake systems and 
catabolic pathways for alternative C sources, as 
for example the ribose utilization operon, the N-
acetyl glucosamine (GlcNAc) utilization operon, 
or the Glycerol uptake factor (Blencke et al. 
2003). But also lipid metabolism, respiration 




well as peptide transporters are negatively 
regulated by CCR (Blencke et al. 2003).  
PtsH can also be transiently phosphorylated at 
H15 by activity of enzyme I (EI) PtsI, which itself 
acquires its phosphate from phosphoenol 
pyruvate (PEP). When glucose is abundant and 
taken up by the phosphotransferase system 
(PTS), the phosphate is transferred to the sugar, 
but when glucose is scarce, PtsH can 
phosphorylate catabolic enzymes specific for 
other PTS substrates, which contain PEP-
carbohydrate PTS-regulatory domains (PRDs) 
and are thereby activated (Stülke et al. 1998). 
1.4.2. Regulation of nitrogen 
utilization 
Nitrogen (N) metabolism in B. subtilis is 
regulated mainly by three proteins, the global 
regulator TnrA, the transcriptional repressor 
GlnR and the glutamine synthase (GS) GlnA 
(Fisher 1999; Gunka, Commichau 2012). B. 
subtilis preferentially utilizes glutamine or 
ammonium as N sources and the pleiotropic 
regulator TnrA is the major molecular switch. In 
absence of glutamine, TnrA activates the genes 
necessary for ammonium transport and 
assimilation as well as the transporters und 
utilization operons for other N sources and at 
the same time TnrA represses GS and GlnR and 
genes and operons that are responsible for 
reactions consuming ammonium (like amino 
acid synthesis) as well as several unknown 
genes (Atkinson, Fisher 1991; Wray, jr. et al. 
1996; Yoshida et al. 2003; Zalieckas et al. 2006; 
Khademi, Stroud 2006; Mirouze et al. 2015). In 
presence of the preferred N source glutamine, 
the DNA-binding capability of TnrA is strongly 
impaired by interaction with feedback inhibited 
(FBI)-GS and additionally, the complex of FBI-GS 
and GlnR represses transcription of glnRA, of 
tnrA and of genes activated by TnrA, like the 
urea utilization operon (Wray, jr. et al. 1997; 
Brandenburg et al. 2002; Fisher, Wray, jr. 2008; 
Hauf et al. 2016). 
1.4.3. Stringent response 
In addition to the regulation of N and C source 
utilization, a second major N-related regulatory 
mechanism exists in B. subtilis, which is 
switching the molecular programing between a 
rich, amino acid containing and minimal, amino 
acid limited environments. This mechanism is 
called stringent response and includes two 
major pleiotropic regulatory mechanisms, one 
of them being conveyed by the global branched-
chain amino acid-responsive regulator CodY 
(Sonenshein 2005; Geiger, Wolz 2014). During 
growth in presence of amino acids, CodY acts as 
a transcriptional repressor for operons and 
genes responsible for acquisition and synthesis 
of amino acids like the peptide transporter 
operons opp and dpp, the branched-chain amino 
acid transporter gene bcaP, as well as the  
aspartokinase III gene thrD and the threonine, 
isoleucine and leucine synthetic ilv-leu and hom 
operons among many others (Slack et al. 1995; 
Molle et al. 2003; Belitsky, Sonenshein 2008; 
Kriel et al. 2014; Belitsky et al. 2015a; Belitsky 
et al. 2015b). The DNA binding activity of CodY 
is enhanced in presence of branched-chain 
amino acids and this way ensures that those 
amino acids are not produced under rich 
medium conditions (Shivers, Sonenshein 2004). 
However, CodY is also activated by GTP, which 
conveys the second major stringent response 
mechanism, ‘stringent transcription control’ 
(Ratnayake-Lecamwasam et al. 2001; Handke et 
al. 2008; Tojo et al. 2010; Brinsmade, 
Sonenshein 2011; Steinchen, Bange 2016). 
During the transition from rich medium to an 
amino acid starvation condition, from 
exponential to stationary phase, and at initiation 
of sporulation, GTP is depleted by action of 
(p)ppGpp synthase RelA (Lopez et al. 1979; Ochi 
et al. 1981; Tojo et al. 2008). In S. aureus and E. 
coli, RelA has been shown to be activated by the 
presence of uncharged tRNA molecules, 
signaling amino acid limitation (Pedersen et al. 
1973; Rojiani et al. 1989; Geiger et al. 2010; 
Brown et al. 2016). There are also two minor, so 
called small (p)ppGpp synthases, RelP and RelQ, 
but their exact functions are still unknown 
(Geiger, Wolz 2014). The stringent response 
messenger (p)ppGpp furthermore inhibits the 
GTP synthetic enzymes GuaAB, Gmk and HprT, 
facilitating GTP depletion and at the same time 
rerouting flux of the purine precursor IMP in the 
direction of ATP synthesis (Lopez et al. 1981; 
Beaman et al. 1983; Kriel et al. 2012). Besides 
the inactivation of CodY due to absence of GTP, 
the lower GTP level and concomitantly rising 
ATP level have an additional, transcriptional 
effect on transcripts starting with adenines or 
guanines (Krasny et al. 2008; Tojo et al. 2008; 
Tojo et al. 2010). It was shown that the guanine 




influence on transcription depending on the 
ATP and GTP (and correspondingly (p)ppGpp) 
levels. During exponential growth in a nutrient 
rich medium, high concentrations of GTP are 
present and transcripts initiated with a guanine 
are produced normally, while transcripts 
initiated with an adenine are less efficiently 
produced due to (relatively) low ATP 
concentrations. During stringent response, GTP 
gets depleted and ATP is produced in higher 
amounts than usual, which leads to the opposite 
situation (Lopez et al. 1979; Ochi et al. 1981; 
Tojo et al. 2008; Tojo et al. 2010). This kind of 
regulation has been shown in detail for the ilv-
leu operon and several operons of glucose and 
pyruvate metabolism. Moreover, stringent 
response as very recently also been shown to be 
important for the adaptation to fatty acid 
starvation in B. subtilis (Pulschen et al. 2017). 
1.4.4. Regulation of the aspartate-
derived amino acids 
The amino acids asparagine, lysine, threonine, 
isoleucine and methionine have aspartate as a 
common precursor in B. subtilis. The synthesis 
of the aspartate-derived amino acids lysine, 
threonine, isoleucine and methionine is initiated 
by the activity of three aspartokinases that feed 
into a branching pathway, which is very 
differentially regulated by action of allosteric 
feedback inhibition as well as transcriptional 
repression and activation (Figure 4). Already 
the initial step is highly regulated, as the 
aspartokinases I, II and III are under control of 
different feedback inhibitory and activating 
interactions. Essential aspartokinase I DapG 
earns its name, because it is feedback inhibited 
by diaminopimelate (DAP), an intermediate of 
the branch leading to peptidoglycan (PG) and 
lysine (Graves, Switzer 1990). Aspartokinase II 
LyC, a non-essential paralog of DapG, is 
transcriptionally inhibited by lysine by a lysine-
dependent riboswitch (Grundy et al. 2003; 
Wilson-Mitchell et al. 2012). Aspartokinase III 
ThrD is transcriptionally activated by lysine, 
synergistically feedback inhibited by lysine and 
threonine and repressed by CodY (Graves, 
Switzer 1990; Kobashi et al. 2001). Essential L-
aspartate-4-semialdehyde (ASA) 
dehydrogenase Asd uses the product of 
aspartokinase, aspartyl-phosphate (Asp-P) and 
forms ASA (Daniel, Errington 1993). 
 
Figure 4: Scheme showing the regulation of the 
aspartate-derived amino acids. Amino acids are 
three-letter-code; ASA, L-aspartate-4-
semialdehyde, H-Ser, homoserine; PG, 
peptidoglycan; DAP, diaminopimelate. Blue box, 
part of the Thr pathway encoded in the hom 
operon. Red and green lines show inhibitory and 
activating regulation, respectively. Dotted lines 
show metabolic pathways containing more than 
one enzyme. 
At this point the pathway divides into the DAP 
and the homoserine branches. The DAP branch 
starts with the formation of (4S)-4-hydroxy-
2,3,4,5-tetrahydro-(2S)-dipicolinate from ASA 
and pyruvate by the also essential 4-hydroxy-
tetrahydrodipicolinate synthase DapA (Grant 
Pearce et al. 2017; Daniel, Errington 1993). 
Further down this branch divides again into the 
lysine and PG synthesis pathways. The 
homoserine branch starts with activity of the 
homoserine dehydrogenase Hom (Parsot, 
Cohen 1988). Here, the pathway divides again. 
Homoserine is consumed by activity of 
homoserine O-succinyltransferase MetA feeding 
into methionine synthesis and by homoserine 
kinase ThrB feeding into threonine and 
isoleucine synthesis (Rowbury, Woods 1964; 
Zubieta et al. 2007). The genes encoding the 
pathway leading from homoserine to threonine, 
Hom, ThrB and threonine synthase ThrC are 
part of the hom operon, which is under 
transcriptional control of CodY and TnrA (Kriel 
et al. 2014; Mirouze et al. 2015). This pathway is 
furthermore feedback inhibited by sensitivity of 
Hom to threonine (Parsot, Cohen 1988). 
Threonine can either be catabolized to glycine 
by threonine dehydrogenase Tdh and 2-amino-




isoleucine synthesis pathway by activity of 
threonine dehydratase IlvA, which forms 2-
oxobutanoate (2-OB) (Hatfield et al. 1970; 
Hatfield, Umbarger 1970a, 1970b). IlvA is also 
under transcriptional control of CodY (Molle et 
al. 2003). Subsequently, the enzymes encoded in 
the ilv-leu operon acetolactate synthase IlvBH 
and ketol-acid reductoisomerase IlvC as well as 
dihydroxy-acid dehydratase IlvD and the 
branched-chain amino acid aminotransferases 
YwaA and YbgE produce isoleucine (Ward, jr, 
Zahler 1973; Berger et al. 2003). The synthesis 
pathways of isoleucine, leucine and valine share 
these last steps although with differing 
substrates. The ilv-leu operon is tightly 
regulated through CcpA, TnrA, CodY, stringent 
transcription control and a tRNA-dependent 
riboswitch-conveyed antitermination in 
absence of branched-chain amino acids 
(Grundy, Henkin 1994; Ludwig et al. 2002; Molle 
et al. 2003; Tojo et al. 2004; Belitsky, Sonenshein 
2008). IlvD and the ubiquitous 
aminotransferases YwaA and YbgE are also 
under transcriptional control of CodY (Molle et 
al. 2003; Kriel et al. 2014). Many enzymes in 
amino acid metabolism, including all three 
aspartokinases, Hom and IlvH contain 
regulatory aspartate kinase-chorismate mutase-
tyrA (ACT) domains, which are known to 
regulate proteins dependent on binding to small 
molecule effectors, which are mostly amino 
acids (Grant 2006; Curien et al. 2008; Lo et al. 
2009). 
1.4.5. Oxidative stress response 
Oxidative stress originates mainly (as the name 
says) from the intrinsic nature of oxygen, which 
is one of the most important elements for most 
living organisms due to redox chemistry and 
respiration. Oxygen in solution has the 
capability to oxidize amino acids, metals and 
cofactors and cleave bonds. Redox chemistry 
leads to the formation reactive oxygen species 
(ROS) like superoxide (O2-) or hydrogen 
peroxide (H2O2) and reactive nitrogen species 
(RNS) like nitric oxide (NO). Together, these 
reactive species can lead to inhibition of central 
metabolic functions and DNA damage, 
eventually causing cell death. Bacteria possess 
many mechanisms by which they can deal with 
this natural but harmful problem of their 
chemistry and under normal conditions, this is 
well managed. During conditions where 
additional oxidative potential is present, 
bacteria activate the so called oxidative stress 
response, which protects vulnerable targets in 
the cell and activates detoxification and repair 
pathways. This can happen, when pathogenic 
bacteria encounter the immune system, where 
host cells secrete NO and other reactive species 
to defend themselves. B. subtilis, which is not a 
pathogen, but a soil bacterium encounters this 
condition either on substrates that have 
oxidative properties or due to the secretion of 
reactive species by competing organisms. The 
targets of ROS in B. subtilis are diverse. Thiols 
can be oxidized irreversibly by ROS, which is 
especially the case for those found in side chains 
of cysteine and homocysteine (demethylated 
methionine) residues within proteins (Di 
Simplicio et al. 2003; Lee et al. 2007; 
Winterbourn, Hampton 2008). When these 
residues are exposed to the solvent and located 
in crucial parts of enzymes or are involved in 
catalysis, this oxidation can lead to irreversible 
inactivation (Hondorp, Matthews 2004; 
Hochgrafe et al. 2005; Winterbourn, Hampton 
2008). Furthermore, solvent exposed [4Fe-4S]+ 
clusters (FeS clusters), which are often present 
in dehydratases, are vulnerable to iron 
oxidation leading to loss of one iron atom, 
inactivating the enzymes containing these 
clusters (Beinert, Kiley 1999; Imlay 2006). The 
released iron cations themselves exhibit toxic 
Fenton chemistry, leading to the production of 
highly reactive hydroxyl species in reaction with 
hydrogen peroxide (Rogers, Ding 2001; 
Woodmansee, Imlay 2003; Imlay 2006; Spiro 
2007). ROS also interfere with iron homeostasis, 
because the pleiotropic metal homeostasis 
repressor Fur is prone to oxidation (Bsat et al. 
1998). Fur represses genes encoding proteins 
responsible for iron uptake and metabolism and 
oxidation of the bound iron leads to the inability 
to bind DNA and therefore uncontrolled uptake 
of iron, leading to even more harmful Fenton 
chemistry and DNA damage (Imlay, Linn 1988; 
Varghese et al. 2007). NO can directly harm the 
respiratory chain of B. subtilis by inhibition of 
cytochrome oxidases and together with ROS 
forms other RNS like dinitrogen trioxide (N2O3) 
and can modify cysteine and tyrosine residues 
as well as FeS clusters, also leading to release of 
reactive iron cations (Brown et al. 1997; Rogers, 
Ding 2001; Di Simplicio et al. 2003; Fang 2004; 




Interestingly, B. subtilis even encodes an NO 
synthase, which is thought to be important for 
the activation of oxidative stress response 
(Gusarov, Nudler 2005).  
Oxidative stress response is conveyed by five 
major players, the general stress sigma factor σB 
and the oxidative stress-responsive regulators 
PerR, OhrR and Spx as well as the novel low 
molecular weight (LMW) thiol bacillithiol (BSH) 
(Zuber 2009; Chandrangsu et al. 2017). The 
sigma factor σB is promoting the general stress 
response by activation of transcription of about 
150 general stress-related genes under many 
conditions like envelope, heat, alkaline, acid, and 
oxidative stress (Hecker, Völker 2001; Hecker et 
al. 2007). The repressor PerR is more 
specifically responding to peroxide stress and 
its DNA binding is inhibited by structural 
modification through peroxide, allowing 
expression of the DNA protecting iron 
resistance protein MrgA, catalase KatA, 
alkylhydroperoxide reductase AhpCF, heme 
biosynthetic genes and Spx (Bsat et al. 1998; 
Herbig, Helmann 2001; Lee, Helmann 2006; 
Leelakriangsak et al. 2007; Traore et al. 2009).  
The transcriptional repressor OhrR received its 
name because it responds specifically to organic 
hydroperoxides (OHPs) (Fuangthong et al. 
2001; Fuangthong, Helmann 2002). Oxidation of 
a regulatory cysteine residue by OHP and 
subsequently by BSH, coenzyme A (CoA) or 
cysteine leads to release from the DNA and 
expression of the peroxiredoxin OhrA 
(Fuangthong, Helmann 2002; Lee et al. 2007). 
The Spx-mediated stress response involves 
many different genes not only related to 
oxidative, but also heat stress. Within the 
oxidative stress response, Spx mediates 
resistance to thiol-specific and paraquat stress 
(Zuber 2009; Antelmann, Helmann 2011). Spx 
carries a SsrA tag and is under physiological 
conditions rapidly proteolyzed by ClpXP under 
mediation of the adaptor protein YjbH  (Nakano 
et al. 2003b; Garg et al. 2009). During oxidative 
stress, a regulatory motif containing two 
cysteine residues undergoes oxidation to a 
disulfide bond, allowing transcriptional 
regulation (Nakano et al. 2003a; Nakano et al. 
2005). According to the current model, under 
the same condition, ClpX and the adaptor 
protein YjbH become inactive due to their own 
disulfide switches, leading to lower efficiency of 
Spx proteolysis (Zuber 2009). When present in 
high concentrations, Spx inhibits all genes 
requiring activation by a positive regulator 
because it binds to RNA polymerase alpha 
subunit, interfering with other regulators 
(Nakano et al. 2003b; Zuber 2004; Rochat et al. 
2012). In addition to this pleiotropic regulatory 
mechanism, Spx regulates dozens of specific loci 
by activation and repression conferred by a 
conserved Spx cis element (Zuber 2004; Erwin 
et al. 2005; Reyes, Zuber 2008; Zuber et al. 2011; 
Rochat et al. 2012). Spx activates the 
thioredoxin system TrxAB, cysteine/methionine 
biosynthetic and repair enzymes like YrrT, 
MccAB, MtnN, MsrAB  and CysK,  and other 
redox-related proteins like the synthesis 
pathway for the LMW thiol BSH (Nakano et al. 
2003a; Choi et al. 2006; You et al. 2008; Gaballa 
et al. 2013). In addition to activation, Spx also 
represses several genes, as for example 
surfactin production enzymes and comS 
(Nakano et al. 2003b).  
A novel LMW thiol, BSH was identified in bacilli, 
which is also present in staphylococci, 
streptococci and deinococci (Newton et al. 2009). 
It is involved in oxidative stress resistance by 
e.g. the protection of proteins from irreversible 
oxidation and detoxification of methylglyoxal as 
well as in the resistance to fosfomycin (van Loi 
et al. 2015; Chandrangsu et al. 2017). BSH is 
produced from the substrate UDP-GlcNAc by 
three enzymes, glycosyltransferase BshA, 
deacetylase BshB and the putative cysteine 
ligase BshC (Gaballa et al. 2010; VanDuinen et al. 
2015). The reactions of BshA and BshB have 
been demonstrated in vitro, but the reaction of 
BshC has not been closer characterized to date, 
probably due to an unknown cofactor to the 
reaction (VanDuinen et al. 2015). B. subtilis 
encodes the first two genes bshA and bshB1 in 
one operon with the methylglyoxal synthase 
encoding gene mgsA and the biotin ligase birA 
which is under control of Spx as earlier 
mentioned. The gene encoding BshC is encoded 
separately in a bicistronic operon together with 
ylbQ, which is also under control of Spx (Gaballa 
et al. 2013). Additionally, there is a Spx 
regulated paralog of bshB1, bshB2, which is 
encoded in a tricistronic operon with two 
unknown genes and is thought to have a minor 




BSH is thought to be the most important redox 
buffer in B. subtilis and is present in relatively 
high concentrations of 1-5 mM in the cytosol 
which is considerably higher than the 
concentrations of other thiols in this organism 
(Sharma et al. 2013). It can be present as a thiol 
or as a disulfide of two BSH molecules (BSSB) 
and the fact that most of it is measurable as the 
reduced form BSH has given reason to assume 
the existence of BSSB reductases, which to date 
remain to be found with YpdA, YqiW and YphP 
as hot candidates (Sharma et al. 2013; 
Chandrangsu et al. 2017). A function as a metal 
ion buffer has been shown by the capability of 
BSH to sequester zinc and copper ions (Ma et al. 
2014; Kay et al. 2016). Furthermore, BSH 
deficient mutants have been shown to be 
susceptible to hypochlorite, diamide, ROS, 
osmotic, acid and alkaline stress (Gaballa et al. 
2010; Chi et al. 2011). Other studies showed that 
BSH is also important for resistance to 
fosfomycin, because BSH deficient cells are 
more susceptible to this antibiotic and the 
fosfomycin resistance conveying epoxide 
hydrolase FosB requires BSH as a cofactor 
(Gaballa et al. 2010; Lamers et al. 2012; 
Thompson et al. 2014). BSH probably also 
conveys resistance to reactive electrophile 
species (RES) by either sequestration and direct 
S-conjugation or as a cofactor for the putative S-
transferase YfiT, which is a homolog of BstA 
from Staphylococcus aureus. BstA has been 
shown to detoxify RES by S-conjugation and 
subsequent export of mercapturic acids (Rajan 
et al. 2004; Newton et al. 2011; Perera et al. 
2014). BSH is also important for the 
detoxification of MG. It binds to MG forming 
BSH-hemithioacetal, which is catabolized to 
lactate by glyoxalases I and II GlxA and GlxB, 
respectively (Chandrangsu et al. 2014). One 
intermediate of this pathway, S-lactoyl-BSH is a 
messenger molecule that activates the three-
component potassium/proton antiporter 
KhtSTU, which imports H+ into the cytosol, 
leading to acidification and thus preventing 
nucleophilic damage by MG (Chandrangsu et al. 
2014). There is also evidence that BSH is 
involved in formaldehyde detoxification in other 
bacilli (Harms et al. 1996; Nguyen et al. 2009; 
Chandrangsu et al. 2017). Strains deficient in 
BSH also show lower activity of FeS cluster 
containing enzymes leading to lower 
concentrations of branched-chain amino acids 
leucine and isoleucine (Fang, Dos Santos 2015; 
Rosario-Cruz et al. 2015; Chandrangsu et al. 
2017). It is however unknown, by what 
mechanism BSH is involved in FeS cluster 
synthesis.  
Another major role of BSH is reversible 
bacillithiylation of cysteines prone to 
irreversible oxidation (Chi et al. 2011; Chi et al. 
2013). There have been studies identifying the 
bacillithiylation targets (Chi et al. 2011; Chi et al. 
2013; van Loi et al. 2015). The best studied 
examples so far are the methionine synthase 
MetE and the previously mentioned organic 
hydroxide resistance regulator OhrR. 
Bacillithiylation leads to methionine 
auxotrophy under oxidative stress, which could 
be relieved by addition of the amino acid, 
demonstrating the inactivation of target 
enzymes.  Further bacillithiylation targets under 
investigation are the translation factor TufA, 
AroA, GuaB and ribosomal protein RpsM among 
many others (Chi et al. 2011; Chi et al. 2014). In 
other firmicutes, glyceraldehyde-3-phosphate 
dehydrogenase Gap is considered a major target 
for bacillithiylation, but in B. subtilis, Gap is 
protecting itself from oxidative damage by an 
internal disulfide switch (Chi et al. 2011; Imber 
et al. 2017).  Very interestingly, bacillithiylation 
is not observed under H2O2 stress indicating a 
very specific regulation of this mechanism (Chi 
et al. 2013). The reversibility of bacillithiylation 
is due to the enzymatic function of 
bacilliredoxins. So far two have been identified, 
BrxA, BrxB and the candidate YtxJ is under 
investigation (Gaballa et al. 2010; Chi et al. 2013; 
Gaballa et al. 2014). However, other than the 
thioredoxin system TrxAB, BrxAB are not 
essential and it is hypothesized that they exhibit 
redundant functions concerning bacillithiylated 
proteins (Gaballa et al. 2010; Gaballa et al. 2014; 
Chandrangsu et al. 2017). 
1.5. Underground metabolism 
In addition to cellular metabolism, there is a 
growing notion of the so called underground 
metabolism. The word underground describes 
the major property of what could also be called 
alternative or invisible metabolism. Most of the 
known enzymatic functions of E. coli can 
actually be carried out by a minority of the 
enzymes. 37% of the identified enzymes can use 
more than one substrate and are able to catalyze 




(Nam et al. 2012). The implicit redundancy is 
thought to be an indicator for a, to a certain 
degree proceeding, specialization of enzymes, 
with contemporary enzymes being specialists 
and their ancestors generalists (Khersonsky, 
Tawfik 2010; Innan, Kondrashov 2010; Nam et 
al. 2012). As a byproduct of selection for more 
specific reactions, generalist traits are retained 
although not selected for. When the ability to 
carry out side reactions does not cause toxicity, 
or is inefficient enough not to be selected 
against, then it can be carried along 
(Khersonsky, Tawfik 2010). The ability to carry 
out side reactions can also be a collateral effect 
of selection for another trait (Khersonsky, 
Tawfik 2010). It is important to note, what effect 
the realization of underground metabolism has: 
Pathways are not necessarily linear, branched 
or circular, but might in reality be an endless, 
interconnected network (Khersonsky, Tawfik 
2010). This fact is, of course, of great interest for 
the development of novel synthesis pathways 
for biotechnological application (Notebaart et 
al. 2017). Several works have been dedicated to 
the harnessing of this new reservoir. Examples 
with relation to vitamin B6 have brought up 
exciting alternative pathways. One group 
established a bioinformatical platform, which 
can predict promiscuous enzyme activity, called 
PROPER (Promiscuity Predictor) (Oberhardt et 
al. 2016). By a permissive homology search and 
comparison of functions and reaction 
mechanisms, PROPER was able to predict a 
promiscuous PLP synthesis activity of ThiG in E. 
coli, which could also be shown in a multi-copy 
replacement experiment (Oberhardt et al. 
2016). Another group applied a genetic 
approach by roadblocking E. coli´s DXP-
dependent B6 synthesis pathway and 
overexpression of a E. coli ORF plasmid library 
(Kim et al. 2010). By overexpression of the 
genes encoded in the ORFs, promiscuous 
activities became visible and it was possible to 
identify several enzymes rescuing growth and 
comprising three serendipitous pathways 
bypassing the PE dehydrogenase PdxB (in more 
detail in the discussion) (Kim et al. 2010). These 
successful approaches demonstrate the 
potential of underground metabolism. And this 
potential might be further facilitated by 
combination of underground metabolism with 
the knowledge about alternative pathways from 
other organisms to form novel, hybrid pathways 
comprising reactions of underground 
metabolism and heterologous enzymes 
(Rosenberg, Commichau in preparation).  
1.6. Aims and scope of this work 
This work aims to add to the knowledge 
required for an economically competitive and 
ecologically sustainable, fermentative 
production of the valuable substance vitamin 
B6. To achieve this, the deleterious cross-talk 
between the heterologous pathway and host 
metabolism is investigated to allow the 
development of strategies to circumvent this 
obstacle in the future. Furthermore, genetic 
engineering and targeted evolution approaches 
are applied to optimize an existing B. subtilis 
vitamin B6 production strain. Also, a reverse 
engineering approach to generate a novel, 
hybrid pathway is applied exploiting rewiring of 
underground metabolism with the heterologous 
pathway and its application in other systems is 
proposed. Lastly, the blue-print for an optimized 
and streamlined vitamin B6 production strain 
based on the biochemical and kinetic 
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2. Material and Methods 
2.1. Material 
Materials used in this work are listed in the 
appendix. 
2.2. Bacterial strains and plasmids 
Bacterial strains and plasmids used in this work 
are listed in the appendix 
2.3. Media and solutions 
All media, buffers and solutions were prepared 
with deionized water (ddH2O) unless stated 
otherwise. Sterilization was done by 
autoclavation for 20 minutes at 121°C and 2 bar. 
Temperature sensitive solutions and reagents 
were sterilized by filtration through a 0.22 µm 
nominal pore diameter filter membrane. 
Concentrations depicted as per cent are w/v 
unless otherwise stated. For solidification, 
media were supplemented with 1.5% Agar-Agar 
(Commichau et al. 2015b). Chemicals were 
commercially acquired from either Sigma 
Aldrich (Merck KGaA, Darmstadt) or Carl Roth 
GmbH + Co. KG (Karlsruhe). 
2.3.1. Stocks and additives 
5x C-salts 
20 g KH2PO4 
80 g K2HPO4 x 3 H2O 
16.5 g (NH4)2SO4 
Ad 1000 ml ddH2O 
 
III´ salts 
0.232 g MnSO4 x 4 H2O 
12.3 g MgSO4 x 7 H2O 
Ad 1000 ml ddH2O 
 
10x MN 
136 g K2HPO4 x 3 H2O 
60 g KH2PO4 
10 g Sodium Citrate x 2 H2O 
 
IPTG 
1000x Stock solution: 1 M in ddH2O 
Final concentration: 1 mM in medium 
 
X-Gal 
1000x Stock solution: 40 mg ml-1 in DMF 
Final concentration: 40 µg ml-1 in medium 
Plates and media containing X-Gal were stored 
in the dark. 
2.3.2. Antibiotics 
All used antibiotics were prepared as 1000x 
stock solutions in ddH2O or 70% (v/v) ethanol 
(EtOH). For the selection of ermC, erythromycin 
and lincomycin were used in combination. In 
Table 1 the selective concentrations are shown. 
Antibiotics were sterilized by filtration and 
added to the media after autoclaving. Media and 
plates containing tetracycline were stored in the 
dark. 
Table 1: Selective concentrations of antibiotics used 








Ampicillin ddH2O - 100 
Chloramphenicol EtOH 5 15 
Erythromycin EtOH 2 - 
Kanamycin ddH2O 10 50 
Lincomycin ddH2O 25 - 
Phleomycin ddH2O 35 35 
Spectinomycin ddH2O 150 - 
Tetracycline EtOH 12.5 - 
 
2.3.3. Complex media 
SOB medium 
20 g Tryptone 
5 g Yeast Extract 
0.58 g NaCl 
0.186 g KCl 
Ad 980 ml ddH2O 
After autoclaving, the following, sterile 
compounds were added: 
10 ml 1 M MgCl2 
10 ml 1 M MgSO4 
 
LB medium 
10 g Tryptone 
5 g Yeast Extract 
10 g NaCl 






8 g Nutrient Broth 
0.25 g MgSO4 x 7 H2O 
1 g KCl 
Ad 1000 ml ddH2O 
After autoclaving, the following, sterile 
compounds were added: 
1 ml 0.5 M CaCl2 
1 ml 10 mM MnCl2 
2 ml 2.2 mg ml-1 Ferric Ammonium Citrate (CAF) 
2.3.4. Defined minimal media 
C minimal medium 
20 ml 5x C-salts 
1 ml 5 mg ml-1 Tryptophan 
1 ml 2.2 mg ml-1 CAF 
1 ml III´ salts 
Ad 100 ml ddH2O 
 
CE minimal medium 
C minimal medium 
2 ml 40% Potassium Glutamate (E) 
Ad 100 ml ddH2O 
 
CSE minimal medium 
C minimal medium 
2 ml 40% Potassium Glutamate 
2 ml 30% Sodium Succinate (S) 
Ad 100 ml ddH2O 
 
2.3.5. Buffers and solutions 
Buffer W 
12.114 g Tris  
8.77 g NaCl 
0.3722 g Na2EDTA x 2 H2O 
HCl to pH 8 
Ad 1000 ml ddH2O 
 
Buffer E 
0.027 g D-Desthiobiotin 
Ad 50 ml Buffer W 
 
Buffer Z 
1.068 g Na2HPO4 
0.552 g NaH2PO4 
75 mg KCl 
24.7 mg MgSO4 
Ad 50 ml ddH2O 
Directly before use: 175 µl β-Mercaptoethanol 
 
LD Mix 
100 mg Lysozyme 
10 mg DNase I 
Ad 10 ml ddH2O 
 
LD Buffer 
4 ml Buffer Z 
20 µl LD Mix 
 
5x TBE Buffer 
54 g Tris base (T) 
27.5 g Boric acid (B) 
20 ml 0.5 M EDTA pH 8.0 (E) 
Ad 1000 ml ddH2O 
 
50x TAE Buffer 
242 g Tris base (T) 
57.1 ml Acetic acid (A) 
100 ml 0.5 M EDTA pH 8.0 (E) 
Ad 1000 ml ddH2O 
 
10x TBS Buffer 
60 g Tris base (T) 
90 g NaCl 
Adjust pH to 9.2 with NaOH 
Ad 1000 ml ddH2O 
TB Buffer 
3.46 g PIPES 
18.64 g KCl 
Ad 940 ml ddH2O 
After autoclaving, the following, sterile 
compounds were added: 
2.2 g CaCL2 x H2O 
55 ml 1 M MnCl2 
Ad 60 ml ddH2O 
 
5x Laemmli Buffer 
1.4 ml 1.5 M Tris HCl pH 6.8 
5 ml Glycerol 
0.5 g Sodium dodecyl sulfate (SDS) 
1.6 ml β-Mercaptoethanol 
0.02 g Bromophenol Blue 




1.3 ml 30% Acrylamide-Bisacrylamide 
1 ml 1.5 M Tris HCl pH 6.8 
5.5 ml ddH2O 
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80 µl 10% SDS 
80µl 10% Ammonium persulfate (APS) 
8 µl Tetramethylethylenediamide (TEMED) 
 
12% Running gel 
6 ml 30% Acrylamide-Bisacrylamide 
3.8 ml 1 M Tris HCl pH 8.8 
4.9 ml ddH2O 
150 µl 10% SDS 
150 µl 10% APS 
6 µl TEMED 
 
Native EMSA 6% PAA gel 
7 ml 30% Acrylamide-Bisacrylamide 
3.5 ml 5X TBE 
24.5 ml ddH2O 
175 µl 10% APS 
52.5 µl TEMED 
 
Coomassie staining solutions 
Staining solution 
5 g Coomassie Brilliant Blue R250 
100 ml Acetic acid 
450 ml Methanol 
Ad 1000 ml ddH2O 
 
Destaining solution 
100 ml Acetic acid 
450 ml Methanol 
Ad 1000 ml ddH2O 
 
Silver staining solutions 
Fixing solution 
50 ml Methanol 
12 ml Acetic acid 
100 µl 37% Formaldehyde 
Ad 100 ml ddH2O 
  
Thiosulfate solution 
20 mg Na2S2O3 x 5 H2O 
Ad 100 ml ddH2O 
 
Impregnator 
0.2 g AgNO3 
37 µl 37% Formaldehyde 
Ad 100 ml ddH2O 
 
Developer 
6 g NaCO3 
2 ml Thiosulfate solution 
50 µl 37% Formaldehyde 
Ad 100 ml ddH2O 
 
Stop solution 
1.86 g EDTA 





25 g Skim milk powder 
100 ml 10x TBS 
1 ml Tween 20 
Ad 1000 ml ddH2O 
 
Transfer Buffer 
15.1 g Tris base 
72.1 g Glycine 
750 ml MeOH 
Ad 5000 ml ddH2O 
 
Buffer III 
12.1 g Tris base 
5.8 g NaCl 
Adjust pH to 9.5 with NaOH 




5x DNA loading dye 
5 ml Glycerol 
200 µl 50x TAE buffer 
0.01 g Bromophenol Blue 
0.01 g Xylencyanol 







2.4.1. Common techniques 
Methods that represent state-of-the-art lab 
techniques, well-known and regularly 
performed by most members of the fields of 
molecular biology and microbiology, are 
summarized and referenced in the following 
Table 2. 
2.4.2. Cultivation of bacteria 
Unless otherwise stated, bacteria were grown at 
a temperature of 37°C, liquid cultures were 
placed on shakers and agitated at 200 rpm. 
Liquid B. subtilis cultures were inoculated from 
single clones on SP agar plates not older than 
three days, grown SP plates were stored at room 
temperature (RT). For experiments in minimal 
medium, unless otherwise stated, a single 
colony of B. subtilis from a complex medium 
plate was used to inoculate a complex medium 
preculture. A minimal medium preculture was 
then inoculated from this complex medium 
preculture. Finally, the main culture was 
inoculated from the minimal medium 
preculture. Growth in liquid media was 
measured by determination of the optical 
density at 600 nm (OD600), using the Amersham 
Ultrospec 2100 pro photo spectrometer or the 
Synergy MC platereader (Commichau et al. 
2015b; Sambrook et al. 1989). 
2.4.3. Storage of bacteria 
For storage over several days to weeks, plates 
with E. coli cells were stored at 4°C, those with 
B. subtilis cells were stored at RT in the dark. For 
long-term storage, cells were resuspended in 
medium containing 10% (v/v) DMSO and stored 
at -80°C (Commichau et al. 2015b). 
2.4.4. Harvest and washing of cells 
For volumes lower than 50 ml, the Kendro 
Biofuge primo R was used with 5000 rpm for 
6 minutes. For volumes between 50 and 500 ml, 
Sorvall RC6 plus was used at 5000 rpm for 
15 minutes. Lysozyme treated B. subtilis cells 
were centrifuged for 2 minutes at 13,000 rpm 
using the Kendro Biofuge primo R to pelletize 
the protoplasts and keep the cell wall fragments 
in solution.  E. coli cells were harvested using the 
same centrifuges at 5000 rpm for 15 minutes. 
 
 
Table 2: Common techniques used in this work. 
Method (alphabetical order) Reference 
Absorption measurement Sambrook et al. 1989 
Coomassie staining of protein gels Fazekas de St Groth et al. 1963 
Ethidium bromide staining of DNA gels Sambrook et al. 1989 
Gel electrophoresis of DNA Sambrook et al. 1989 
Gel electrophoresis of proteins (SDS PAGE) Laemmli 1970 
Ligation of DNA fragments Sambrook et al. 1989 
Plasmid preparation from E. coli Sambrook et al. 1989 
Precipitation of nucleic acids Sambrook et al. 1989 
Protein quantification via Bradford assay Bradford 1976 
Sequencing according to the chain termination method Sanger et al. 1977 
Sequencing according to the Solexa/Illumina method Bentley et al. 2008 
Silver staining of protein gels Merril et al. 1981 
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2.4.5. DNA manipulation and strain 
construction 
DNA manipulation and strain construction was 
carried out as recently described (Commichau et 
al. 2015b; Rosenberg et al. 2016). Insertion and 
deletion cassettes were constructed using the 
Long Flanking Homology (LFH) PCR method 
(Wach 1996). Primers, templates and vectors 
used are described in the results part and listed 
in the appendix. PCR products and plasmid DNA 
up to a fragment length of 1000 bp were 
sequenced by Seqlab Sequence Laboratories 
Göttingen (Germany) using the Sanger 
sequencing method. Whole Genome Sequencing 
(WGS) was performed by the Göttingen 
Genomics Laboratories (G2L, Germany) 
according to the Illumina method. 
2.4.6. Protein expression and 
purification 
Recombinant expression in and purification of 
Strep-tagged proteins from E. coli were 
performed as recently described (Rosenberg et 
al. 2016; Commichau et al. 2015b). Briefly, genes 
encoding proteins of interest were amplified in 
a PCR reaction and cloned into the respective 
overexpression vector (pGP172, pGP574 or 
pET-SUMOadapt) in E. coli DH5α. Single clones 
were isolated and sequenced. Checked 
constructs were used to transform 
E. coli BL21(DE3), which then carried a plasmid 
with the gene encoding the protein of interest 
under a conditional promoter. Overexpression 
of recombinant proteins was performed in 
liquid LB medium at 37°C by addition of IPTG 
after the cells reached an OD600 of 0.6-0.9 for 1-
3 hours. The ideal duration of induction was 
tested for each individual construct. Cultures 
were harvested by centrifugation, the pellet was 
washed in Buffer W and stored at -20°C for later 
use. For purification, pellets were resuspended 
in Buffer W and cells were disrupted using the 
French Press method with 18,000 psi using the 
French Pressure Cell Press. Cell debris was 
pelletized by centrifugation and the cell-free 
crude extract was passed through a Strep-Tactin 
Sepharose column, the column bed volume (CV) 
depended in the construct. The column was 
washed with 10 CV of Buffer W and proteins 
were eluted three times by addition of first 0.5 
CV and then twice 1 CV of Buffer E. Expression 
and purification of the proteins were visualized 
using SDS PAGE and Coomassie straining. 
Protein amounts were measured using the 
Bradford assay. The used constructs, duration of 
induction and protein amounts are mentioned 
in the results part.  
2.4.7. Bacillithiylation assay 
To identify bacillithiylated proteins, a 
previously published protocol was applied (Chi 
et al. 2013). Strains were grown in 30 ml C Glc 
minimal medium with 0.1 µM PL to an OD600 of 
0.4 at 37°C. Then the cultures were washed, split 
and resuspended in 30 ml C Glc minimal 
medium. One of the resulting cultures was 
supplemented with 0.1 µM PL. Both cultures 
were grown to an OD600 of 0.5 and 2 OD600-1 ml 
of the cultures were centrifuged and the pellets 
were stored at -20°C. For analysis of the 
bacillithiylated proteins the pellets were 
resuspended in 45 µl LD Buffer and incubated 
for 1 hour at 37°C to digest the cell wall. 
Subsequently the samples were frozen at -20°C 
for 3 hours and thawed to lyse the cells. Protein 
amounts were measured using a Bradford assay 
and an equivalent of 15 µg protein was 
subjected to SDS-PAGE. The protein bands were 
then blotted onto a MeOH-activated PVDF 
membrane, using a semi dry procedure (60 
minutes at 80 mA in Transfer Buffer), which 
subsequently was blocked with Blotto 
overnight. The membrane was incubated with a 
specific antibody (rabbit  anti-BSH-tagged 
proteins, diluted 1:500 in Blotto, courtesy of 
Haike Antelmann) for 3 h (Chi et al. 2013). After 
washing with blotto and incubation with an 
anti-rabbit immunoglobulin G-alkaline 
phosphatase secondary antibody, the 
bacillithiylated proteins were visualized using a 
CDP detection system as described previously 
(Commichau et al. 2007). 
2.4.6. Strep-tagged protein 
interaction experiment (SPINE) 
Genes encoding proteins of interest were cloned 
into the respective expression vectors (pGP380 
or pGP382) using DH5α and single colonies 
were isolated and sequenced. Checked plasmids 
were used to transform B. subtilis 168 which 
would then synthesize the Strep-tagged version 
of the protein of interest.  A single clone of 
transformed B. subtilis 168 was used for the 
SPINE in liquid LB medium, which was carried 
out as previously described (Herzberg et al. 




encoding the Strep-tagged protein of interest 
were used to inoculate a 500 ml LB culture, 
which was grown to an OD600 of 1. The culture 
was then split into two 250 ml cultures. One 
culture was treated with 
4% paraformaldehyde/PBS to a final 
concentration of 0.6%, while the other was 
treated with the volume of PBS as control. After 
20 minutes incubation at 37°C, both cultures 
were harvested by centrifugation, pellets were 
washed in Buffer W. Both pellets were used to 
purify proteins as described in 2.4.6. Purified 
and co-purified proteins were visualized using 
SDS PAGE and silver staining, protein bands 
were sequenced by our cooperation partners at 
the University of Greifswald, Dr. Elke Hammer 
and Prof. Uwe Völker (UV) using GC MS/MS. 
2.4.7. Isothermal titration 
calorimetry (ITC) 
ITC experiments were carried out with an ITC 
200 microcalorimeter as previously described 
(Gundlach et al. 2015). All experiments were 
carried out with freshly purified and dialyzed 
protein. Exact buffer conditions and parameters 
are described in the figure legends.  
2.4.8. Size exclusion chromatography 
coupled multi-angle light 
scattering (SEC-MALS) 
SEC-MALS was performed as previously 
described (Rosenberg et al. 2015). Purified 
protein was analyzed in degassed buffer (20 mM 
Tris, 150 mM NaCl, 1 mM MgCl2) using an Äkta 
system with a S75 Superdex 10/300GL column, 
a miniDawn Treos multiangle light scattering 
system and an Optilab T-rEX RI detector. Data 
was analyzed with ASTRA version 6.1 software 
(Wyatt Technology). 
2.4.9. Bacterial two-hybrid assay 
(B2H) 
B2Hs were carried out to visualize interactions 
between two proteins of interest as previously 
described (Rismondo et al. 2015). Briefly, the 
genes encoding the proteins of interest were 
cloned into the vectors carrying the reading 
frames encoding the T18 or T25 domain of the 
Bordetella pertussis adenylate cyclase, fusing 
them to the reading frame either 5`or 3`of the 
gene (pUT18, pUT18C, p25-N, and pKT25). 
Cloning was performed using E. coli XL1-blue. 
Always one checked T25-fused version of the 
first and one T18-fused version of the second 
gene encoding a protein of interest were used to 
co-transform E. coli BTH101. After 
transformation, the cells were dropped onto a 
plate containing X-Gal and cells containing 
plasmids encoding interacting proteins turned 
blue, because the domains of the adenylate 
cyclase were brought into close proximity and 
could produce cAMP, which would activate 
transcription of the reporter gene lacZ. As 
positive control, pKT25-Zip and pUT18C-Zip 
were used, because Zip is known to show a very 
strong self-interaction. The constructs used are 
mentioned in the results part. 
2.4.10. Crosslinking experiment 
Crosslinking experiments were carried out as 
described elsewhere (Rosenberg et al. 2015).  In 
short, purified protein was incubated in 
Buffer W containing different amounts of 
glutardialdehyde (GAL) for 1 hour at RT, the 
reaction volume being 20 µl. The reaction was 
stopped by addition of 4 µl of 200 mM Glycine. 
Afterwards, 6 µl of 5x Laemmli Buffer were 
added, the sample was cooked at 95°C for 
10 minutes and subjected to SDS PAGE with 
subsequent silver or Coomassie staining. 
Protein and crosslinker amounts and 
concentrations are depicted in the results part. 
2.4.11. Electrophoretic mobility 
shift assay (EMSA) 
EMSAs were carried out as described elsewhere 
(Rosenberg et al. 2016). DNA and protein 
amounts as well as used proteins are described 
in the results part. 
2.4.12. β-galactosidase reporter 
(LacZ) assay 
LacZ assays were carried out as described 
previously (Rosenberg et al. 2016). Briefly, 
strains carrying the constructs of interest were 
grown in minimal medium to an OD600 of 0.5-0.8 
and then harvested by centrifugation. Pellets 
were stored at -20°C. For analysis, the pellets 
were resuspended in LD Buffer and lysed at 
37°C for 1 hour. Cell debris was removed by 
centrifugation and the reaction with ONPG was 
performed at 28°C until the samples showed 
visible yellow coloration, which was followed by 
addition of Na2CO3 to stop the reaction. 
Absorption at 420 nm was measured and the β-
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galactosidase activity was calculated according 
to the formula: 
𝑂𝐷 420 𝑛𝑚
(∆𝑇 𝑂𝐷 595 𝑛𝑚)
 2005.3475. 
The OD 595 nm represents the absorption at 
595 nm as measured in the Bradford assay with 
the remaining crude extract. Growth conditions, 
used strains and constructs are described in the 
results part. 
2.4.13. Drop dilution assay 
Drop dilution assays were carried out as 
described elsewhere (Rosenberg et al. 2017b). 
In short, single clones of the strains of interest 
were picked from fresh SP plates and used to 
inoculate the precultures as described above. 
After incubation, the cells were again washed 
twice and resuspended in C Glc to an OD600 of 1. 
From these cultures, serial dilutions were made 
at steps of 1 to 10. 5-10 µl of these dilutions 
were then dropped on minimal medium plates. 
For drop dilution assays under conditions in 
absence of vitamin B6, the cells from the 
preculture were washed in C Glc twice and 
incubated at 28 or 37°C for at least one hour to 
dilute the remaining vitamin B6. Strains and 
dilutions are depicted in the results part. 
2.4.14. Coevolution of mutually 
dependent strains 
Strains of interest were picked from fresh SP 
plates and inoculated together as cocultures and 
as control as single cultures. Cultures were 
incubated at 37°C and passaged in different 
intervals mentioned in the results part. To 
distinguish the strains, they were regularly 
plated on plates containing antibiotics and when 
needed they were isolated and genomic DNA 
was used for amplification of the constructs of 
interest by PCR and Sanger sequencing by 
Seqlab. 
For coevolution on minimal medium plates, the 
strains were streaked out on plates either next 
to each other to allow diffusion of the 
metabolites though the agar, or they were plated 
as a mixed culture to allow direct cell-to-cell 
contact. When the strains were plated next to 
each other, a negative control with a stripe of 
medium cut out between the strains was done as 
well as a positive control with the exchanged 
metabolites externally applied to the medium. 
Plates were incubated at 37°C. 
2.4.15. Fluorescence microscopy 
Fluorescence microscopy was performed with a 
Zeiss Axioskop 40 with 100x magnification 
using a HXP 120 light source. YFP and GFP were 
visualized using filter sets F36-528 and 37, 
respectively. Cells were cultivated in the dark 
prior to analysis. Pictures were analyzed with 





3.1. A toxic pathway 
Vitamin B6 is thought to be essential to all 
known forms of life due to its involvement in 
many crucial and some essential enzymatic 
functions of the cell (Percudani, Peracchi 2003, 
2009). However, vitamin B6 is also known to be 
toxic at concentrations above a certain 
threshold because it interacts with metabolites, 
which can lead to deamination and with 
proteins, partly inactivating them (Vermeersch 
et al. 2004; Dong, Fromm 1990; Ohsawa, 
Gualerzi 1981; Metzler, Snell 1952; Shanbhag, 
Martell 1991). Furthermore, it has been shown 
that 4HTP, an intermediate of the DXP-
dependent pathway, is toxic and that B.  subtilis 
can adapt to this by resistance mechanisms 
involving proteins of threonine biosynthesis 
(Commichau et al. 2015a; Rosenberg et al. 
2016). Of course, these detrimental effects of the 
vitamin itself and of at least one intermediate of 
the pathway are one reason for the lack of an 
existing production strain for this valuable 
compound. Taken the fact that a profitable 
fermentative production would require the 
production of approximately 10 g l-1 vitamin B6 
(25 mM), the product resistance is one of the 
major obstacles of fermentative production 
(Rosenberg et al. 2017a). In this work, the 
mechanisms of resistance are investigated. 
Ultimately, the understanding of the 
mechanisms of sensitivity should help us to 
uncover the so far unknown interactions of 
vitamin B6 and its biosynthetic pathways with 
the rest of the cell in both, heterologous and 
endogenous environments. 
3.1.1. The 4-hydroxythreonine 
resistance protein ThrR 
As described above and in the introduction 
(1.3), 4HTP is toxic to B. subtilis cells. This was 
found, when the DXP-dependent pathway was 
expressed and 4HTP was fed to the cells to 
enhance the production of PN. The resistant 
mutants (e.g. BV708) had detrimental 
mutations in the loci of the branched chain 
amino acid transporters BcaP and YbxG and an 
activating mutation in the promoter of the 
threonine biosynthetic operon consisting of 
hom, thrB, and thrC (Commichau et al. 2015a). 
Interestingly, similar mutations in the promoter 
region of the hom operon (Phom) had been 
observed in a study that investigated 
suppressors overcoming isoleucine auxotrophy 
(Vapnek, Greer 1971b, 1971a). The so called spr 
pseudo-revertants overcame the lack of the 
threonine dehydratase IlvA by enhanced 
expression of the hom operon, leading to the 
unmasking of a minor threonine dehydratase 
activity of ThrC. Some of these mutations were 
located in Phom and others were detrimental 
mutations in the putative regulatory protein 
encoding thrR gene. ThrR is an ACT-domain 
containing protein, which was therefore thought 
to be a regulatory protein with a possible small 
molecule effector (see 1.4.4). It was also 
previously shown that Phom contained a CodY-
responsive element, which could indicate an 
interesting competitive or synergistic 
regulation by these two (putative) regulators 
(Belitsky, Sonenshein 2013). Previous works in 
this lab had investigated, whether the protein 
ThrR was a regulator of the hom operon and 
found that it indeed bound to the promoters of 
hom and thrD, aspartokinase III (Rosenberg et 
al. 2016). Furthermore, the existing EMSAs and 
LacZ assays suggested that threonine was an 
effector of the ThrR activity, which would make 
sense, because this would establish a feedback 
inhibition loop leading to the inhibition of 
threonine synthetic genes when threonine is 
abundant. As part of this work, this regulatory 
relationship between threonine and other 
amino acids and ThrR and its regulatory activity 
on the hom operon was investigated. 
It was known that ThrR can bind DNA 
suggesting that it would oligomerize in the 
manner that many DNA-binding proteins would 
do. To visualize this oligomerization in solution 
and in vitro, the purified protein was subjected 
to SEC-MALS and a crosslinker experiment. The 
ThrR protein was overexpressed in E. coli BL21 
(DE3) from the existing plasmid pBP323 
encoding the N-terminally strep-tagged version 
(Rosenberg et al. 2016). The cultures were 
grown to an OD600 of 0.8 and were induced by 
addition of IPTG for 3 hours at 37°C. 
Subsequently, the protein was purified by 
affinity chromatography using a strep-tactin 
Sepharose matrix and elution with 
desthiobiotin.  Figure 5 shows that ThrR forms 
tetramers in solution and dimers in vitro, 
suggesting the existence of a dimer of dimers. It 
however remains unknown, which of the 




of DNA binding. In the following, existing EMSAs 
of purified, strep-tagged ThrR with wildtype 
Phom and addition of threonine were repeated 
and in contrast to the previous results they 
showed no effect of threonine on the DNA 
binding capability (Figure 6A). Furthermore, the 
suppressor mutations C26T and T9C (from spr8 
and BV708, respectively) in the promoter 
regions did show an influence on the expression 
of the hom operon and on the binding capability 
of ThrR in previous experiments. But again, in 
contrast to this the new data did not show any 
effect on the capability of ThrR to bind to its 
operator (Figure 6B). 
 
 
Figure 5: ThrR likely forms a dimer of dimers. (A) 
SEC-MALS was performed with purified strep-tagged 
ThrR. RIU stand for the differential refractive index 
units. The peak eluting at ~15 ml represents a size of 
~80 kDa, which corresponds to a tetramer of the 
strep-tagged ThrR. No dimers were observed in this 
experiment. (B) The crosslinking experiment was 
carried out with the same batch of protein after SEC 
and showed a distinct band at ~18 kDa in the 
absence of GAL and an additional band at 35 kDa in 
presence of the crosslinker. This size corresponds to 
a dimer. No tetramers could be detected in this 
experiment, possibly due to the cooking step in the 
protocol. A 12% PAA, SDS gel with 1kb ladder was 
subjected to PAGE and strained with Coomassie as 
described in the methods section. 
These data indicated that the regulation by ThrR 
might either not be dependent on threonine, or 
that the in vitro approach was not suitable to 
show this relation because an adapter protein or 
second effector was necessary to convey the 
regulatory effect. To assess whether ThrR was 
directly binding threonine, an ITC experiment 
was performed with ThrR in combination with 
threonine and its catabolic product 
2-oxobutanoate (2-OB) (Figure 7, 2-OB not 
shown). These data showed no evidence for any 
interaction between the protein and its 
suspected effector threonine or 2-OB, leaving 
only the conclusion that the effector must be a 
different small molecule or a protein, which 
itself might bind threonine. 
 
Figure 6: The DNA-binding ability of ThrR is not 
threonine-dependent. (A and B) EMSAs were 
carried out with purified, strep-tagged ThrR 
expressed from pBP323. In all conditions with 
DNA, Phom (amplified with primers MT24/MT25) 
and PnrgA (negative control, amplified with primers 
CD1/CD2) were added to a final amount of 1 pmol. 
The negative control was always added to the 
reactions and run on the same gel but was cut out 
to save space; no shift of the negative control was 
observed in any of the experiments conducted. 
The reaction volume was 20 µl. (A) Phom shifts with 
addition of 6 pmol of purified protein, regardless 
of the mutations in the promoter sequence. (B) 
EMSAs in the presence and absence of 0.5% 
threonine (Thr). The control shifts at 
approximately 2 pmol ThrR, which is earlier than 
in A. This is likely due to the use of newly purified 
protein and promoter DNA batches and the error 
margin of the Nanodrop and Bradford 
quantification. However, the addition of threonine 





This lead to the hypothesis that not threonine, 
but a compound up- or downstream in the 
biosynthetic pathway (see 1.4.4) was the 
effector of ThrR. First, the transcriptional 
activity of Phom in the presence of members of the 
aspartate derived amino acids pathway 
(aspartate, homoserine, threonine, isoleucine, 
and valine) as well as other amino acids that 
might be regulatorily related to this pathway 
(serine, glycine, tryptophan, phenylalanine, 
lysine, cysteine, and methionine) was tested. To 
avoid toxic effects of the amino acids and by that 
a bias on the LacZ assay, the highest non-toxic 
concentrations of the amino acids for strain 168 
were tested in growth experiments in CSE Glc 
medium (Figure S 1 and Figure S 2 ,Table 3). 
Notably, the threonine concentration that was 
used for previous LacZ assays was considerably 
higher than the identified highest non-toxic 
concentration (0.5% compared to 0.004%, 
respectively), which could explain the deviation 
of the results and is in good agreement with 
previous studies (Belitsky 2015; Lamb, Bott 
1979a, 1979b). The identified concentrations 
were used to analyze the transcriptional activity 
of Phom in vivo using LacZ assays. As depicted in 
(Figure 8A), many added amino acids had no 
strong effect on the transcriptional activity of 
Phom. However, the transcriptional activity of 
Phom was strongly inhibited by CAA, which acted 
as a positive control. Furthermore, homoserine 
and isoleucine had an inhibitory effect, lowering 
the activity to approximately 50%.  
Table 3: Maximal non-toxic amino acid 
concentrations in CSE Glc medium.  
Homoserine is a precursor of threonine and the 
product of Hom and Isoleucine is a downstream 
product of the same pathway, which can be won 
out of homoserine via threonine and 2-OB. 
Interestingly, the opposite effect was observed 
for lysine and cysteine, addition of which lead to 
a 2-3x upregulation of the operon. Lysine has 
previously been shown to induce thrD, which 
taken together with the new data could indicate 
a positive regulation of the complete aspartate 
derived amino acid pathway by lysine, diverting 
the aspartate derived metabolites from the 
diaminopimelate pathway into its direction. The 
regulation by cysteine, however, remains 
mysterious (see Figure 8). Next, the effect of 
ThrR and CodY on the regulation of Phom was 
analyzed. Figure 8B shows that the deletion of 
codY alone lowered the transcriptional 
repression of Phom by isoleucine. The deletion of 
thrR on the other hand lead to a deregulation of 
 
Figure 7: ITC of 10 µM ThrR with 
150 µM threonine in reaction buffer (20 mM Tris, 
150 mM NaCl, 1 mM MgCl2). Injections of 14 µl of 
ligand solution with 1 µl s-1 and 300 seconds 
spacing at 20°C, a reference power of 12.5 µcal s-1 
and 500 rpm stirring. The experiment showed no 
saturation curve and the amplitude of the peaks 
indicates no other than water-solvent interactions. 





















Phom in absence of any added amino acid (except 
glutamate) and in presence of homoserine and 
isoleucine (separate and in combination), 
cysteine, and threonine. The latter again showed 
no influence at all on the promoter activity, 
supporting the previous findings of this study.  
 
Figure 8: Activity of Phom in wild type and mutant 
background with addition of amino acids. (A and 
B) Cells were grown in CSE Glc medium 
(containing glutamate) with addition of the named 
amino acids (three-letter-code, homoserine: H-
Ser). Each dot represents one independent 
biological replicate, bars represent means of 
those. Wild type values of A and B are partly 
identical and from the same experiment. (A) The 
activity of Phom is lower in the control condition 
with CAA, indicating a functional reporter system. 
Otherwise, homoserine and isoleucine inhibit 
activity while lysine and cystine enhance it. (B) 
Phom is deregulated in the thrR mutant background, 
double mutants of thrR and codY behave the same 
except for conditions with isoleucine, where the 
mutations exhibit an additive effect. In the 
codY mutant background, repression by isoleucine 
is reduced. 
However, the presence of isoleucine and/or 
homoserine still inhibited transcription in the 
thrR codY double mutant indicating additive 
inhibition by these regulators and an additional 
regulatory mechanism. Neither the deletion of 
codY, nor of thrR influenced the upregulation by 
lysine, indicating that its presence completely 
inhibited ThrR or it already activated the 
promoter to its maximum by a different 
mechanism. Furthermore, double deletion of 
codY and thrR had no additive effect on 
transcriptional regulation except for the 
condition with isoleucine. This and the lowered 
regulation in the codY single mutant suggest that 
the regulation by isoleucine is conveyed via 
CodY. Subsequently, the interaction of lysine 
and cysteine with ThrR was tested with the help 
of an ITC experiment. The experiment with 
lysine showed no interaction with ThrR (data 
not shown), while the experiments with 
cysteine showed ambiguous results depending 
on the absence or presence of a reducing agent 
(Figure S 3). Furthermore, the influence of 
isoleucine and homoserine on DNA binding of 
ThrR was tested in additional EMSAs, but also 
showed no influence. These investigations gave 
no evidence for the interaction of ThrR with any 
of the tested amino acids despite the obvious 
regulatory effects on the target.  
 
Figure 9: ThrR and CodY do not interact in a B2H. 
N- and C-CodY or ThrR mean that the adenylate 
cyclase domains T25 and T18 are fused to the N- 
or C-terminal end of the proteins, respectively. 
ThrRΔ and CodYΔ are variants lacking the DNA-
binding domains. Only self-interactions could be 





As mentioned earlier, an alternative working 
hypothesis was that ThrR is not itself binding an 
effector but that it is regulated by a protein, 
which integrates the effector availability and 
passes the signal on. It had been described that 
Phom is also bound by CodY, which made this 
protein a valid candidate for the interaction, 
although the LacZ assays suggested otherwise. 
 
Figure 10: BirA could not be confirmed as a 
potential interaction partner. (A) A SPINE was 
performed with plasmid pBP620 in strain 168, the 
picture shows a silver stained SDS gel of the 
samples after cooking. Elution fractions one to 
three (E) were applied to the gel. The lower band 
at ~18 kDa corresponds to ThrR, the band at 
~25 kDa was cut out and analyzed by cooperation 
partners in Greifswald and turned out to be BirA. 
(B) A B2H with BirA and ThrR. C- and N-BirA or 
ThrR stand for C- or N-terminally attached 
adenylate cyclase domains. Both proteins show 
strong self-interaction in this B2H but again no 
interaction with each other. 
A B2H was performed investigating the 
interaction between CodY and ThrR. We tested 
the full-length proteins and truncated versions 
lacking the DNA-binding activity, to avoid polar 
effects and false positives in the host E. coli 
(Slack et al. 1995). In the process, plasmids 
pBP600 to pBP615 were constructed carrying 
the full-length and truncated versions of both 
proteins in the four B2H plasmid backbones 
pUT18, pUT18C, pKT25 and p25-N. As shown in 
Figure 9, both CodY and ThrR interact with 
themselves but not with each other in this assay. 
For CodY the self-interaction is independent 
from the truncation which is not surprising 
because the truncation is very small. In the case 
of ThrR, the self-interaction of the truncated 
version is strongly reduced, indicating an 
involvement of the DNA-binding domain, which 
has been completely removed. The self-
interaction of ThrR complements the 
crosslinking and SEC-MALS data that showed a 
multimeric complex. In the following, an 
untargeted approach was chosen to take all 
possible interactions into account. A SPINE was 
performed with ThrR. In the process, the two 
genes encoding the full-length versions and the 
truncated CodY and ThrR were introduced into 
the SPINE vectors pGP380 and pGP382 yielding 
plasmids pBP616 to pBP623. Figure 10A shows 
the silver-stained SDS gel of the experiment with 
the N-terminally tagged version of ThrR. The 
band at ~25 kDa was cut out and the protein 
was analyzed via GC MS/MS by cooperation 
partners in Greifswald (Table 4). BirA was 
clearly the most abundant protein and also 
much more abundant in the samples without the 
crosslinker formaldehyde (FA), which could 
indicate a specific interaction between BirA and 
ThrR (Herzberg et al. 2007).  
Table 4: Proteins in the investigated gel piece 
identified by mass spectrometry (Cooperation 







birA|BSU22440| 36 kDa 41 11 
rok|BSU14240| 22 kDa 7 
 
rpsC|BSU01220| 24 kDa 5 6 
yceC|BSU02890| 22 kDa 3 2 
yceE|BSU02910| 21 kDa 2 2 






The interaction between these two proteins was 
peculiar, since BirA is a trigger enzyme involved 
in biotin and not amino acid metabolism. It acts 
as the essential biotin ligase transferring the 
cofactor to the ACCase subunit AccB and at the 
same time as a repressor for the biotin 
biosynthetic bio operon in presence of a surplus 
of biotin. However, biotin is bound to lysine in 
its target proteins and lysine has been shown to 
regulate the target of ThrR above. This might 
indicate a role in the recycling of lysine from 
biotinylated proteins as has been described in 
Enterococcus faecalis (Koivusalo et al. 1963). A 
B2H to investigate the interaction between full-
length BirA and ThrR was performed. Most 
plasmids for this study were present, however 
two versions of the birA plasmids were not 
available yet, so it was cloned into pUT18 and 
p25-N producing plasmids pBP624 and pBP625. 
The experiment yielded no evidence for an 
interaction between the two proteins (Figure 
10B), but only strong self-interactions for both 
proteins. 
To conclude, ThrR is a regulator of the threonine 
synthetic hom operon, but the mechanism of 
regulation and possible effectors remain 




3.1.2. Adaptation to toxic amounts of 
pyridoxal 
As previously introduced, vitamin B6 can be 
toxic due to its reactivity, which naturally poses 
a problem for an industrial production by 
fermentation. It is to date unknown, whether PL 
is as toxic as the phosphorylated PLP and 
whether the toxicity takes effect only inside the 
cell or also at the membrane or cell wall. To 
elucidate this, it is imperative to find the yet 
unknown importers and exporters of the B6 
vitamers and the dedicated phosphatases, 
which ensure retention of the imported 
vitamers (see 4.5). It was hypothesized that 
cultivation of B. subtilis in presence of toxic PL 
amounts would lead to the emergence of 
suppressor mutants which mutated the 
unknown import systems for the B6 vitamers, 
the B6 kinase encoding pdxK gene or deregulate 
the unknown phosphatases. The identification 
of the unknown transporter systems could help 
the construction of a versatile production strain 
circumventing toxicity by either accomplishing 
product resistance or changing cultivation and 
production conditions to avoid accumulation of 
a toxic product. Here, the toxicity of vitamin B6 
for B. subtilis and its mode of action were 
investigated.  
First, the inhibitory concentration for growth of 
the B. subtilis wild type strain SP1 was 
determined.  
 
Figure 11: Growth of B. subtilis SP1 is inhibited by 
millimolar amounts of PL. Cells were grown in 
C Glc medium supplemented with no to 4 mM PL 
and incubated at 37°C with agitation. In absence of 
externally added PL, the cells proliferate normally, 
while already addition of 1.5 mM PL slows growth 
down and 3 mM PL inhibit growth completely. 
Values are means of technical triplicates.    
As depicted in  Figure 11, SP1 was grown in 
minimal medium containing different amounts 
of pyridoxal (PL). 1.5 mM PL were detrimental 
for growth of the strain, and 3 mM PL 
completely inhibited growth. Subsequently, 
different amounts of strain SP1 were spread on 
minimal medium with and without toxic 
amounts of PL. As shown in Figure 12, SP1 
formed suppressor mutants resistant to 
3 mM PL and which themselves and formed 
satellites. When two suppressors and a group of 
satellites were transferred to fresh minimal 
medium with 3 mM PL, the suppressors could 
grow normally but the satellites formed new 
suppressors.  Moreover, the clones formed by 
the satellites predominantly grew in proximity 
of the suppressors (Figure 12). Two suppressor 
clones were picked, streaked out under the 
same conditions and they were designated as 
BP924 and BP925. To check, whether the 
resistant strains grew better than the SP1 wild 
type, a growth experiment in liquid minimal 
medium and a drop dilution experiment with 
and without toxic amounts of PL were carried 
out. In the experiment in liquid medium also PN 
was tested in order to verify the reports that PN, 
in contrast to PL, is not a toxic vitamer (Prunetti 
et al. 2016).  
 
Figure 12: B. subtilis SP1 forms suppressor 
mutants on C Glc minimal medium containing 
3 mM PL. Interestingly, satellite colonies arise 
around the suppressors. The suppressor mutants 
(1 and 3) can be restreaked on minimal medium 
containing 3 mM PL, but the satellite colonies (2) 
themselves form suppressors and can be fed by 
the suppressors. This indicates that the resistant 
clones secrete something that allows the satellites 
to grow. Numbers on the left depict plated cells. 
The inlay is a magnification of the plate with 
3 mM PL and 5x107 cells, from where the 





Figure 13: PL is toxic, while PN is not and the 
suppressor mutants are more resistant than SP1 
on solid medium, but not in liquid medium. (A and 
B) Strains were grown in C Glc minimal medium 
with addition of different amounts of PN and PL. 
Values are means of technical triplicates. (A) PN 
has no effect on growth of SP1 up to a 
concentration of 10 mM, indicating that this 
compound is not toxic. (B) In liquid medium, no 
difference of growth is observable between the 
suppressor mutants BP924, BP925 and SP1 
(black). All strains grow normally without PL, are 
impaired in growth with 2 mM and completely 
stop growth in presence of 4 mM PL. (A and B) 
Values are means of technical triplicates. (C) Drop 
dilution assay of SP1, BP924 and BP925 on solid 
C Glc medium with and without 3 mM PL. All 
strains grow the same on C Glc minimal medium 
but the suppressors BP924 and BP925 grow better 
on 3 mM PL. Cells were resuspended to an OD600 of 
1 and serial dilutions were made in 10-1 steps, the 
highest dilution being 10-5. 10 µl of each dilution 
was dropped onto the plate. 
Figure 13 shows that PN indeed has no toxic 
effect even when present in concentrations up 
to 10 mM. Furthermore, the suppressor mutants 
grew better than the wildtype on solid minimal 
medium with 3 mM PL, but showed no 
enhanced resistance in liquid medium. This 
difference might be related to the ability to form 
satellites and the different diffusion conditions 
in liquid medium compared to solid agar plates. 
The genomic DNA of BP924 and BP925 was 
isolated and subjected to illumina sequencing by 
the Göttingen Genomic Laboratory (G2L). The 
strains acquired a point mutation in the 
promoter of the biotin biosynthetic operon 
(PbioW) 96 bases upstream of the bioW start 
codon, in the sublancin 168 exporter encoding 
gene sunT and in a non-coding region 24 bases 
downstream of the tRNA (m7G46) 
methyltransferase encoding gene trmB (Table 
5).  
The mutation in sunT leads to a frame shift in the 
first third of the reading frame, very likely 
causing a non-functional protein. The expected 
consequence would be the lack of sublancin 168 
production and an accumulation of SunA, the 
precursor of the lantibiotic. The mutation 
downstream of trmB might very well be inside 
the terminator region and could have an 
influence on the expression of ytnP or malS, 
which are both located downstream without 
additional terminators. Furthermore, according 
to expression data, a terminator sequence is 
located inside the trmB reading frame. This 
could mean that the mutation has influence also 
on the expression of trmB itself due to the 
strengthening or weakening of a premature 
termination during transcription. Lastly, the 
mutation in PbioW, which has been found in both 
isolated suppressors indicated that the amount 
of biotin synthesizing proteins might have an 
influence on the resistance to PL.
Table 5: Mutations acquired by PL-resistant clones. 
Gene Position* Sequence change 
BP924 





PbioW 3,095,526 A96G 
TtrmB 3,059,523 ΔT24  





To check the PbioW and TtrmB mutations, the 
promoter and terminator sequences of the wild 
type SP1 and the suppressors were fused to the 
lacZ gene constructs to assess the influence on 
transcription. The promoter of the bio operon 
was introduced into the vector backbone pAC7, 
producing pBP627 and pBP630 with the wild 
type and mutated promoter sequence, 
respectively. The  wild type and mutated 
putative terminator of trmB was introduced into 
pAC6 with addition of the constitutive promoter 
Pa 5’ of the terminator sequence and the 
resulting plasmids were designated pBP628 and 
pBP631, respectively (Gundlach et al. 2017). 
The constructs were used to transform B. 
subtilis SP1 and recombination was confirmed 
with an amylase test on starch agar, resulting in 
strains BP968, BP969, BP971, and BP972. The 
LacZ assays revealed that the mutation 
downstream of trmB had no influence on the 
expression of the reporter. However, the 
mutation in PbioW had a strong deregulatory 
effect (Figure 14). This indicates that a stronger 
expression of the biotin synthesizing enzymes 
has a protective effect. It was unclear whether 
this mutation was beneficial because the cells 
were lacking biotin under high PL stress or 
whether they needed the proteins for a different 
function, e.g. to bind large amounts of PL to 
lower the concentration of vitamers in solution. 
It was also possible that the bio operon was 
repressed by PL or that the repressor BirA was 
regulated by PL. To check the latter hypothesis, 
another reporter fusion was constructed with 
the birA promoter in pAC7, giving pBP629. The 
plasmid was also used to transform SP1, 
resulting in strain BP970. Strains BP968 to 
BP972 were grown in presence of low 
concentrations of PL and the highest non-toxic 
concentration of isoniazid (IA), a B6 antagonist 
that depletes vitamin B6 from the cytosol, and 
the β-galactosidase activity was measured. The 
toxicity of isoniazid was tested in a previous 
experiment (Scherr, Rafelson 1962) (Figure S 4). 
However, the activity of PbirA was very low and 
the addition of 10 µM PL or IA had no influence 
on the expression of any of the promoters (data 
not shown). It was unknown what effect toxic 
amounts of PL would have on the expression. 
This condition was tested as part of a master 
thesis by Oğuz Bolgi and showed, that the 
addition of toxic amounts of PL had a 
deregulatory effect on PbirA and an inhibitory 
effect on PbioW, indicating that the expression of 
the repressor of the bio operon was enhanced 
under these condition, leading to a detrimental 
inhibition of biotin synthesis (Bolgi 2017).  
 
Figure 14: A mutation in the promoter region of 
bioW leads to deregulation of the promoter. (A) 
Scheme of the promoter sequence and annotated 
features. The -35 and -10 regions of PbioW are 
shown bold and with grey background. The 
underlined bases are the putative BirA binding 
site (bio operator, bioO), which was determined by 
sequence similarity with the described bioO from 
E. coli (Bower et al. 1996) and the ribosomal 
binding site (RBS). The identified mutation is 
shown in bold with an asterisk. (B) β-
Galactosidase activity assay with the wildtype and 
mutated sequences of PbioW and TtrmB, showing that 
the mutation in the terminator region has no effect 
on expression of the marker gene, while the bioW 
promoter is approximately 4x more active in 
presence of mutation A96G. Dots are independent 
biological replicates, bars are the means of those. 
Taken this hypothesis, external addition of 
biotin should also allow for growth with 
3 mM PL. Therefore, SP1 was plated on minimal 




acids (CAA) were placed on the same plate. CAA 
served as a positive control because it has been 
previously described that PL interacted with 
amino acids, which should lower the amount of 
PL in solution and thus its toxicity (Choi 2015). 
Also as part of the mentioned master thesis, it 
could be shown that the external addition of 
CAA or biotin has a protective effect in solid and 
liquid medium with addition of toxic PL 
amounts, supporting the work hypothesis (Bolgi 
2017). 
Summarizing it can be said that B. subtilis can 
grow in presence of 3 mM PL with the external 
addition of either amino acids or biotin; or 
mutations deregulating the biotin synthesizing 
protein encoding genes. This connection 
between the two vitamins is completely novel 
and might indicate an unknown regulatory 




3.2. Optimization of B6 production 
by targeted evolution 
As introduced and shown previously, the 
fermentative production of vitamin B6 was until 
now not possible due to obstacles mainly related 
to pathway and product toxicity. The reasons for 
this were still under investigation and even if we 
knew everything about the interference 
between host and heterologous pathways, the 
optimization would be a complicated genetic 
engineering process. Therefore, this task was 
given into the hands of evolution. To do so, an 
evolutionary pressure needed to be created 
forcing the strains to accumulate the desired 
mutations. The desired mutation targets were, 
of course, the genes conferring resistance to the 
metabolites and products of the pathway, but 
also the import and export, the channeling, and 
the modification of the related compounds. 
Little is known so far about B6 metabolism apart 
from the synthetic route and many targets of the 
cofactor (Rosenberg et al. 2017a). E.g. the 
bacterial transporters as well as related 
transcription factors have not been identified or 
characterized yet. Therefore, the desired 
approach should provide answers to two 
questions: (1) what do we need to do to 
optimize the production of vitamin B6, and (2) 
what are the yet unknown players in B6 
metabolism and related pathways? The 
methods presented here were to prove the 
principle and concept of the feeding 
experiments and should be used to scale the 
process up, e.g. through targeted evolution in 
multiwell plates and selection for speed of 
growth. 
3.2.1. Co-culture of mutually 
dependent B6 producers 
As described previously, the existing production 
strains for vitamin B6 have reached obstacles as 
the unbalanced expression of the synthetic 
genes and the toxicity of metabolites and 
products (see 1.3). As an approach to optimize 
the expression of the pathway genes and the 
modification as well as transport of the 
metabolites and to find novel interaction 
partners of B6 metabolism, the existing 
production strain was divided into several 
strains expressing partial pathways.  
 
Figure 15: Experimental design and proof-of-
concept of mutually dependent strains. (A) 
Combinations of mutually dependent strains 
exchanging the shown metabolites. All strains 
were constructed in a ΔpdxST background. No. I is 
a combination of BV606, which produces PN and 
BP901, which converts PNP to PLP. No. II is a 
combination of BP902, which produces 4HTP and 
can convert PNP into PLP and BV605, which can 
convert 4HTP to PNP.  No. III is a combination of 
BP900, which can produce 4HTP and BV609, 
which can convert 4HTP to PLP. (B) Proof-of-
concept. The strains were streaked out on C Glc 
minimal medium next to each other and 5 µl of a 
10 mM PL solution was dropped onto one side of 
the plate as an internal positive control (black 
dot). The combination of BV605 and BV604 serves 
as a negative control and these strains only grow 
near to the drop of PL. Both the wild type SP1 and 






Figure 16: Co-cultured strains 
exchanged genetic information. The co-
cultures were streaked out on SP plates 
containing antibiotics selecting for the 
specific strains and single clones were 
streaked on the SP plates shown in the 
figure, containing the depicted 
antibiotics (tetracycline, tet; 
spectinomycin, spc; chloramphenicol, 
cm; kanamycin, kan). When the 
cultures were streaked before the first 
passage, the strains could be separated 
from each other and could only grow on 
plates containing the antibiotics 
selecting for their respective resistance 
markers. After two passages however, 
the strains could not be separated 
anymore, and the clones could also 
grow on plates containing all 
antibiotics. This indicated that the 
strains acquired all B6 synthetic 
constructs recombining to BV606 
pBV415 after only two passages. 
 
These strains were all constructed in a ΔpdxST 
background making them B6 auxotrophs that 
could only live in coculture exchanging the 
metabolites and the product, PL. Figure 15A 
depicts the experimental design with the strain 
combinations exchanging different metabolites 
to thrive in minimal medium without external 
PL. The co-cultures of these strains were to be 
passaged to allow the strains to accumulate 
mutations beneficial for growth together. This 
way we would create evolutionary pressure 
towards the optimization of the pathway and 
possibly the transport of the metabolites. The 
strains were constructed using the existing 
production strain BV606 (ΔpdxST amyE::SC1 
sacB::SC2*) encoding the pathway genes epd, 
pdxB, serC (synthetic construct 2*, SC2*), pdxA, 
and pdxJ (synthetic construct 1, SC1), and the 
plasmid pBV415 carrying pdxH and the 
kanamycin resistance gene kan (Commichau et 
al. 2014). The resulting strains were BP900 
(ΔpdxST sacB::SC2*), BP901 (ΔpdxST pBV415),  
and BP902 (ΔpdxST sacB::SC2* pBV415). 
Furthermore the existing strains BV604 
(ΔpdxST), BV605 (ΔpdxST amyE::SC1), BV609 
(ΔpdxST amyE::SC1 pBV415) were used. The 
different constructs were transferred into the 
SP1 background using genomic DNA and 
successful transformation was checked on 
antibiotic plates also ensuring that only the 
desired constructs were transferred. Initial 
proof-of-concept experiments showed that the 
strains could indeed feed each other and live in 
co-culture on plates (Figure 15B). In the 
following the combinations I and III were 
inoculated from cryo-cultures as co-cultures in 
LB complex medium to an OD600 of 0.1 (0.05 per 
strain) and the cultures were passaged to an 
OD600 of 0.1 when grown. The combination of 
BV605 and BP900 served as a negative control 
because this combination lacks pdxH, the gene 
encoding the pyridoxine oxidase. The 
combination of BV606 pBV415 and BV604 
served as a positive control (Table 6).  
Table 6: Growth of co-cultures in complex medium. 
Values are the optical density at 600 nm measured 
after growth overnight (P0 and P1) and after 8 hours 
(P2). 
Culture P0 P1 P2 
I 1.3 2 1 
III 1.2 2.1 1 
Pos. Ctrl. 1.9 2.4 0.9 
Neg. Ctrl. 1.6 1.5 0.2 
All co-cultures grew to OD600 1-2 overnight, 
indicating that the medium or the cells 




P2 the negative control slowed down growth 
showing that the combination of mutually 
dependent strains allowed growth, while the 
combination of strains that lack one of the B6 
biosynthetic steps could not do so.  
 
Figure 17: B6 production test on C Glc minimal 
medium plates. Precultures of the used strains 
were mixed prior to drops were applied to the 
medium. Combinations I-III were tested. BV604 
was used as an indicator for B6 production (white 
circle). On all plates, the positive control 
BV606 pBV415 allowed growth of BV604. 
Combinations I and III also allowed growth of the 
same, I almost as strongly as the control. 
Combination II and the single strains did not allow 
for growth of BV604. 10 µl of the cultures were 
dropped onto the plate. 
The cultures were streaked out on antibiotic 
medium to separate and single out the strains 
before passaging. These plates showed that the 
strains had very quickly (latest after two 
passages) exchanged genetic information and 
exchanged the genes necessary for de novo 
synthesis of vitamin B6 (Figure 16). 
Additionally, the combinations I-III were 
dropped onto a plate with the auxotrophic 
BV604 to show the production of vitamin B6 on 
plate. BV606 pBV415 served as a positive 
control, the single strains as negative controls. 
The strains were grown in complex medium 
precultures overnight and then mixed before 
being dropped on the plate. As shown in Figure 
17, combinations I and III could feed the 
auxotrophic strain BV604, while combination II 
and the single strains could not do so. To check, 
whether this feeding is also due to genetic 
exchange as shown in the experiments in liquid 
medium, mixed cultures were picked and 
streaked onto SP medium with antibiotics 
selecting for all antibiotic markers of the 
constructs. Figure 18 shows that combinations I 
and III both formed single clones that could 
grow on those plates, indicating that also on 
plate, the strains rapidly exchange the genes for 
de novo synthesis of vitamin B6. 
 
Figure 18: Growth of combinations I and III on SP 
medium selecting for clones that combined all B6 
synthetic constructs by genetic exchange. 
Combination I showed clearly visible single clones, 
combination III showed several small single 
clones. 
Therefore, the observed growth of the strains in 
co-culture is likely not due to successful feeding, 
but due to the acquisition of the whole 
recombinant pathway necessary for the de novo 
synthesis of PLP. This, admittedly predictable 
behavior showed that B. subtilis has impressive 
capabilities to exchange genetic information in 
very short time. This fact is further investigated 
and optimized for usage as a transformation 
method in 3.3. It also showed that this approach 
could only be successful when the strains were 
stripped of the capability to take up DNA, 
preventing the recombination of the constructs. 




used strains by insertion of a phleomycin 
cassette. The cassette was first inserted into SP1 
using LFH, resulting in strain BP914. The 
construct was amplified using primers JR126, 
JR127, JR129, and JR130 as well as CZ126 and 
CZ127. Furthermore, the plasmid based pdxH 
construct was replaced by a genomic construct 
(described in more detail in 3.5.2). The pdxH 
gene from E. coli DH5α in combination with Pa, a 
synthetic, constitutive promoter (Gundlach et al. 
2017), was inserted into the aprE locus of SP1 
via a marker-less LFH giving strain BP911.
 
Figure 19: Non-competent consortia do not exchange genomic information but also cannot feed each other. (A) 
A scheme illustrating the strains in the different consortia and the metabolites they exchange. (B) OD600 of 
consortia and controls measured before passaging in a 24-hour interval. The consortia were inoculated as 
triplicates with 0.1 µM PL in passage 0, PL amount was halved with every passage. A 1-3 and C 1-3 originated 
from a previous experiment and were passaged twice before, BP915 served as negative control. The measured 
optical densities of the negative control as well as consortia A and B were lower with every passage except for A 
2, which grew like the positive controls A 4-6. The positive controls C 1-3 reached optical densities around 4 to 
12, C 4-6 reached higher optical densities with each passage. (C) Evaluation of consortium A 2 in comparison to 
A 5. Consortium A 2 could grow on C 2% Glc minimal medium independent of PL, while consortium A5 could 
not. The SP plates checking for antibiotic markers showed that neither consortium exchanged genetic 
information (no growth on SP tet spc cm PL, which allows growth only for strains with antibiotic markers of 
BP918 and BP919). Furthermore, consortium A 5 contains both strains BP918 (ΔpdxST::tet amyE::SC1 spc 
aprE::pdxH ΔcomG::phleo), which could grow on SP tet spc PL, and BP919 (ΔpdxST::tet sacB::SC2* cat 
ΔcomG::phleo), which was able to grow on SP tet cm PL. Consortium A 2 however, only consisted of BP918. No 




The successful integration was ensured by 
selection on C Glc minimal medium containing 
PN, which only allows growth in presence of 
PdxH. Due to the fact that the deletion of the 
comG operon would abolish the competence of 
the strains, the pdxH construct was first 
introduced yielding strains BP912 (ΔpdxST 
amyE::SC1 aprE::pdxH) and BP913 (ΔpdxST 
amyE::SC1 sacB::SC2* aprE::pdxH). Afterwards 
the deletion of comG was transferred to the 
target strains. The resulting strains were BP915 
(ΔpdxST ΔcomG), BP916 (ΔpdxST aprE::pdxH 
ΔcomG), BP918 (ΔpdxST amyE::SC1 aprE::pdxH 
ΔcomG), BP919 (ΔpdxST sacB::SC2* ΔcomG), 
BP921 (ΔpdxST aprE::pdxH amyE::SC1 
sacB::SC2* ΔcomG), BP922 (ΔpdxST amyE::SC1 
sacB::SC2* ΔcomG). The combinations for the 
new co-cultures in liquid medium are shown in 
Figure 19A. 
Consortium A was made up of the 4HTP 
producer BP919 and BP918, which had the 
capability to convert 4HTP to PLP. Consortium B 
consisted of BP922, which could convert PNP to 
PLP and BP916, which was a PNP producer. 
Consortium C was a positive control consisting 
of the producer strain BP921 and the 
auxotrophic strain BP915. BP915 alone served 
as a negative control. Preliminary experiments 
showed that the consortia would not grow in 
minimal medium when they were washed in 
CE Glc before inoculation, which was thought to 
be because the strains would need more time to 
acquire mutations that allow feeding in co-
culture. Therefore, the experiment was started 
with the addition of 0.1 µM PL. The amount of 
externally added PL was halved with every 
passage. In anticipation that one of the strains in 
the consortia would start growth before the 
other and might use up nutrients before 
mutations that allow co-feeding occur, the 
minimal medium was modified. It was decided 
to use CE Glc instead of C Glc minimal medium 
to ensure sufficient amino acid and nitrogen 
supply. Furthermore, 2% glucose were added to 
the medium instead of the usually applied 0.5% 
to make sure that carbon supply was not 
limiting growth of the strains. The CE Glc 
cultures were inoculated from LB precultures to 
an OD600 of 0.1 (in case of combinations 0.05 for 
each strain each) and passaged to an OD600 of 0.1 
every day. Triplicates of each consortium were 
used. It must be noted that the experiment was 
performed with fresh consortia and consortia 
from a previous experiment. A 1-3 and C 1-3 
have previously been passaged twice and were 
plated on SP medium supplemented with 
tetracycline and PL prior to this experiment 
(data not shown). As shown in Figure 19B, the 
overall OD600 measured after 24 hours lowered 
every day for the negative controls as well as for 
consortia A and B. However, the positive 
controls consortium C 1-3, which consisted of 
the strains BP921 and BP915 reached very high 
optical densities of 4 to 12 after one passage 
indicating that none of the nutrients was 
limiting growth and that they were well adapted 
to the medium. In contrast, the fresh consortia C 
4-6 grew to higher OD600 with each passage. 
Furthermore, consortium A 2 also reached very 
high optical densities, while the other replicates 
behaved like B and C. This could have indicated 
that the strains in this consortium became able 
to feed each other. To check this, the well-grown 
replicate A2 was streaked on SP plates with 
antibiotics selecting for strains BP918 (SP tet 
spc PL) and BP919 (SP tet cm PL) as well as on 
plates checking genetic exchange (SP tet spc cm 
PL). The strains were also streaked onto CE 2% 
Glc. This was done to check whether the strains 
could grow independently of externally added 
PL.  As depicted in Figure 19C, the strains did not 
exchange genetic information showing that the 
deletion of comG had the desired effect. 
Consortium A 5, which showed decreasing 
growth in the passaging experiment, also 
showed no growth on CE 2% Glc minimal 
medium. Consortium A 2 could grow on this 
medium however, indicating again that the 
strains could exchange metabolites. 
Interestingly, the antibiotic marker plates 
showed that consortium A 2 was no consortium 
anymore but only consisted of BP918. This 
indicated that BP918 formed suppressor 
mutants that could grow independent of BP919 
in the absence of externally added B6 and 
completely overgrew the consortium. A fact, 
which has also been observed for other strains 
carrying pdxJ, pdxA, and pdxH (see 3.4.1). 
Therefore, consortium A was considered 
unsuitable for co-culturing.  
The remaining consortium B showed decreasing 
growth in the experiment shown in Figure 19B, 
indicating that no feeding occurred. It was 
hypothesized that the toxicity of 4HTP might be 
a reason. Therefore, the experiment was 




have been shown to be an antidote of 4HTP 
toxicity (Commichau et al. 2014). As depicted in 
Figure 20, the growth of the consortium again 
decreased over the passages until it completely 
stopped after P3. Peculiarly, the positive control 
consortium C again reached a very high OD600. It 
was checked how the distribution of the strains 
in consortium C 2 was by plating on SP 
containing PL and tetracycline and on SP with 
chloramphenicol. The former should allow 
growth of BP915 and BP921, the latter of only 
BP921. 
 
Figure 20: Consortium B was also not able to 
establish stable co-feeding. OD600 of consortia and 
controls measured before passaging in a 24-hour 
interval. The consortia were inoculated as 
triplicates. B 10-12 and C 7-9 were inoculated with 
0.1 µM PL in passage 0, PL amount was halved 
with every passage. B 7-9 were cultivated without 
PL. C 7-9 again served as positive controls.  
Before plating, samples of consortium C 2 were 
diluted 1 to 1,000,000 in 1X C salts. The 
experiment was carried out in triplicates and 
showed that the culture was made up almost 
exclusively of the producer strain BP921 (Table 
7).  The CFUs on the plates were almost 
identical, indicating that at least very most of the 
cells in the culture were of strain BP921. This 
hinted at inefficient feeding of PL in this 
consortium, because common knowledge about 
producer-consumer (“cooperator/cheater”) 
relations indicated that the distribution should 
be exactly the opposite in the case of successful 
feeding (West et al. 2006). 
Table 7: Composition of consortium C 2 
Medium SP tet PL SP cm 
CFUs 81 70 83 66 64 120 
Mean 78 83 
   
It was hypothesized that this was due to the 
absence of existing transport mechanisms for 
the heterologous products of the pathway and 
possibly inefficient secretion or uptake of PL 
from the medium (see 4.5). However, the 
passaged BP921 clones from the consortia 
might have acquired interesting mutations 
allowing for more rapid growth in minimal 
medium and more efficient production of 
vitamin B6. However, the passaged strains 
neither grew significantly better than the 
original strain, nor did they produce more 
vitamin B6 (Figure S 5). At this point it was 
decided that the co-feeding approach in liquid 
medium was not promising and was aborted in 
favor of a plate-based approach (see 3.2.2). 
Taken together, when the DXP-dependent 
pathway was split into several parts and 
expressed in different strains of B. subtilis and 
these strains were cultured together, they 
rapidly exchanged the genetic information 
necessary to reestablish the complete 
biosynthetic pathway. This was an interesting 
outcome indicating that the combination of the 
pathway in one strain was favored over the 
division of labor between mutually dependent 
strains. When this problem was circumvented 
by deletion of the genes necessary to take up 
DNA from the medium, the strains did not 
exchange genetic information anymore. 
However, the strains also did not manage to 
establish a stable consortium, indicating that the 
necessary machinery is not present and not 
easily acquired by B. subtilis using the described 
approach (see 4.6).  
3.2.2. Co-cultivation of strains 
exchanging B6 and amino acids 
The previous approaches showed that strains 
expressing partial B6 pathways were not able to 
exchange the metabolites they were required to 
feed each other to form a stable consortium. It 
was hypothesized that the reason for this would 




proteins and enzymes for the heterologous 
metabolites. Furthermore, some of the strains 
would form suppressors that could grow in 
absence of the other strain of the consortium 
leading to overgrowth. To circumvent these 
problems a consortium of strains exchanging 
endogenous products was designed (Figure 
21A). The strains would exchange threonine and 
PL, for both of which transporters and enzymes 
should be present. Threonine is taken up by B. 
subtilis via the transporter SteT and possibly 
also by the isoleucine and valine transporter 
BcaP (Georgopoulos 1969; Reig et al. 2007; 
Belitsky 2015). For PL, the feeding has been 
shown during previous experiments (Figure 
15). Furthermore, the deletion mutants should 
be stable since neither for the pdxST, nor the 
thrC mutant suppressors have been described 
previously to the best of knowledge. Strain 
BV604 was transformed using the genomic DNA 
of BKE32250 (ΔtrpC) giving BP920 (ΔpdxST 
ΔthrC), whose genomic DNA was then 
transferred to BP913, producing BP962 (ΔpdxST 
aprE::pdxH amyE::SC1 sacB::SC2* ΔthrC) 
(Boston Genetic Stock Center, Rudner, 
unpublished). BP962 was threonine 
auxotrophic but expressed the heterologous B6 
pathway allowing it to feed PN and PL. The other 
strain in the consortium was constructed by 
transformation of BV604 with genomic DNA 
from BKE27910 (ΔthrR), giving BP908 (ΔpdxST 
ΔthrR) (Boston Genetic Stock Center) 
(Rosenberg et al. 2016). Strain BP908 is PL 
auxotrophic and lacks ThrR, which has been 
shown previously to inhibit threonine synthesis. 
It was therefore hypothesized that a thrR 
mutant would overproduce threonine. As 
shown in Figure 21B, the strains were streaked 
out on C Glc minimal medium plates next to each 
other. As negative control, a piece of agar was 
vertically cut out between the strains to prevent 
diffusion of PL or threonine through the agar. As 
a positive control for the different strains, the 
agar was cut out horizontally and threonine or 
PL were added to the different halves to allow 
growth of the different strains. The strains were 
streaked out as described and the plates were 
incubated at 37°C. The strains were able to grow 
without the addition of threonine or PL when 
the metabolites could diffuse through the agar. 
The negative control however, showed no 
growth indicating that the diffusion was 
required for growth under these conditions. 
Lastly, on the positive control plates, both 
strains could grow in presence of their 
respective auxotrophy marker and also allowed 
the other strain to grow under this 
circumstance. The strains were passaged when 
growth was observable by scraping of all cells 
off the agar and plating on fresh plates after 
resuspension in 1x C salts. Cells were always 
taken from the feeding plates and same amounts 
were applied to the three setups of feeding, 
negative control and positive control. The 
strains needed eight to 14 days to show growth, 
with no tendency to grow faster (Table 8). 
However, the qualitative determination of 
growth can be misleading because no 
quantitative measurements were performed. 
Table 8: Days between passages of the BP962/ 
BP908 consortium. 
Passage 0 1 2 3 4 5 6 
Days 8 9 12 12 14 14 14 
        
As shown in Figure 21B, growth of the strains 
was mostly observable in the central part of the 
plate where the strains were closest to each 
other, forming a “line of growth”. This made 
sense, because at that position the 
concentrations of the exchanged metabolites 
would be highest. However, during some 
passages suppressor mutants of BP962 were 
observed that arose at a distinct range from the 
“line of growth”. These suppressors, when 
streaked on C Glc in absence of BP908 or 
threonine, grew well and proved to be 
suppressors of threonine auxotrophy. 
Furthermore, they were streaked on SP plates 
containing erythromycin and lincomycin to 
check the presence of the thrC deletion cassette 
and grew on this selective medium (Figure 21C). 
The emergence of suppressor mutants that 
could grow independent of the consortium 
again made these strains unsuitable for the 
coculturing experiments and the possible up-
scaling of the process. However, the suppressor 
mutants of the thrC deletion have not been 
observed previously to the best of our 
knowledge and might therefore be very 
interesting. As described above (3.1.1) (Vapnek, 
Greer 1971b, 1971a), cells with a deletion of 
ilvA, which encodes the enzyme directly 




biosynthetic pathway could overcome 
isoleucine auxotrophy by the overexpression of 
thrC, showing the potential of closely related 
enzymes to take over the function of each other. 
Therefore, it was hypothesized that the 
suppressor mutants might have acquired 
mutations in the operons related to threonine 
and isoleucine synthesis or their regulators, 
allowing threonine production by a mechanism 
analogous to the one of the spr suppressors. 
Three suppressors were isolated and 
designated as BP1005, BP1006 and BP1007. 
The loci of thrR, Phom, PilvA, and ilvA were checked 
by sequencing, but no mutations could be 
observed (data not shown). This fact indicated 
that the mechanism of the suppressor mutations 
might be a different one than in the spr 
suppressors and might be worth investigation 
(see 4.7). 
 
Figure 21: The consortium exchanging threonine and PL could thrive over several passages, but suppressors of 
threonine auxotrophy jeopardized the experiment. (A) Scheme illustrating the pair of strains exchanging 
threonine (Thr) and PL. (B) Pictures of the plates before passaging. Shown are the feeding plates (top) and the 
negative controls (bottom), BP908 is always located on the left-hand side, BP962 on the right-hand side. 
Suppressors allowing growth of BP962 on its own were observed starting with P2 (red arrows). (C) The 
suppressor mutants were streaked out on SP agar with erythromycin and lincomycin (E/L) to check whether 
they still carried the thrC deletion cassette. Furthermore, the clones were streaked on C Glc medium without 
addition of threonine to check for threonine prototrophy. The suppressors were able to grow on both media 





3.3. B. subtilis rapidly exchanges 
genetic information in coculture 
As described in 3.2.1, co-cultured strains of B. 
subtilis rapidly exchanged genetic information, 
when selection favored this event. It was 
hypothesized that this behavior could be 
utilized to develop a streamlined an efficient 
transformation protocol using antibiotic 
markers. The observed exchange of cassettes 
containing B6 synthetic enzymes occurred most 
likely due to the evolutionary pressure to form 
one strain that comprises all the required genes. 
This setup was obviously the evolutionarily 
favored setup, as it was not possible to isolate 
consortia that would feed each other even after 
deleting the competence genes required for 
DNA uptake. It should be possible to replace the 
evolutionary pressure to combine the 
biosynthetic B6 pathway with the pressure to 
combine antibiotic markers. Therefore, two 
strains carrying different antibiotic markers in 
different loci were chosen to prove this concept. 
The two strains also carried different 
fluorescent markers in the same loci under an 
identical promoter. BP494 (168 bglS::(hag-cfp)) 
and BP496 (168 amyE::(hag-yfp)) were used to 
inoculate LB complex medium with 50% of the 
selective concentration of kanamycin and 
chloramphenicol in co-culture and single 
culture (Diethmaier et al. 2011). After 
incubation over night at 37°C, the different 
cultures were streaked out on SP complex 
medium plates with different combinations of 
the said antibiotics. As shown in Figure 22A, the 
strains exchanged genetic information over 
night and the resulting strain could grow on SP 
complex medium with both chloramphenicol 
and kanamycin, while the strains that were 
inoculated as single cultures could not. The 
genetic exchange was supposed to be visualized 
by fluorescence microscopy. However, under 
the used conditions, strain BP494 showed 
yellow fluorescence when excited with 
ultraviolet (UV) light and strain BP496 showed 
an extremely low YFP emission, making the 
strains unsuited for the experiment (data not 
shown). Alternatively, the genetic exchanges 
were supposed to be shown by a PCR checking 
for the sizes of the bglS and amyE loci. Figure 
22B depicts the PCR product sizes amplified 
from the genomic DNA of single clones isolated 
from the plates. Curiously, they showed that the 
resulting strain carried both cassettes with the 
fluorescent and antibiotic markers. However, it 
also carried a wild type copy of the bglS locus. 
This indicated a very stable co-culture and a 
second single streak out should be sufficient to 
single out the transformed strain. 
 
Figure 22: Two strains exchange genetic 
information over night as seen on plate and by 
PCR. (A) Plates selecting for growth of BP494 (SP 
kan), BP496 (SP cm) and for a strain carrying both 
markers (SP kan cm). Clearly, only the mixed 
culture could grow on plates with kanamycin and 
chloramphenicol. (B) Agarose gel with products of 
PCR reactions checking the size of the two loci 
used for integration of the kanamycin and 
chloramphenicol resistance genes.  BP494 and 
BP496 show the expected bands for the loci, 
BP494 the wild type amyE (4) and engineered bglS 
locus (1), BP496 the other way around with the 
wildtype bglS (2) and the engineered amyE locus 
(3). The isolated clone from the mixed culture 
showed the product size for the engineered amyE 
locus. However, the PCR checking the bglS locus 
produced two products, one the size of the wild 






Figure 23: BP999 and BP1000 exchanged genetic 
information within 24 hours of co-cultivation as 
shown by fluorescence microscopy. (A) The two 
strains BP999 and BP1000 were mixed on the 
object tray and microscopic pictures were taken 
immediately afterwards. The strains are clearly 
distinguishable, even when close to each other in 
a group (arrow). (B) After 24 hours in culture, 
some cells show both fluorescence signals (solid 
arrow), while most of the cells were still 
distinguishable (arrow with thin head). (C) After 
48 hours, no distinguishable cells could be 
observed, all cells express low signals of both 
fluorescence markers. Pictures are exemplary for 
the experiment. The YFP signal was detected with 
1500 ms exposure. The CFP signal was detected 
with 500 ms exposure. Scale bars show 20 µm. 
 
The missing distinguishability of the fluorescent 
signals was thought to be due to the used hag 
promoter, which is considered constitutively 
active but might be active dependent on the 
growth phase and differentially regulated under 
the complex medium conditions used (Katrin 
Gunka, personal communication). To optimize 
the visualization, new strains expressing the 
two fluorophores under the constitutive gudB 
promoter were constructed. For this, the 
existing plasmids pBP241 (pGP882 PgudB-cfp) 
and pBP26 (pAC5 PgudB-yfp) were used to 
transform SP1 (Gunka 2010). The resulting 
strains were BP999 (lacA::PgudB-cfp) and 
BP1000 (amyE::PgudB-yfp). The strains were used 
to inoculate a co-culture in LB complex medium 
with chloramphenicol and 
erythromycin/lincomycin. As controls, the 
strains were also used to inoculate single 
cultures with their respective selective 
antibiotic. As shown in Figure 23, the strains are 
distinguishable even when mixed. After 
24 hours growth in the same medium with both 
antibiotics single cells with both fluorescent 
markers could be observed. After 48 hours, all 
cells showed both fluorescence signals, 
indicating that the original strains have been 
overgrown by the transformed strain.  
This experiment showed the potential of this 
method to transform strains without the need to 
isolate DNA. This is, of course, only suitable for 
isogenic strains and as shown above, the 
selection of the transformed strains should be 






3.4. Reverse engineering of a 
recombinant B6 production strain 
As described in previous chapters of this work 
and on several occasions in literature, the 
vitamin B6 synthetic pathways were to date 
poorly understood, had pleiotropic effects to the 
hosting organism and were difficult to optimize 
for feasible industrial application (see 1.3, 3.1 
and 3.2). As also described above, other groups 
have previously observed that E. coli had an 
underground metabolism that allowed it to 
bypass the lack of PdxB (see 1.5 and 4.11) (Kim 
et al. 2010). Furthermore, is was shown that B. 
subtilis as well had the ability to bypass blocks of 
several biosynthetic pathways, e.g. for 
threonine, isoleucine and vitamin B6 (3.2.2, 
3.1.1 and 3.2.1/3.4.1, respectively). The latter 
was observed in two independent experiments 
and like the bypass observed by Kim and 
colleagues since the suppressors originated 
from a strain that was lacking pdxST but carried 
the S. meliloti genes pdxAJH and serC. It was 
therefore considered likely that the mechanism 
by which these cells were enabled to grow 
would be analogous to the one known from E. 
coli (Also see 1.5 and 4.11). This hypothetical B. 
subtilis underground metabolism would be an 
invaluable asset to the further optimization of 
vitamin B6 production and could be utilized to 
engineer completely novel and potentially more 
productive fermentation strains. Furthermore, 
the identification of proteins of this 
underground metabolism could lead to the 
discovery of novel enzyme functions or 
regulatory networks related to vitamin B6. 
3.4.1. B6 auxotrophs with a partial 
heterologous pathway can form 
suppressors 
On several occasions, when B6 auxotrophic 
strains carrying a partial DXP-dependent 
pathway from E. coli consisting of pdxA, pdxJ and 
pdxH were cultivated on medium without 
vitamin B6, suppressor mutants arose. This was 
the case during the co-culturing experiments in 
3.2.1 and in a reproduction of previous works by 
Commichau and colleagues. The strain BV609 
was plated on C Glc medium with and without 
4HT, which was known to be readily converted 
to PL by this strain (Commichau et al. 2015a). 
Interestingly, the strain formed suppressor 
mutants on the plate without 4HT, which could 
be passaged on minimal medium and 
continuously grew independently of vitamin B6 
or 4HT. Importantly, literature and the work of 
Commichau and colleagues provided no 
evidence that wild type B. subtilis would need or 
synthesize 4HT or the downstream metabolites 
of the DXP-dependent pathway 
(KEGG)(Commichau et al. 2015a). These 
findings prompted us, as mentioned earlier in 
3.4, to hypothesize that B. subtilis, like E. coli 
would contain an underground metabolism 
allowing it to rewire the partial heterologous 
pathway to its endogenous metabolism. To find 
out at which step the heterologous pathway got 
rewired to the endogenous metabolic network, 
the DXP-dependent pathway was reversely 
engineered starting with the enzyme catalyzing 
the last step, PNP oxidase PdxH. The B6 
auxotrophic strain carrying only the pdxH gene 
from E. coli (BP911) and the strain with the 
pdxA, pdxJ, and pdxH genes (BP912) were 
already available. Additionally, a strain carrying 
pdxJ and pdxH was constructed by integration of 
a LFH cassette containing the E. coli pdxJ gene 
and the spectinomycin resistance gene spc into 
the amyE locus of BP911. The cassette was 
amplified using primers JR192 to JR197 and 
genomic DNA of BV606 as a template. The 
resulting strain was named BP965 (ΔpdxST 
amyE::pdxJ aprE::pdxH). The strains were 
streaked on C Glc medium with and without PL 
and BV604 (ΔpdxST) was used as a negative 
control. The plates were incubated at 37°C for 
five days. As shown in Figure 24A, the negative 
control and BP911 could not grow on minimal 
medium without PL and formed no suppressor 
mutants. The strains BP912 and BP965 
however, formed suppressor mutants at 
frequencies of 5.7 x 10-6 and 2.2 x 10-6, 
respectively. These findings indicated that the 
wild type strain SP1 did not have the capability 
to easily rewire its underground pathway to 
achieve production of vitamin B6 in absence of 
the partial heterologous pathway. To check 
whether also the pdxJ gene alone would be 
sufficient to form suppressors, strain BP1002 
was constructed by transfer of pdxJ from BP965 
to BV604 using genomic DNA. This strain did not 
form suppressor mutants on C Glc medium, 
showing that SP1 does not have the ability to 
easily acquire the PNP oxidase activity of PdxH 





Figure 24: Cells expressing at least PdxJ and PdxH form suppressors on C Glc minimal medium. (A) C Glc minimal 
medium plates with and without PL. The strains BV604, BP911, BP965, and BP912 were streaked on these plates 
after cultures were washed in C Glc medium and hungered for three hours. Plates were incubated at 37°C, 
pictures were taken after four days. (B) Schematic of the DXP-dependent B6 production pathway in the 
heterologous environment. Green enzymes are endogenously present in B. subtilis, blue enzymes are from S. 
meliloti. The Experiment in (A) showed that the endogenous metabolism fed into the heterologous pathway at 
the positions indicated by the red arrow, upstream of PdxJ. 3-phosphohydroxy-1-aminoacetone (APA), the 
product of the previous enzyme PdxA, as well as 4HTP, the product of SerC, are not known to be produced by B. 
subtilis and might originate from underground metabolic activity. 
SP1 required at least the pdxJ and pdxH genes to 
recruit its potential underground metabolism 
and to feed into the B6 synthesis at the level of 
pdxJ. Of the intermediates of the DXP-dependent 
pathway, only E4P and DXP are endogenously 
produced by B. subtilis to the best of knowledge. 
They might however have been produced in 
extremely low amounts by promiscuous gene 
activity, which was enhanced by the 
suppressors. Alternatively, or additionally, the 
suppressors might have acquired mutations 
that allowed enzymes with similar substrates or 





3.4.2. Bacillithiol interferes with the 
heterologous pathway 
Four suppressor mutants of BV609 were 
isolated and the genomic DNA was extracted. 
The genomes of strains BP926, BP927, BP928, 
and BP929 were sequenced by cooperation 
partners in Göttingen (G2L). The results of the 
sequencing experiments are shown in Table 9. 
All suppressor mutants acquired detrimental 
mutations in the putative cysteine ligase 
encoding bshC gene. BshC was also known to be 
required for the synthesis of BSH and very likely 
catalyzes the last step in the synthesis pathway 
(see 1.4.5) (Gaballa et al. 2010). Furthermore, 
two of the strains (BP926 and BP927) acquired 
a point mutation in the gene yqeT, which 
encodes a putative ribosomal protein L11 
methyltransferase belonging to the PrmA 
family.  The mutation A461T lead to the 
exchange of phenylalanine at position 154 to 
tyrosine (F154Y). 
Table 9: Mutations acquired by the BV609 
suppressors on C Glc. 
Strain Locus Coordinates* 
Sequence 
change 
BP926 bshC 1,582,406 
C343T 
(Stop) 
 yqeT 1,627,996 
A461T 
(F154M) 
BP927 bshC 1,582,406 
C343T 
(Stop) 
 yqeT 1,627,996 
A461T 
(F154M) 
BP928 bshC 1,582,406 
C343T 
(Stop) 
BP929 bshC 1,582,944 
T881A 
(Stop) 
* in NC_000964 (Barbe et al. 2009) 
It was however hypothesized that this mutation 
was less important, because the strains carrying 
only the bshC mutation or both mutations all 
grew in a similar fashion (Figure 25). To find out 
whether the mutation of bshC alone was indeed 
sufficient for growth in minimal medium, the 
gene was knocked out by introduction of a LFH 
cassette carrying the chloramphenicol 
resistance marker gene cat. The cassette was 
constructed using primers JR131 to JR134, cat-
fw and cat-rev. SP1 served as template for the 
homologous flanks and pGEM-cat for cat. The 
assembled cassette was introduced into BV604 
yielding strain BP953 (ΔpdxST ΔbshC). The 
genomic DNA of this strain was used to 
transform BP911, BP912, BP965, and BP1002, 
producing strains BP956 (ΔpdxST aprE::pdxH 
ΔbshC), BP959 (ΔpdxST amyE::SC1 aprE::pdxH 
ΔbshC), BP978 (ΔpdxST amyE::pdxJ aprE::pdxH 
ΔbshC), and BP1003 (ΔpdxST amyE::pdxJ ΔbshC). 
The strains with the partial heterologous 
pathway and the deletion of bshC were used for 
a drop dilution assay on C Glc medium with and 
without PL. As shown in Figure 26, all strains 
could grow in presence of PL. On minimal 
medium without PL however, only BP978 was 
able to grow. 
 
Figure 25: The suppressor mutants could grow in 
CSE Glc minimal medium but were much slower 
than the wild type SP1. The cells were grown in 
CSE Glc minimal medium at 37°C. Values are 
means of technical triplicates. 
This showed that (I) only the strain encoding at 
least PdxJ and PdxH could benefit from the 
deletion of bshC and that (II) the deletion of bshC 
alone was sufficient to rewire the two enzymes 
to the endogenous metabolism. A question was, 
whether the deletion of the putative cysteine 
ligase encoding gene bshC was conveying the 
phenotype, or the absence of BSH. To investigate 
this, a different gene from the BSH biosynthesis 
pathway was to be deleted. As described in the 
introduction (see 1.4.5), two paralogs of bshB 
are present in B. subtilis, which was why bshA 
was chosen to be deleted. Fortunately, a 
construct with a de facto deletion of bshA was 





Figure 26: The absence of BSH is beneficial only to cells that express at least PdxJ and PdxH. (A) Schematic of the 
BSH biosynthetic pathway. BSH biosynthesis branches off from peptidoglycan synthesis and uses the precursor 
UDP-GlcNAc, which is converted to BSH by BshA, BshB1/2 and the putative cysteine ligase BshC. (B) Drop 
dilution assays with a B6-auxotrophic strain and isogenic variants expressing PdxH and PdxJ in presence or 
absence of BSH. Drops were placed on plates with and without PL after washing and hungering for three hours 
in C Glc minimal medium. All strains could grow on minimal medium with PL, but only the strain expressing PdxJ 
and PdxH in combination with a deletion of bshC could grow in absence of PL. Plates were incubated at 37°C, 
pictures were taken after two days of incubation. (C) The deletion of either bshC or bshA allows for growth of a 
strain expressing PdxAJH, indicating that the absence of BSH is key. The strains were streaked out on 
C Glc minimal medium after washing and hungering in C Glc minimal medium for three hours. (C) was not 
performed by the author but by Jan-Philipp Becker as part of his Bachelor studies. 
The strain GP88 (trpC2 bshA::pX2) had been 
constructed to delete the gene without 
abolishing expression of the essential genes 
downstream of it (Landmann 2011). The 
construct was transferred to strain BP912 using 
the genomic DNA of GP88 and the integration 
was checked by selection for chloramphenicol 
resistance as part of a students work under 
supervision of the author (courtesy of Jan-
Philipp Becker). The resulting strain BP967 
(ΔpdxST amyE::SC1 aprE::pdxH bshA::pX2) was 
checked by sequencing of the bshA locus by the 
company Microsynth, confirming the 
replacement of the start codon of bshA with a 
stop codon (data not shown). Strain BP967 was 
streaked on C Glc minimal medium without PL 
and strains BP912 and BP959 were used as 
negative and positive controls, respectively. As 
shown in Figure 26C, the negative control 
BP912 (ΔpdxST amyE::SC1 aprE::pdxH) was not 
able to grow, while both BP967 and BP959 
(ΔpdxST amyE::SC1 aprE::pdxH ΔbshC) formed 
distinguishable single colonies. This result could 
indicate that the absence of BSH and not BshC 
was the selected trait of the suppressor mutants. 
However, all suppressors had mutations in bshC, 
and none in bshA, raising the question whether 
strain BP967 might have acquired a mutation in 
bshC itself. Therefore, the locus was checked via 
sequencing by Microsynth and was shown to 
contain the intact wild type sequence (data not 
shown). It was also a question, whether (I) the 
absence of BSH was allowing the cells to grow 
with very low amounts of PL, which they 
produced with the heterologous proteins, or (II) 
BSH would interfere with the rewiring of the 
heterologous enzymes preventing any PL 
production. To find out which was the case, the 
auxotrophic strain BV604 and the isogenic 
strain in which bshC was deleted, BP953, were 
grown in minimal medium supplemented with 
different very low concentrations of PL. In the 
case that the absence of BSH benefits growth at 
very low PL concentrations, BP953 should grow 
better than BV604. As shown in Figure 27, the 
absence of BSH does not enhance growth in with 
limited PL, indicating that it indeed interferes 






Figure 27: The absence of BSH does not enhance 
growth of B. subtilis with low concentrations of PL. 
The cultures were grown in C Glc minimal medium 
supplemented with different amounts of PL. The 
strains did not show any difference in growth 
neither at high, nor at very low amounts of PL. 
Values are means of technical triplicates. 
Therefore, it could be confirmed that the 
absence of BSH, not of BshC is key to allow only 
the B. subtilis strains expressing a partial DXP-
dependent pathway growth on minimal medium 
without PL. 
3.4.3. Bacillithiylation is not the 
driving force for suppressor 
mutations 
The connection between BSH and the utilization 
of the heterologous pathway remained 
enigmatic. As shown in 1.4.5, BSH is mainly 
involved in the response to oxidative stress and 
can protect exposed cysteine residues from 
irreversible oxidation when activated by the 
stress regulator Spx. It does so by 
S-bacillithiylation of the cysteine residues, 
which can be reversed by the specialized 
proteins BrxA and BrxB. In the process, BSH 
inactivates the proteins it protects, as known for 
B. subtilis’ methionine synthase MetE (Gaballa et 
al. 2010; Chi et al. 2011). It is further known that 
vitamin B6 has an antioxidant property (see 
1.2), which might have been impaired in the 
suppressor mutants BP926 to BP929, because 
they produced only minimal amounts of the 
vitamin. It was hypothesized that the low 
amounts of B6 would put the cells under chronic 
oxidative stress activating the oxidative stress 
response conveyed via Spx, leading to 
methionine auxotrophy due to the inactivation 
of MetE. In this case, the strain BP912 should be 
able to grow on minimal medium without PL in 
presence of methionine. To check this, strain 
BP912 (ΔpdxST amyE::SC1 aprE::pdxH) was 
plated on C Glc medium. As shown in Figure 28, 
BP912 could not grow on this medium and again 
formed suppressor mutants. The bsh loci of 
three of the suppressors on C Glc medium with 
only methionine, BP990, BP991 and BP992, 
were amplified and sequenced by the company 
Microsynth. Very interestingly, two of the 
suppressors were found to have frame-shift 
mutations in bshC and one of them in bshA, 
complementing the deletion experiment above 
(Table 10, Figure 26C).  
Table 10: Status of the bsh loci of BP912 suppressors 
on minimal medium with methionine. All mutations 
lead to frameshifts or premature stop codons. 
Strain bshA bshB1 bshB2 bshC 
BP990 n.a. n.a. n.a. ΔA463 
BP991 n.a. n.a. n.a. G482A 
BP992 ΔT1077 wt wt wt 
n.a.: not analyzed 
wt: wild type sequence 
Additionally, the bacillithiylation patterns of 
wildtype SP1, the B6 auxotroph BV604 
(ΔpdxST), BP965 (ΔpdxST amyE::pdxJ 
aprE::pdxH), and BP978 (ΔpdxST amyE::pdxJ 
aprE::pdxH ΔbshC) were checked in a 
Bacillithiylation assay (Chi et al. 2013). The 
named strains were grown in C Glc minimal 
medium with PL to an OD600 of 0.4, were then 
washed in minimal medium without PL and split 
in two cultures: one with PL and one without; 
both cultures were diluted 1:1. The cultures 
were grown to an OD of 0.4 to 0.5. Same 
amounts of crude extracts were used for the 
bacillithiylation assay as described in the 
methods. As shown in Figure 28D, 
bacillithiylation could be observed in all strains 
but BP978, which was consistent with the 
expectations, because this strain lacked BshC 
and therefore the ability to synthesize BSH. For 
strains BV604 and BP965 a mild increase of the 
overall Bacillithiylation signal could be 
observed. However, compared to the signals 
published in previous works, the signal of 




(Chi et al. 2013). A reproduction with NaOCl as a 
positive control confirmed the trend, but was 
inconclusive concerning strain BP965 and 
therefore not shown. Based on this preliminary 
data, no evidence for toxic Bacillithiylation of 
MetE could be found.  
The formation of suppressors on medium with 
methionine and the Bacillithiylation assay 
indicated that the inactivation of MetE and 
resulting methionine auxotrophy were not the 
causative pressure for the inactivation of BSH 
synthesis. 
3.4.4. A link between amino acid 
starvation and B6 limitation 
The investigation of a connection between 
S-Bacillithiylation and the utilization of the 
heterologous B6 biosynthesis pathway lead to 
no conclusive results. Another idea was that 
BP912 would be starved for cysteine in absence 
of sufficient PL. Therefore, the hypothesis was 
that absence of BSH biosynthesis was beneficial 
because the last step from malyl-glucosamine 
(GlcN-mal) and cysteine to Bacillithiol 
consumed cysteine. This hypothesis was 
checked by cultivation of BP912 on minimal 
medium plates and in liquid minimal medium, 
both supplemented with cystine. Cystine was 
chosen, because it proved to be more stable and 
less toxic to B. subtilis in preliminary 
experiments (Figure 28A). Additionally, the 
experiments were carried out with addition of 
casamino acids (CAA) and methionine. As 
shown in Figure 28C, the addition of cystine 
alone had no beneficial effect, neither in liquid, 
nor on solid minimal medium. So was the case 
for the addition of methionine alone and for the 
combination of methionine and cystine. CAA had 
a positive effect, however. As shown in Figure 
28B, the addition of CAA to the minimal medium 
plate allowed growth of BP912 in a defined 
radius around the place where the paper plate 
was placed. In liquid medium (Figure 28E) the 
effect was also visible, but it also became clear 
that the positive growth effect was temporal. 
When methionine or cystine were applied in 
combination with CAA, however, growth in 
liquid medium was greatly enhanced. On solid 
medium, this effect was less prominent (Figure 
28B, C and E). For the interpretation of this 
effect it should be considered, that CAA, which 
are won by hydrolysis of casein, contain only 
low amounts of cystine. It was possible that the 
combination of CAA and cystine or methionine 
(which can be converted to cysteine) was 
beneficial because it supplied the cells with all 
needed amino acids. Considering that vitamin 
B6 is required mainly for amino acid 
metabolism, this indicated a connection to B6 
limitation in general and less to the utilization of 
the heterologous pathway. To date, only few 
publications had shown a direct link between B6 
limitation and amino acid starvation, albeit this 
connection seemed obvious. It would therefore 
be very interesting to further investigate this 
connection and for the first time directly prove 
this effect of vitamin B6 deficiency. It was also 
tried to generate suppressors of the B6 
auxotrophic strain BV604 under conditions with 
low amounts of amino acids. However, these 
experiments did not lead to viable suppressor 
mutants so far (not shown). 
The starvation for cysteine or/and methionine 
alone did not seem to be the driving force for the 
suppressor mutations in the BSH synthesizing 
gene bshC observed in Figure 24. However, the 
addition of a complex mixture of amino acids 
consisting of CAA and sulfur-containing amino 
acids had a positive growth effect, which might 
be related to the introduction of the 
heterologous, DXP-dependent pathway or to the 
effects of B6-starvation in general and might be 





Figure 28: Amino acid starvation and PL limitation are connected but not related to the suppressor mutation of 
the BSH synthetic genes. (A) Positive control of BP912 streaked onto C Glc minimal medium with PL. Cysteine 
(Cys), methionine (Met) and cystine (Cyn) were dropped onto the plate to show toxic effects (0.1 mg each). 
Cysteine showed a relatively strong inhibitory halo, cystine only a very small one. (B) BP912 formed suppressors 
in presence of Met and CAA. CAA caused a halo where growth seems to be inhibited, but outside the halo growth 
seemed to be promoted. (C) BP912 formed suppressors in presence of Cyn alone and in combination with Met 
and CAA. CAA again showed an inhibitory halo and growth promotion at a greater distance. (A, B and C) Cells 
were washed and starved in C Glc minimal medium prior to plating. Plates were incubated at 37°C for four days. 
(A and B) 0.1 mg of substances were applied on paper discs. (D) Bacillithiylation assay of wild type SP1, B6 
auxotroph BV604 and the strains BP965 and BP978. The BSH deficient strain BP978 shows a very weak signal, 
which is in agreement with the expectation. Strains BP965 and BP978 show a mildly increased bacillithiylation 
in absence of PL, but no strong, distinct band absent in SP1, indicating that bacillithiylation is not the reason for 
the inactivation of BSH synthesis. (E) BP912 could grow in C Glc minimal medium in presence of CAA in 
combination with sulfur-containing amino acids. Cells grew well in the control condition with PL, but barely in 
presence of only Cyn or Met. In presence of CAA, growth was considerably improved, but halted after only a few 
hours. In presence of CAA in combination with Met and/or Cyn, the cells proceeded, starting out faster than with 
PL but reaching only a lower final optical density. PL was added to a final concentration of 0.1 µM, CAA, Met and 





3.4.5. Overexpression of YtoQ 
reestablishes growth  
The previously described approaches did not 
yield a conclusive explanation for the 
mechanism that lead to the detrimental 
suppressor mutations in the BSH biosynthesis 
genes bshC and bshA. It was therefore decided to 
choose an untargeted approach. The suppressor 
mutants BP926 to BP929 as well as the 
constructed strains BP959 and BP978 were able 
to grow in minimal medium but were much 
slower than the wildtype SP1 (Figure 25). This 
gave one the possibility to evolve these strains 
by continuous passaging in minimal medium 
selecting for faster growth. This experiment was 
carried out as part of a master thesis under 
supervision of the author (Yeak 2017). The 
strains BP965 (ΔpdxST amyE::pdxJ aprE::pdxH) 
and BP978 (ΔpdxST amyE::pdxJ aprE::pdxH 
ΔbshC) were used to inoculate C Glc minimal 
medium cultures which were incubated at 37°C 
until growth was visible. They were 
subsequently passaged to fresh medium. Every 
day, the cultures were harvested by 
centrifugation and the medium was replaced 
with fresh one to select for fast growing mutants 
rather than for a consortium of feeding and 
cheating cells. They were passaged over several 
weeks, until they grew over night. BP1032 and 
BP1036, which were retrieved from this 
experiment, grew almost as fast as the wild type. 
(For more detail, see Yeak 2017). Whole genome 
sequencing by our cooperation partners in 
Göttingen revealed that they acquired several 
mutations (G2L, Table 11).  
Table 11: Mutations acquired by the evolved strains 
BP1032 and BP1036. 
Strain Locus Coordinates* 
Sequence 
change** 
BP1036 PytoQ 3,054,693 C55A 











 glyQ 2,608,574 
C76T 
(D26N) 
 comEC 2,638,135 
G1739T 
(A580E) 
* in NC_000964 (Barbe et al. 2009) 
**genom. ampl.: genomic amplification 
 
Strain BP1036 was evolved from BP965 
(ΔpdxST amyE::pdxJ aprE::pdxH) which encoded 
PdxJ and PdxH, BP1032 from the isogenic strain 
lacking bshC, BP978 (ΔpdxST amyE::pdxJ 
aprE::pdxH ΔbshC).  
 
Figure 29: The evolved strains acquired genomic 
modifications that enhance the expression of the 
unknown gene ytoQ. (A) BP1032 showed an 
approximately three times amplification of a 
genomic region stretching from ytoQ to ytzE. (B) 
BP1032 acquired a mutation in the putative 
promoter region of ytoQ, 55 bp upstream of the 
start codon. Putative -35 and -10 regions are 
shown in bold with grey background. The mutated 
residue is shown in bold with an asterisk. The 
ribosomal binding site (RBS) is underlined. (C) 
LacZ assay with the wild type and mutated PytoQ 
constructs. The mutated promoter region as a 6-8x 
higher activity than the wild type. Dots represent 
independent biological replicates; bars show 
means of those.  
Intriguingly, BP1036 also acquired a mutation in 
bshC, supporting the hypothesis that the 
absence of BSH is required for the rewiring of 
the endogenous metabolism to the heterologous 




mutations in the essential glycyl-tRNA synthase 
encoding glyQ gene and in the competence-
related channel encoding comEC gene. When the 
original strains of the two evolved strains were 
resequenced by Microsynth, it was found that 
already BP978 had acquired the mutation in 
comEC, possibly as a side effect of selection for 
transformants. The mutation in glyQ was very 
interesting, especially because the amino acid 
glycine and the substrate of PdxJ APA have a 
very similar molecular structure, possibly 
indicating an involvement of the tRNA synthase 
in the metabolic rewiring (see Figure 40 and 
4.12). The mutation in glyQ is likely located on 
the dimerization interface and might alter 
oligomerization (structure 1J5W from PDB, 
Figure S 7 supplements) (Berman 2000). It is 
however unlikely that the enzyme has become 
inactive since it is essential in B. subtilis (Michna 
et al. 2016). However, both evolved strains 
harbored modifications concerning the 
unknown gene ytoQ. BP1032 had an increased 
coverage in an area covering a 19kb genomic 
region from ytoQ to ytzE of 434 compared to 151 
in the rest of the genome (R script Code S 1). 
This indicated that the area has been amplified 
and is on average present in three copies in the 
genome of BP1032 (Figure 29A). The other 
strain had a point mutation 55 bases upstream 
of the start codon of ytoQ (C55A) in what might 
be the promoter region (Figure 29B). If the 
mutation in the promoter region was causing an 
up regulation, this could mean that 
overexpression of ytoQ was reestablishing 
wildtype growth of the strains in minimal 
medium without externally added PL. To test 
this hypothesis, first a LacZ construct with the 
intergenic region upstream of ytoQ was 
constructed. The intergenic region was 
amplified using primers JR268 and JR269 and 
was cloned into pAC7, using genomic DNA of 
BP1036 and SP1 as templates, producing 
pBP637 (PytoQ(C55A)-lacZ) and pBP638 (PytoQ-
lacZ), respectively. The plasmids were used to 
transform the wildtype SP1 and integration was 
checked using an amylase test (not shown). The 
resulting strains BP996 (amyE::PytoQ(C55A)-
lacZ)  and BP997 (amyE::PytoQ-lacZ)   were used 
to determine the promoter activity in a LacZ 
assay in C Glc minimal medium and as shown in 
Figure 29C, the mutated promoter region 
indeed showed a 6-8x higher activity than the 
wild type promoter region. 
 
Figure 30: Overexpression of ytoQ in a strain with 
the partial DXP-dependent pathway and without 
BSH restored growth to wild type (wt) level. (A) 
Growth of BP965 and BP978 with the pBQ200 
empty vector (EV) or the ytoQ overexpression 
construct pBP639 in presence of PL. (B) Same as 
(A) without added PL. (C) Growth of the wild type 
SP1 and BP978 pBP639 without added PL. (C) was 
not performed by the author but by Kah Yen Yeak. 
All values are means of technical triplicates. All 
experiments were carried out in C Glc minimal 
medium at 37°C. 
Taken this strong evidence that overexpression 




observed phenotype, an overexpression 
construct was designed. The gene was amplified 
from the SP1 genome using primers JR266 and 
JR267 and was cloned into pBQ200. The 
resulting plasmid pBP639 was used to 
transform the strains BP965 and BP978 in 
parallel with pBQ200 as empty vector control. 
Growth of the strains was compared in a 
platereader experiment in C Glc minimal 
medium with and without added PL. As shown 
in Figure 30A, both BP965 and BP978 could 
grow in presence of PL irrespective of the 
presence or absence of the ytoQ overexpression.  
However, in absence of PL, only BP978 could 
grow. BP978 with the empty vector grew very 
slowly, as previously observed for the 
suppressors BP926 to BP929 (Figure 30B). In 
contrast BP978 was growing very rapidly when 
the ytoQ overexpression vector was present. 
Indeed, when BP978 pBP639 was compared to 
the wildtype strain SP1 by Kah Yen Yeak they 
grew in a very similar fashion (Figure 30C). Very 
interestingly, the overexpression of ytoQ was 
only beneficial for the strain lacking BSH. This is 
a similar outcome as in the case of BSH, where 
the deletion of bshC was only beneficial when 
the heterologous proteins PdxJ and PdxH were 
present in the same strain. It was hypothesized 
that the function of YtoQ is required for growth 
of the strains expressing PdxJ, PdxH and lacking 
BSH in minimal medium. The mutation of the 
promoter or the genomic amplification would 
then have facilitated the enzymatic or 
regulatory function of YtoQ to feed more of the 
unknown compound X into the heterologous 
pathway. To test this hypothesis a drop dilution 
assay was performed with ytoQ deletion strains. 
For that the existing mutant BKE29850 (ΔytoQ) 
was used to isolate genomic DNA and for 
transformation of SP1 yielding BP1016 (ΔytoQ). 
The genomic DNA of this strain was then used to 
generate BP1017 (∆pdxST ∆ytoQ amyE::pdxJ 
aprE::pdxH) and BP1018 (∆pdxST ∆bshC ∆ytoQ 
amyE::pdxJ aprE::pdxH). These strains were 
used for a drop dilution assay together with 
additional controls (Figure 31). All strains could 
grow on C Glc minimal medium in presence of 
PL, but without PL strains BP1017 and BP1018 
were not able to grow. This showed that even in 
a strain with the partial heterologous pathway 
and without BSH, the absence of YtoQ is 
detrimental for growth. That indicated that the 
function of YtoQ was required for the rewiring 
of PdxJ and PdxH to endogenous metabolism. 
Furthermore, also in the drop dilution 
experiment, BP978 pBP639 grew like the 
wildtype, complementing the experiment in 
liquid medium. 
In summary, B6 auxotrophic B. subtilis strains 
expressing pdxJ and pdxH from E. coli and lack 
BSH were evolved to grow like the wildtype in 
minimal medium without addition of vitamin 
B6. These strains acquired mutations that lead 
to an overexpression of the so far 
uncharacterized protein YtoQ. A reversely 
engineered strain with a plasmid-based 
overexpression construct of YtoQ could grow 
like the wildtype in minimal medium. 
Furthermore, it was shown that the unknown 
function of YtoQ was required for the growth of 
the strains expressing the partial DXP-
dependent pathway. 
 
Figure 31: YtoQ is required 
for growth of the B6 
auxotrophic strains 
expressing the partial DXP-
dependent pathway. Drops 
were placed on plates with 
and without PL after washing 
and hungering for three 
hours in C Glc minimal 
medium. All strains could 
grow on minimal medium 
with PL, but only strains 
lacking bshC and expressing 
YtoQ could grow in absence of 
PL. Plates were incubated at 
37°C, pictures were taken 




3.4.6. YtoQ likely conveys the ability 
to synthesize APA  
Figure 24 shows a scheme of the truncated 
pathway and shows at which points the cells 
were most likely feeding into it. Strains BP1032 
and BP1036 only contain PdxJ and PdxH, so the 
only possible point where feeding occurs is 
upstream of PdxJ. The known substrates for 
PdxJ are APA and DXP, the latter being the 
product of the endogenous, essential enzyme 
Dxs. APA was not known to be produced by B. 
subtilis to the best of knowledge, however the 
current data hinted at the presence under the 
tested conditions. It was therefore hypothesized 
that this metabolite was produced by an 
enzymatic reaction of YtoQ or by an enzyme 
directly or transcriptionally regulated by YtoQ. 
A database search for YtoQ and similar proteins 
revealed that YtoQ is similar to nucleoside 
deoxyribosyl transferases (HHPred). 
Furthermore, according to KEGG database it 
contains in addition to the transferase domain a 
poorly conserved helix-turn-helix (HTH) motif, 
which might indicate DNA binding and thus a 
regulatory function. To check the potential DNA-
binding capability, the online tool DP-bind was 
used with the known regulator ThrR as a control 
(Kuznetsov et al. 2006; Hwang et al. 2007). As 
shown in Figure 32, the DNA-binding prediction 
profile of YtoQ has similarity to the known DNA-
binding protein ThrR, possibly indicating 
regulatory activity (see also Table S 1). 
However, EMSAs to show unspecific binding to 
plasmid DNA and PCR products were not able to 
show any DNA-binding (not shown). It was 
therefore proceeded with the search for the 
pathways that could possibly feed into the 
heterologous pathway. The substrates for a 
reaction producing APA would likely contain an 
amino group and would originate from central 
carbon metabolism or amino acid metabolism. It 
would also be possible that bases were 
substrates for a hypothetical reaction. As shown 
in Figure 24, the BSH synthesis shares a 
precursor with peptidoglycan synthesis, which 
is UDP-GlcNAc, an amino sugar bound to a base 
and as such a possible substrate for YtoQ, which 
is similar to a nucleoside deoxyribosyl 
transferase. The fact that the suppressor 
mutants all mutated BSH synthesis would make 
sense in the case that UDP-GlcNAc was the 
substrate for the required YtoQ function. 
 
 
Figure 32: YtoQ has a DNA-binding prediction profile similar to a known regulator. The prediction was done with 
DP-bind (Kuznetsov et al. 2006; Hwang et al. 2007). The designators 1 and 0 mean predicted binding or no 






Figure 33: B6 auxotrophic 
strains with the partial DXP-
dependent pathway formed 
suppressor mutants also on 
GlcNAc and glycine; GlcNAc and 
DX have different effects on the 
bshC deletion mutants. (A) 
Strains BP912 (pdxAJH bshC), 
BP959 (pdxAJH ΔbshC), BP965 
(pdxJH), and BP978 (pdxJH 
ΔbshC) were streaked onto 
C Glc minimal medium with 
paper plates containing 0.1 µg 
of either GlcNAc or glycine, the 
positive control contained 
2.4 µg PL. Plates were 
incubated at 37°C overnight. 
Strains able to produce BSH did 
form suppressors as on 
medium without additives and 
bshC deletion mutants grew 
better on GlcNAc than on 
glycine. (B) Growth of strains 
BP965 and BP978 with GlcNAc 
and glycine. BP978, which 
lacked BSH, showed enhanced 
growth in the late phase in 
presence of GlcNAc. (C)  
Comparison of BP965 and 
BP978 with the pBQ200 empty 
vector (EV) and the YtoQ 
overexpression plasmid 
pBP639 in presence of DX. DX 
had no effect on growth of 
strains producing BSH but a 
negative effect on bshC deletion 
strains, which was even 
stronger in combination with 
pBP639. (B and C) Cells were 
grown in C Glc minimal 
medium with PL as positive and 
without any additives as 
negative control (Ctrl.) at 37°C. 
Values are means of technical 
triplicates. 
Furthermore, it has been mentioned above that 
glycine has a similar chemical structure as APA, 
basically lacking ‘only’ one methyl group at the 
position of the 2-hydroxy group and one of the 
evolved strains acquired a mutation in the 
essential glycyl-tRNA synthase in addition to the 
up-mutation of PytoQ. Glycine and GlcNAc were 
therefore fed to strains expressing the partial 
DXP-dependent pathway to check whether 
these compounds would allow growth like the 
bshC deletion mutants. As shown in Figure 33A, 
the strains did still form suppressors on this 
medium and did not grow like the bshC deletion 
strains. Glycine did not seem to have any effect 
on growth of neither BP912 (∆pdxST amyE::SC1 
aprE::pdxH) nor BP965 (∆pdxST amyE::pdxJ 
aprE::pdxH) and also not the isogenic bshC 
deletion mutants BP959 or BP978, respectively. 
Peculiarly, GlcNAc showed an effect on BP959 




grew considerably better on C Glc minimal 
medium supplemented with this compound 
than on the medium with glycine. This could 
have indicated that the absence of BSH and the 
overexpression of YtoQ would add up to 
accumulation of GlcNAc. To further investigate 
this relationship, an experiment in liquid 
medium was performed. For that different 
isogenic bshC deletion strains with and without 
the heterologous genes pdxJ and pdxH were 
grown in C Glc minimal medium supplemented 
with 1% GlcNAc. As shown in Figure 33B, in 
liquid medium a mild effect of 1% GlcNAc could 
be observed for BP978, which grew better in the 
later growth phases in presence of the 
compound compared to the condition without. 
However, growth was still considerably slower 
than in presence of PL. No effect could be 
observed for any of the other strains. These data 
give some hints that GlcNAc might be beneficial 
in absence of BSH, but together with the other 
data, no direct feeding into the pathway could be 
shown (see 4.10.1). To bring light to this 
relationship, metabolic flow analysis by 
metabolome assays and heavy isotope labelled 
metabolite experiments will be performed in the 
future.  
Another idea was that APA would be produced 
by underground metabolism in sufficient 
amounts already and that YtoQ would produce 
DXP and that its overexpression would relieve 
the drainage of DXP from the essential thiamine 
and isoprenoid synthesis pathways. As 
previously described (see 1.2.1), in α- and γ-
proteobacteria, Dxs and its product DXP are 
essential to several pathways: DXP-dependent 
B6 biosynthesis as well as thiamine and 
isoprenoid metabolism. In B. subtilis, Dxs is also 
essential, but only for the latter two functions. 
Therefore, it was hypothesized that DXP was 
depleted by the enzymatic activity of PdxJ and 
that YtoQ would replenish the DXP pool by its 
endogenous or a promiscuous activity. To test 
this hypothesis, strains BP965 and BP978 with 
the YtoQ overexpression plasmid pBP639 and 
the empty vector controls were grown in C Glc 
minimal medium supplemented with 0.5% of 
the dephosphorylated DX. As shown in Figure 
33C, strain BP978 pBP639 again grew very well 
and there was barely any difference between the 
conditions with and without PL, supporting the 
previous experiments. The addition of DX had 
no effect on the BP965 variants and BP978 with 
the empty vector, but BP978 pBP639 grew 
considerably worse in the presence of DX. The 
reasons for this negative effect on growth were 
unknown. 
In summary, the precursor of BSH synthesis 
GlcNAc and the dephosphorylated form of the 
substrate of PdxJ DX had some effect on the 
growth of the strains expressing the partial DXP-
dependent B6 synthesis pathway indicating an 
involvement in the rewiring of the heterologous 
enzymes to endogenous metabolism. However, 
the substrate(s) for the reaction(s) feeding into 
the pathway remain unknown. Future 
metabolome analyses, heavy isotope labelling 
and in vitro analysis will shed light on the 
connection between the observations.  
3.4.7. Purified YtoQ oligomerizes as 
dimers of dimers 
The function of YtoQ remained widely unknown, 
but we could very reproducibly show that the 
unknown protein was required for the feeding 
into the partial DXP-dependent pathway. In 
addition to the genetic approaches to unravel 
the function of YtoQ, the protein was also 
analyzed biochemically and structurally. For 
this purpose, three in vitro constructs were 
designed. For uncomplicated purification and 
YtoQ, the encoding gene was cloned into the 
vectors for N- and C-terminal Strep-tagged 
expression, pGP172 and pGP574, respectively. 
Both vectors were used, because it was 
unknown, whether one of the tags would be 
detrimental for the catalytic or regulatory 
function. In addition to these plasmids ytoQ was 
also cloned into the vector pET-SUMOadapt, 
which adds a N-terminally located His-tag, but 
also the N-terminal SUMO tag, which should 
enhance solubility of the protein and can also be 
cut off, to use the untagged protein in vitro. For 
these constructs, the gene was amplified with 
the primer pairs JR296/297, JR298/299 and 
JR300/301 for the vectors pET-SUMOadapt, 
pGP172 and pGP574, respectively. The products 
were integrated into the vectors via restriction 
cloning and the plasmids were used to 
transform E. coli DH5α. The sequenced 
(Microsynth) plasmids were then isolated from 
the cells and used to transform the expression 
strain BL21 (DE3), which in contrast to DH5α 
was carrying the T7 polymerase, which was 




plasmids put the gene under control of a T7 
promoter. Figure 34A shows the purification of 
the Strep-tagged protein variants. The 
purification of both, the N- and C-terminally 
Strep-tagged versions was very efficient with 
yields of approximately 3-5 mg from 500 ml 
culture. The purified protein was used for in 
vitro oligomerization analysis by a cross-linking 
experiment with glutardialdehyde (GAL). Figure 
34B shows that the protein formed a strong 
dimer band in presence of the cross-linker, but 
also weaker bands corresponding to the size of 
a tri-, tetra- and hexamer. This indicated the 
capability of YtoQ to form relatively large 
oligomeric structures. This data is to be 
complemented by SEC-MALS in the future. 
Furthermore, the protein was handed to the 
structural biochemistry department for a 
crystallization assay, which yielded proteinous 
crystals awaiting further investigation (Figure 
34C).
 
Figure 34: YtoQ was easily purified 
and formed oligomeric structures in a 
cross-linker experiment. (A) 
Plasmids pBP641 (641) and pBP642 
(642) were used to overexpress YtoQ 
in E.  coli BL21 (DE3). Induction was 
carried out for 1.5 h at 37°C in 500 ml 
LB medium. The Strep-tagged 
proteins were purified using 
Streptactin-sepharose columns and 
eluted with D-Desthiobiotin. 4 µl of 
crude extract (CE), flow through (FT), 
wash fraction 5 (W5) and the elution 
fractions 1-3 (E1-E3) were separated 
by an SDS-PAGE using a 12% 
polyacrylamide gel and visualized 
using a Coomassie staining. The yield 
of the N- and C-terminally tagged 
proteins was 10 and 6.8 mg ml-1, or 5 
and 3.4 mg total protein, respectively. 
(B) 50 pmol of the purified proteins 
were cross-linked in vitro using 
glutardialdehyde (GAL).  Both the N- 
and C-terminally tagged YtoQ formed 
oligomers in this experiment. Bands 
corresponding to the sizes of dimers, 
trimers, tetramers and even larger 
complexes were visible (orange 
triangles for N-terminally tagged 
construct). The proteins were 
separated by an SDS-PAGE using a 
12% polyacrylamide gel and 
visualized using silver staining. (C) 
Exemplary pictures of proteinous 
crystals, which formed at pH 4-7 with 
addition of either polyethylene glycol 





3.5. Streamlining of the production 
pathway 
As previously described (see 1.3), there have 
been many groups trying to establish a 
fermentative platform for vitamin B6 
production. Furthermore, a major part of this 
work has been devoted to optimize the 
production strain designed and constructed by 
Commichau and colleagues (Commichau et al. 
2014; Commichau et al. 2015a). However, to 
date none of the previous approaches led to the 
desired outcome of a strain producing sufficient 
B6 for industrial application. It was 
hypothesized that at least 10 g l-1 would have to 
be produced in a fermentative approach within 
a few days to compete against the currently used 
chemical synthesis (Rosenberg et al. 2017a). 
The DXP-independent pathway consists of only 
two enzymes, which form a heterotetracosamer 
(24-mer), rendering genetic engineering 
difficult due to the high possibility of polar 
effects in oligomerization and structural 
integrity of the complex (Rosenberg et al. 
2017a). The DXP-dependent pathway on the 
other hand has been shown to produce toxic 
intermediates and to have possibly detrimental 
effects on other pathways in the host organism  
as shown for the  tryptophan synthesis pathway 
(Rosenberg et al. 2017a; Commichau et al. 
2015a). However, the approach by Commichau 
and colleagues was a brute force 
overproduction by strong and constitutive 
promoters, which did not consider the specific 
activities and possible accumulation of 
intermediates. It is imaginable that the strict 
streamlining of the pathway by modular and 
tightly controlled expression of the single 
enzymes might circumvent the accumulation of 
toxic intermediates and interference with 
endogenous metabolism. 
The following chapter will assess the required 
enzyme amounts, provide a proof of concept and 
propose a strategy to construct a streamlined 
production pathway. 
3.5.1. Assessment of the required 
enzyme amounts for streamlined 
production 
For the streamlining of the DXP-dependent B6 
synthesis pathway it was assumed that the 
initial substrate E4P was present in saturating 
amounts to allow vmax and kcat to be true. It was 
furthermore assumed that all cofactors were 
present in saturating amounts. This way, the 
needed amounts of the enzymes could be 
calculated using the kcat to assure that none of 
the intermediates would accumulate far above 
the kM of the enzyme downstream. The results of 
this chapter are also summarized in Table 12. 
Conversion of E4P to PE by Epd 
There are two publications that characterized 
the activity of Epd from E. coli (Zhao et al. 1995; 
Boschi-Muller et al. 1997). Zhao and colleagues 
identified the kM to be 960 µM and vmax 
91.2 x103 U mg-1, calculating the kcat to be 200 s-1 
per tetramer. This however is impossible, since 
the vmax together with the stated tetramer 
molecular weight of 132 kDa would add up to a 
kcat of incredible 200,000 s-1, which can be 
considered unlikely. It was therefore assumed 
that there was a mistake and the 200 s-1 were 
taken, as is also stated in uniport 
(http://www.uniprot.org/uniprot/P0A9B6). 
Boschi-Muller and colleagues determined the 
kcat to be 20 s-1 of a unit they did not state. 
However, the experimental data they presented 
hinted at a turnover of approximately 9 s-1 per 
aptamer (specific activity of 14.7 U mg-1 
multiplied by M of 37.170 kDa). 
Concluding, one mole Epd would produce 10-50 
moles of PE from E4P per second. For this 
theoretical approach, the ideal conditions will 
be considered and the turnover of 50 s-1 will be 
taken as given. 
Conversion of PE to HPAKB by PdxB 
Rudolph and colleagues have investigated this 
enzyme and determined the kM to be 2.9 µM and 
the kcat 1.4 s-1 (Rudolph et al. 2010). Under ideal 
conditions one mole of this enzyme would 
generate 1.4 moles of HPAKB from 1.4 moles of 
PE. This turnover per aptamer of enzyme is at 
least 7x slower than of Epd and would already 
lead to a significant accumulation of PE without 
streamlining. Indeed, on several occasions 
mutant carrying detrimental mutations in epd 
were observed, when the pathway was 
dispensable (Commichau et al. 2014)(and data 
not shown). 
Conversion of HPAKB to 4HTP by SerC 
SerC is one of the genes of the DXP-dependent 




in the Gram-positive B. subtilis and has an 
essential function in the serine synthesis. 
Therefore, the heterologous SerC from E. coli 
should serve as a dedicated enzyme for the 
recombinant DXP-dependent pathway in the 
rationally designed strain. SerC was 
characterized by Drewke and colleagues. 
However, they were only able to measure the 
reverse reaction from 4HTP to HPAKB with a kM 
of 110 µM and a kkat of 0.15 s-1 (Drewke et al. 
1996). One mole of PdxB will therefore likely 
produce 0.15 moles of 4HTP from 0.15 moles of 
HPAKP. 
Conversion of 4HTP to APA by PdxA 
The conversion of 4HTP to APA is only semi-
enzymatic. The first step from 4HTP to AOPB is 
carried out by PdxA and the second step to APA 
is a spontaneous decarboxylation. Again, two 
groups analyzed this enzyme and came to 
similar kinetics. Cane and colleagues 
determined the kM to be 85 µM and the kcat as 
1.66 s-1 (Cane et al. 1998; Cane et al. 1999). A 
third publication determined the kcat to be 1.4 s-1 
(Laber et al. 1999). All of these publications 
from the nineties assumed that the PdxA dimers 
would contain two active enters, however 
according to more recent structural analyses, 
every dimer only contains one catalytic center 
which is made up of residues from both 
aptamers, doubling the kcat (Sivaraman et al. 
2003). The turnover per mole of enzyme does 
not change because of this, which is why one 
mole of PdxA will ideally produce 1.66 moles of 
APA and CO2 from 1.66 moles of 4HTP per 
second. 
Conversion of APA and DXP to PNP by PdxJ 
This reaction also has been investigated by Cane 
and colleagues, who did the kinetics for DXP and 
the kM turned out to be 26.9 µM and the kcat 
0.07 s-1 (Cane et al. 1999). Therefore, one mole 
of PdxJ will under perfect circumstances 
produce 0.07 moles of PN from 0.07 moles of 
APA and DXP. 
Oxidation of PNP to PLP by PdxH 
The last reaction in the PLP synthesis pathway 
is carried out by PdxH, which has been 
determined to have a kM of 2 µM and a kcat of 
0.76 s-1 (Zhao, Winkler 1995). Furthermore it 
was shown that PdxH is feedback-inhibited by 
PLP (Zhao, Winkler 1995). Under ideal 
conditions one mole of PdxH will produce 
0.76 moles of PLP and H2O2 from 0.76 moles of 
PNP and O2 per second, which is at least 10x 
faster than the reaction upstream. 
 












Amt. needed for 
10 g l-1 PNP 
[g l-1] 
% of PDW at 
OD600 = 10 
Epd 50 1 0,0046 37,14 0,0002 0.02 
PdxB 1.4 36 0,1659 41,2 0,0068 0.85 
SerC 0.15c 333 1,5484 39,6 0,0613 7.66 
PdxA 1.66 30 0,1399 35,9 0,0050 0.63 
PdxJ 0.07 714 3,3181 26,2 0,0869 10.87 
PdxH 0.76 66 0,3056 25,55 0,0078 0.98 
Dxs 0.8 63 0,2903 67,44 0,0196 2.45 
a highest reported value 






3.5.2. The insertion of a genomic 
pdxH construct enhanced growth 
As shown above, the enzymes of the 
recombinant DXP-dependent B6 synthesis 
pathway are required in very different amounts. 
To show an effect on the pathway as a proof of 
principle, the last reaction from PNP to PLP by 
the PNP oxidase PdxH was streamlined by 
insertion of a genomic pdxH construct replacing 
the plasmid based construct. This should lower 
the gene dose and therefore the relative enzyme 
amount in the cell. Furthermore, this should 
lower the amount of produced PLP and the 
accumulation of non-toxic PNP. However, the 
gene dose of the genomic construct is identical 
with the inserted SC1 containing pdxJ and since 
PdxH is approximately 10x faster than PdxJ, the 
streamlining was still not perfect. However, in 
the case we saw an effect, this would already 
have been strong evidence for the potential of 
streamlining. Strains carrying the genomic pdxH 
construct was already mentioned above (see 
3.2.2). The pdxH gene was amplified from E. 
coli DH5α with primers JR75 and JR78 and the 
constitutively active promoter Pa and a 
synthetic, perfect RBS were placed in front of the 
pdxH start codon with JR75 (Gundlach et al. 
2017). The flanking regions were amplified with 
JR74, JR76, JR77, and JR79. The pdxH gene and 
the flanks were fused by PCR and the resulting 
LFH construct was used to transform the B6 
auxotrophic strain BV604 (ΔpdxST). The 
successful integration of the marker-less 
construct was checked by selection on plates 
containing 1 µM PN, which only allowed growth 
in presence of a functional PLP oxidase. The 
resulting strain BP911 (ΔpdxST aprE::pdxH) was 
transformed using the genomic DNA of BV411-1 
(amyE::SC1), resulting in strain BP912 (ΔpdxST 
aprE::pdxH amyE::SC1) (Commichau et al. 
2014). Strain BP912 was subsequently 
transformed with genomic DNA from BV412-1 
(sacB::SC2*) resulting in strain BP913 (ΔpdxST 
aprE::pdxH amyE::SC1 sacB::SC2*) (Commichau 
et al. 2014). This strain was lacking the 
endogenous B6 synthesis genes pdxST but 
contained the complete DXP-dependent 
synthesis pathway in single copy as part of 
genomic constructs. BP913 was compared to the 
wildtype strain SP1 and the previously 
published strain BV606 (ΔpdxST amyE::SC1 
sacB::SC2*) pBV415, which carried the plasmid-
based pdxH construct (Commichau et al. 2014). 
As shown in Figure 35, strains BP913, BV606 
pBV415 and SP1 were compared in liquid C Glc 
minimal medium. Strain BP913 grew almost like 
the wildtype, while BV606 pBV415 grew 
markedly slower. These data showed that even 
a small change in the amount of one of the 
enzymes could have an influence on the 
production strain and how promising the 
streamlining of the pathway could be. 
 
Figure 35: The genomic integration of pdxH and 
lower gene dosage have a slight growth effect on 
the heterologous strain. Strains were grown in 
C Glc minimal medium at 37°C. Values are means 
of technical triplicates. 
3.5.3. Rational design of a vitamin B6 
production strain 
Considering that the different enzymes of the 
recombinant pathway from Epd to PdxH 
catalyze their reactions at different speed, it 
might be useful to adjust the amounts of the 
enzymes in the production strain as has been 
shown above Figure 35. In case of Epd, for 
example, the turnover per mol is at least 7 times 
faster than of PdxB. This means that PE will 
accumulate when the two enzymes are present 
in the same amounts (meaning that expression 
of both is controlled by one or the same 
promoter). If PdxB was expressed 7 times 
stronger than Epd, less PE would accumulate, 
however. Of course, this is an idealized view on 
how kinetics work. All these enzymes have been 
tested in their respective host organisms or in 
vitro and never in a recombinant B. subtilis 
strain. Furthermore, we know little about 
possible feedback mechanisms, which might 




enzymes in the pathway (as known for PdxH 
Zhao, Winkler 1995). To hypothesize which 
protein amounts are needed in the final cell or 
culture, it is needed to know the amount of total 
protein in living bacterial cells.  Delgado and 
colleagues showed that growing E. coli cells 
consist of 70% water and that 50-55% of the dry 
weight is made up by proteins, and it is assumed 
that this data would also be true for B. subtilis 
(Delgado et al. 2013). A fermenter with a volume 
of 1 l with a culture with the OD600 of 10 will 
contain approximately 8x1012 cells. When each 
cell has a dry weight of approximately 200 fg 
during stationary phase (Delgado et al. 2013), 
the total bacterial dry mass in the fermenter is 
(8 x 1012 cells x 200 x 10-15 g = 1600 x 10-3 g =) 
1.6 g and the protein weight is 0.8 g. To calculate 
the needed amount of the pathway proteins, 
first an amount of B6 to be produced with the 
strain is defined. For an industrially interesting 
amount, 10 g l-1 in a 48h fermentation process, 
which would be 0.041 moles per liter of PLP 
(M=247.142 g mol-1) or 0.040 mol l-1 of PNP 
(M=249.158 g mol-1) was previously defined 
(Rosenberg et al. 2017a). For fermentation it 
would be more useful to produce PNP to 
circumvent the toxic effects of PLP, which is why 
the following calculations were done for PNP. 
The fermentation time of 48 hours is equal to 
172800 seconds. By dividing the needed amount 
of PNP molecules by the time in seconds, one can 
calculate the needed minimal turnover per 
second, corresponding to the lowest possible 
number of catalyzed reactions by the slowest 
enzyme that still allows to reach the targeted 
amount within 48 hours: 
0.040 mol l-1/172800 s = 2.32 x 10-7 mol l-1 s-1. 
From the turnover and the molecular weight of 
each enzyme, it can be calculated which amount 
of enzyme is needed and together with the 
reported dry weight of the cells, what 
percentage of the protein dry weight (PDW) this 
makes up (Table 12). First, the needed minimal 
turnover is divided by the turnover of each 
individual enzyme to calculate the required 
amount in mol l-1. Then this is multiplied with 
the molecular weight in g mol-1 yielding the g l-1 
needed for 10 g l-1 PNP within 48 hours. With the 
given data from Delgado and colleagues the 
approximate percentage of the PDW is 
calculated by dividing the needed grams per 
liter of each enzyme by the PDW (0.8 g l-1) (Table 
12). These amounts are then compared to the 
proteome of B. subtilis. According to a 2D-Gel 
analysis by Eymann and colleagues, the most 
abundant protein is TufA, which makes up 5.4% 
of the total protein detected on the gel, followed 
by IlvC (2.5%), Hag (2.3%), RplL (2%), and MetE 
(1.9%) (Eymann et al. 2004). The most 
abundant B6-synthetic gene, PdxS (YaaD) is 
ranked at place 99 and makes up 0.2% of the 
total protein. Considering that not all proteins 
are in the pI range that was chosen and that 
there must be a certain number of proteins not 
detected, the percentage might be even lower 
than stated. Looking at the recombinant 
pathway, the required amounts of some of the 
enzymes are relatively high. The required 
amount of PdxJ and SerC, for example, is higher 
than the amount of the most abundant protein 
in the normal B. subtilis cell. This, of course, is a 
serious problem. Workarounds could be a 
considerably higher OD600, and/or longer 
fermentation times in combination with a lower 
expression of the pathway genes.  
A recent publication presented promoter and 
RBS libraries that can modulate expression over 
a large range which can modulate GFP 
expression from nM to mM concentrations in 
exponential and stationary phase (Guiziou et al. 
2016). This is perfect to modulate the 
expression of the single enzymes in the B6 
pathway in fed-batch or single batch 
fermentation (Table 13). The weakest promoter 
was chosen for the enzyme that was required in 
the lowest amounts, Epd. For the other enzymes 
promoters with the desired relative strength 
were chosen (Table 13). The strength of the 
promoters was determined by Guiziou et al. 
using GFP expression, which can be used to 
predict the amounts of protein that will be 
produced by the promoters (Guiziou et al. 
2016). The predicted PNP amounts produced by 
this setup (if the E. coli proteins were expressed 
like GFP) is ~50 times higher than planned. To 
adjust the expression to fit the required 
amounts RBS R2-8 fits perfectly. It almost 
exactly modulates the expression by a factor of 
0.02 and could be used to achieve the desired 
enzyme amounts (Table 13). For better 
comparability, Guiziou and colleagues designed 
the constructs with a standardized transcription 
start sequence (TSS) from PfbaA (GGAGAAAA), 
which should also be used in the rationally 




expression. This way the new synthetic 
constructs will look as shown in Table S 2.
 



















Epd 1 PS22 1,00 0,29 0,0046 0,0160 
PdxB 36 PV7 36,00 10,45 0,1659 0,0159 
SerC 333 PymdA 309,00 89,70 1,5484 0,0173 
PdxA 30 PY13 28,24 8,19 0,1399 0,0171 
PdxJ 714 PY4 723,67 209,87 3,3181 0,0158 
PdxH 66 PS10 63,28 18,35 0,3056 0,0167 








4.1. The multifaceted regulation of 
the hom operon 
As described in the introduction, the amino acid-
dependent regulation of the hom operon and of 
the gene encoding aspartokinase III, thrD has 
been investigated in previous studies, showing 
that aspartokinase III is induced by lysine and at 
the same time inhibited by a combination of 
lysine and threonine (see 1.4.4, Kobashi et al. 
2001; Graves, Switzer 1990). Both the hom 
operon and thrD are also believed to be 
inhibited in presence of branched chain amino 
acids by the regulator CodY, which binds to a 
conserved recognition site in their promoters 
(Belitsky, Sonenshein 2013; Sonenshein 2005). 
The exact regulatory effects of different amino 
acids on the hom operon are shown above and 
in Rosenberg et al. 2016. Interestingly, no 
regulation by threonine, the product of the 
enzymatic pathway encoded in this operon 
could be observed. The same holds true for most 
other tested amino acids. The operon is only 
repressed by isoleucine and homoserine and 
only the effect of isoleucine is CodY-dependent 
(Figure 8). A study by Kriel et al. showed that 
when ppGpp synthesis was induced in presence 
of CodY, the hom operon was strongly activated, 
which was also the fact in a ppGpp codY double 
mutant. Complementarily, in a conditional 
ppGpp mutant in presence of CodY and with 
abundant GTP (which enhances CodY activity, 
Brinsmade, Sonenshein 2011), the operon was 
almost completely shut down (Kriel et al. 2014). 
Taken the fact that this dissertation finds only 
evidence for CodY-dependent regulation of hom 
through isoleucine, the inhibition observed by 
Kriel et al. most likely is conveyed through this 
amino acid. However, the same study also found 
that the hom operon is regulated under the same 
conditions in a CodY-independent manner, as 
shown by the lack of activation in a ppGpp codY 
double mutant with abundant GTP (Kriel et al. 
2014). The latter observation can be partially 
explained by the inhibition through ThrR 
presented in this work. Figure 8 shows that 
ThrR inhibits transcription of the hom operon 
constitutively and in presence of most amino 
acids except for lysine and cysteine, which both 
activate transcription to the level of a thrR 
mutant. However, even the codY thrR double 
mutants are regulated by homoserine and 
isoleucine, which indicates that this regulation 
is conveyed by yet another mechanism, which 
might be GTP-dependent, as described by Kriel 
and colleagues. An explanation for a non-
proteinous GTP-dependent regulation of 
transcription during stringent response has 
been elaborated before the cited Kriel study. It 
is known that transcription initiation during 
stringent response in B. subtilis is controlled by 
the purines at positions +1 and +2 of the 
transcript, called ‘stringent transcription 
control’ (Tojo et al. 2010). This distinguishes B. 
subtilis from E. coli, where ppGpp inhibits 
initiation of transcription by RNA-polymerase 
and allows the ppGpp-independent 
upregulation of transcripts starting with 
adenines during GTP limitation in stringent 
response. The hom operon starts with two 
adenines as described in the publication this 
work is part of (Rosenberg et al. 2016), which 
explains why it is not upregulated when GTP is 
abundant although CodY and ppGpp are absent 
(Kriel et al. 2014). 
Another possibility is that homoserine and 
isoleucine have influence on the glutamine-
dependent transcriptional regulator TnrA, 
which has been shown to inhibit the hom operon 
during nitrogen limitation (Mirouze et al. 2015). 
However, the used CSE minimal medium 
contains glutamate and ammonium, which 
should lead to absence of TnrA repression 
(Wray et al. 2001; Gunka, Commichau 2012). 
Summarizing, the hom operon is regulated by at 
least four mechanisms being (I) CodY-
dependent inhibition of transcription in 
presence of isoleucine and GTP, (II) the 
inhibition by ThrR in absence of cysteine and 
lysine, (III) the N-dependent inhibition by TnrA, 
and (IV) stringent transcription control, a GTP-
dependent mechanism. 
4.2. The regulation of the hom 
operon by ThrR 
The data presented in 3.1.1 is part of a work 
which shows that the previously 
uncharacterized ACT-domain containing 
protein ThrR is a transcriptional regulator of the 
thrD and hom operons encoding aspartokinase 
III, homoserine dehydrogenase, homoserine 
kinase and threonine synthase and therefore a 
major part of the threonine and isoleucine 




visible only because several publications over 
more than three decades reported several 
phenotypes. In the 70’s Vapnek and Greer 
reported the capability of threonine synthase 
ThrC to take over the function of threonine 
dehydratase IlvA by deregulation of the hom 
operon, in 1986 Parsot showed that the two 
enzymes had a common ancestor (and are 
indeed 25% identical) and in the project this 
work is a part of, a new mutation in the 
unknown gene thrR revealed that the hom 
operon is actually repressed by the encoded 
regulator ThrR (Vapnek, Greer 1971a, 1971b; 
Parsot 1986; Rosenberg et al. 2016). However, it 
could take another decade until the effector of 
ThrR will be found. ThrR contains a weakly 
conserved helix-turn-helix (HTH) motif from 
residue 27 to 56 and a well conserved aspartate 
kinase-chorismate mutase-tyrA (ACT) domain 
from residue 70 to 141 (KEGG). ACT domains 
are known to have regulatory effects and often 
bind small molecule ligands, which are mostly 
amino acids (Pfam PF01842 , Liberles et al. 
2005). For example the  regulation of 
aspartokinase III by lysine is conveyed by an 
ACT domain (Kobashi et al. 2001, uniprot). 
Therefore, the initial hypothesis was that ThrR 
would be an amino acid-dependent regulator. 
However, although DNA-binding and cysteine 
and lysine-dependent regulation of hom by ThrR 
could be shown, no interaction between ThrR 
and these amino acids could be proven by ITC 
measurements (data not shown for lysine, for 
cysteine see Figure S 3). In the case of cysteine, 
the ITC measurements are difficult to interpret. 
In absence of a reductive agent, there is a very 
strong but unstable signal indicating a binding 
ratio of 1:1 but in presence of DTT, no strong 
signal could be observed. This might hint at a 
different exothermic reaction than the 
interaction between cysteine and ThrR as for 
example an oxidation of cysteine to cystine or 
cysteine sulfonic acid (Poole 2015). On the other 
hand, DTT might lead to an inactivation of ThrR. 
Future experiments as for example NMR might 
shed light on the interaction between ThrR and 
cysteine (Otting 1993). So long, no amino acid 
seems to interact directly with ThrR. However, 
the regulation by isoleucine, homoserine, 
cysteine and especially lysine is obvious. An 
explanation for this divergence might be an 
indirect regulation of ThrR by the amino acids as 
it is the case for TnrA (Wray et al. 2001). ACT 
domains have been shown to take part in 
dimerization (Grant 2006) and might therefore 
also take part in the interaction between 
proteins. The applied techniques to identify 
possible proteinous interaction partners show 
no reproducible results, however. The possible 
interaction with CodY was ruled out by a B2H 
and SPINE and so was the interaction between 
BirA and ThrR. The fact that BirA was found in 
the SPINE is likely due to a cross-contamination. 
Summarizing, ThrR is a novel regulator of the 
hom and thrD operons, but the mechanism by 
which it is regulated itself remains unknown. 
4.3. Update on the regulation of 
aspartate-derived amino acids 
In B. subtilis, isoleucine, threonine, lysine and 
methionine all derive from aspartate and 
therefore are called the aspartate-derived 
amino acids. The regulation of the pathways 
leading to the different amino acids are very 
differentially regulated by transcriptional 
inhibition and activation and allosteric feedback 
inhibition (see 1.4.4). Figure 36 shows a scheme 
for the regulation of these pathways dependent 
on the abundance of different amino acids. The 
differential regulation starts with the three 
aspartokinases I, II and III, DapG, LysC and ThrD, 
respectively. DapG is known to be inhibited by 
DAP and therefore thought to be the designated 
enzyme for initiation of the pathway leading to 
lysine and peptidoglycan (Graves, Switzer 
1990). The same holds true for LysC, which is 
transcriptionally repressed by lysine (Grundy et 
al. 2003; Kochhar, Paulus 1996). ThrD is 
inhibited by threonine and lysine in 
combination, indicating a more general role 
than the other two feedback-inhibited 
aspartokinases (Kobashi et al. 2001). At the 
same time, ThrD is transcriptionally activated 
by lysine and so are Hom, ThrB and ThrC, the 
threonine synthetic enzymes (Graves, Switzer 
1990; Rosenberg et al. 2016). This indicates that 
the aspartokinases function like a sorter, 
distributing metabolites to either of the 
pathways, suggesting possible channeling 
mechanisms. In the case that lysine, threonine 
and DAP are all equally abundant, all 
aspartokinases will be inactive, DapG is 
inhibited by DAP, LysC will be repressed by 
lysine and ThrD will be inactivated by lysine and 




transcriptional activation by lysine. This might 
be an insurance that the cell will have enough 
aspartokinase to swiftly start producing ASA if 
needed. In the situation that lysine and DAP are 
abundant, but threonine is limited, lysine and 
DAP inhibit DapG and repress LysC, but ThrD is 
still active due to the lack of inhibition by 
threonine. When threonine is abundant but DAP 
and lysine are scarce, Hom is feedback inhibited 
and ASA is funneled into the DAP pathway 
(Yeggy, Stahly 1980; Parsot, Cohen 1988; 
Gutiérrez-Preciado et al. 2009). Furthermore, 
homoserine and isoleucine will most likely also 
be abundant under these circumstances, leading 
to transcriptional inhibition of Hom, ThrB and 
ThrC. Additionally, the transcriptional 
activation of these three enzymes by cysteine 
shown in this work guarantees threonine 
synthesis when cysteine is abundant, by pulling 
homoserine into threonine synthesis. This 
mechanism is very elegant, since the 
aspartokinases will be inhibited once the other 
aspartate-derived amino acids are abundant 
and do not need to be inhibited also by cysteine. 
 
Figure 36: Scheme illustrating the regulation of 
the aspartate derived amino acid pathways. Amino 
acids are three-letter-code; ASA, L-aspartate-4-
semialdehyde, H-Ser, homoserine; PG, 
peptidoglycan; DAP, diaminopimelate. Blue box, 
part of the Thr pathway encoded in the hom 
operon. Red and green lines show inhibitory and 
activating regulation, respectively. Dotted lines 
show metabolic pathways containing more than 
one enzyme. 
In summary, the synthesis of aspartate-derived 
amino acids is a very sophisticated, fine-tuned 
tree of pathways originating from three sorter-
like aspartokinases. 
4.4. Biotin as a vitamin B6 antidote 
It has been previously shown and demonstrated 
here that exogenous PL is toxic to cells above a 
certain threshold, which for B. subtilis is 
approximately 3 mM (Figure 11, Vermeersch et 
al. 2004; Dong, Fromm 1990; Ohsawa, Gualerzi 
1981; Metzler, Snell 1952; Shanbhag, Martell 
1991). The reasons for this toxicity are most 
likely inactivation of proteins (Vermeersch et al. 
2004; Dong, Fromm 1990) and non-enzymatic 
deamination of metabolites as shown for amino 
acids (Metzler, Snell 1952; Shanbhag, Martell 
1991; Keller et al. 2015). In 3.1.2 it is shown that 
B. subtilis can form suppressor mutants that are 
able to live in presence of toxic amounts of PL on 
solid medium. Interestingly, the suppressors 
also allow growth of neighboring cells (Figure 
12) and are not able to grow in liquid medium 
with toxic PL amounts (Figure 13B). This might 
indicate that the acquired mutations lead to the 
secretion of either (I) a beneficial metabolite 
(antidote) or (II) a PL(P)-degrading 
or -modifying enzyme. Both mechanisms would 
have stronger effect in a more stable and 
diffusion restricted environment like agar 
plates, because the factor conveying resistance 
does not diffuse away as fast and the toxic 
compound does not get replenished as fast as in 
liquid medium, fitting the observation in Figure 
13. Possibility (I) could be explained by the need 
for amino acids, which are depleted by 
deamination through PL. In this case the 
secretion of amino acids could be beneficial by 
interaction with PL resulting in a lower 
concentration of free vitamers. Indeed, external 
addition of casamino acids allows growth of B. 
subtilis in presence of toxic PL amounts (Bolgi 
2017). A mechanism like (II) is commonly 
known from β-lactamases, which are secreted 
into the medium, degrade β-lactam antibiotics 
and lead to the formation of satellite colonies, 
which themselves do not necessarily encode the 
resistance (Medaney et al. 2016). However, the 
suppressor mutants acquired genomic 
alterations leading to the up-regulation of the 
biotin synthesis operon (see Table 5 and Figure 
14). Furthermore, additional results from this 
lab could show that the external addition of 
biotin improved growth in presence of toxic 




resistance is caused by the accumulation and 
seemingly also secretion of another B vitamin, 
biotin. Biotin and PLP are metabolically 
connected, because both 8-amino-7-
oxoonanoate synthase BioF and 7,8-
diaminopelargonic acid aminotransferase BioA 
are PLP-dependent enzymes (Mann, Ploux 
2011). Apart from that, the two vitamins have 
quite different functions. Vitamin B6 is involved 
mainly in the amino acid-related metabolism, 
while vitamin B7 is involved in the synthesis of 
fatty acids by biotinylation of the acetyl-CoA 
carboxylase subunit AccB and in pyruvate 
metabolism through the biotin-dependent 
pyruvate carboxylase PycA (Cronan, Waldrop 
2002; Valle 2017). Despite these differences, 
there are currently three working hypotheses 
for the effect of biotin, some of which have 
already been tested: 
1) Biotin and PL or PLP could interact directly. 
This way biotin would lower the amount of free 
vitamers thereby lowering the probability of 
harmful interactions. The biochemical basis for 
this could be an interaction of pyridoxal with the 
secondary amines of biotin or the primary 
amino groups of the precursor 7,8-diamino-
onanoate. These compounds and PL might form 
a Schiff base and leave a great percentage of the 
interaction partners in an intermediate state, 
because non-enzymatic deamination is 
inefficient at pH<9 (Shanbhag, Martell 1991). 
However, biotin and PL could not be shown to 
interact directly in ITC measurements, hinting 
that PL might not be able to interact with 
secondary amines (Bolgi 2017). It might 
however be possible that external addition of 
biotin leads to an accumulation of its precursors, 
which could then interact with PL. This 
hypothesis remains to be tested. 
2) PLP might compete with biotin for the 
biotinylation site of AccB and BirA. It is known 
that PLP interacts with lysine residues in PLP-
dependent enzymes, which is also true for biotin 
in biotinylated enzymes (Toney 2005; Waldrop 
et al. 1994). Furthermore, the toxic effect of 
exogenously added PL has been accounted to 
the modification of lysins in DNA topoisomerase 
and initiation factors (Vermeersch et al. 2004; 
Ohsawa, Gualerzi 1981). This could mean that 
the higher amount of biotin would ensure that 
the biotinylation sites are saturated and less 
prone to binding and modification by PLP. 
Others tried to pinpoint this interaction by 
overexpression of AccB in B. subtilis in order to 
achieve higher tolerance to exogenous PL but 
the experiments gave no evidence for a 
beneficial effect of AccB overexpression (Bolgi 
2017). For future experiments, BirA and PycA 
should also be considered, because also this 
enzyme might be inhibited by PLP. 
3) Lastly, PLP might by an unknown mechanism 
inhibit the expression of the bio operon, 
depleting the essential vitamin biotin. 
Interestingly, experiments showed that this is 
indeed the case. In presence of high amounts of 
exogenous PL, the biotin operon is inhibited 
(Bolgi 2017). Under the same conditions, the 
operon containing the trigger enzyme BirA 
encoding birA gene was upregulated (Bolgi 
2017). It seems therefore plausible that toxic PL 
amounts cause regulatory biotin auxotrophy in 
B. subtilis. This relationship should be proven by 
BirA-independent, constitutive expression of 
the bio operon in the future. However, in the 
presence of toxic PL concentrations, the biotin 
concentration should drop according to our 
observations, which is in contrast to the present 
understanding, that a lower biotin 
concentration leads to derepression of the bio 
operon, because BirA inhibits the bio operon in 
the monomeric, biotin-bound state (Wang, 
Beckett 2017). The fact that the cells anyhow 
acquired deregulating mutations in the 
promoter of the operon indicate that this 
mechanism does not work under the tested 
conditions. Therefore, it should be evaluated 
whether PLP inhibits BirA dimerization and 
enhances DNA binding, creating a pressure to 
deregulate the bio operon. 
4.5. The search for bacterial 
vitamin B6 transporters 
To date, no bacterial vitamin B6 transporter has 
been identified, although the capability to take 
up B6 vitamers has been proven as summarized 
in the following. It was shown a longer time ago 
that only non-phosphorylated vitamers can be 
taken up by E. coli and kinetic measurements 
hint at facilitated rather than simple diffusion 
(Yamada et al. 1977). However, one study 
showed that PN was possibly diffusing through 
membranes of guinea pig jejunum (Yoshida et al. 
1981). Again on the contrary, vitamin B6 is 




E. coli as shown by competition experiments 
(Yamada, Furukawa 1981). The first transporter 
was quite recently identified in Saccharomyces 
cerevisiae. Tpn1p of the purine-cytosine 
permease family is a high affinity PN:proton 
symporter (Stolz, Vielreicher 2003). This 
transporter has 23% identity with B. subtilis’ 
uncharacterized putative purine-cytosine 
permease YxlA with a query cover of 86% 
(BLAST, Altschul et al. 1997). Shortly after 
Tpn1p, the pyridoxine kinase PdxK was found in 
B. subtilis, which is a homolog of PdxK from E. 
coli and is very likely involved in the retainment 
of imported B6 vitamers (Park et al. 2004). The 
novel transporter Bsu1p of the major facilitator 
family was found in Schizosaccharomyces 
pombe, which is not a homolog of Tpn1p. It is 
also a proton symporter and is most likely a 
homolog of the human transporter (Stolz et al. 
2005; Hediger et al. 2013). This transporter has 
24% identity with Bcr from E. coli with a query 
cover of 79% and very low similarity with YdgK 
from B. subtilis (BLAST, Altschul et al. 1997). 
PUP1 (not to be confused with PUP1 from yeast) 
is a vitamin B6 proton symporter from 
Arabidopsis thaliana, which is not homologous 
to the previously known transporters and has 
no homologs in prokaryotes or archaea 
according to pBLAST (Szydlowski et al. 2013; 
Altschul et al. 1997). Additionally, NUP1, a 
homolog of PUP1, was found in Nicotiana 
tabacum (Kato et al. 2015). 
As mentioned above, Tpn1p has quite some 
similarity to a protein from B. subtilis, the 
putative purine-cytosine permease YxlA. YxlA 
together with the known allantoin permease 
PucI is part of the Nucleobase:cation symporter-
1 (NCS1) family, which is known to function as 
proton symporters for nucleobases and vitamin 
B6  (Pfam, Finn et al. 2016). B. subtilis contains 
also three transporters of the NCS2 family, 
PbuX, PucJ and PucK. The similarity of these 
transporters makes all of them strong 
candidates for putative vitamin B6 transporters 
of B. subtilis worth investigation in the future. 
However, the fact that no transporters were 
found to be mutated in the PL-resistant strains 
indicates that B. subtilis either encodes several 
or no dedicated B6 transporters at all. It could 
also be interesting to follow a bioinformatic 
approach, comparing the expression of the B6-
synthetic pdxST genes to known transporter 
genes. The synthetic genes should be needed 
when the cofactor is scarce in the environment, 
while the transporter is dispensable and on the 
opposite, when there is plenty of the cofactor in 
the environment, the synthesis genes are 
dispensable, and the transporters are required. 
Therefore, the dedicated transporters, if there 
are any, should be reversely regulated and it 
should be possible to analyze existing 
transcriptomic and proteomic data to find 
candidates. There is an example for a 
transporter, whose expression is negatively 
corelating with pdxST. The genes encoding the 
Na+/H+ antiporter system KhtSTU, which is 
involved in the detoxification of methylglyoxal 
(MG) (Subtiwiki, Michna et al. 2016; 
Chandrangsu et al. 2014). 
4.6. B. subtilis is not able to feed 
intermediates of B6 synthesis 
In 3.2, the incapability of consortium B to form a 
stable coexistence of the strains showed that 
strains expressing partial B6 biosynthesis 
pathways were not able to feed each other the 
intermediates PN and/or PL. We know however, 
that PL producing strains can feed auxotrophs 
as shown for example in Figure 15 and Figure 
17. Therefore, the vitamer that cannot be fed 
must be PN. There are two possible reasons for 
this. (I) The export of PNP requires 
dephosphorylation and the import successful 
phosphorylation. The enzymes responsible for 
these processes might be inactive under the 
used conditions or specific for PLP in B. subtilis, 
or (II) the production of PNP is feedback-
inhibited and the product never reaches a titer 
sufficient to sustain growth of both strains.  
The first possibility might be explained by the 
fact that some phosphatases are inhibited by 
inorganic phosphate and the used C Glc minimal 
medium is rich in phosphate (Huang et al. 2012; 
Tazoe et al. 2005; Martin-Verstraete et al. 1990). 
Furthermore, a high phosphate concentration 
changes the equilibrium in favor of 
phosphorylated compounds thus preventing 
phosphatase activity and export of vitamers. 
Additionally, the unknown phosphatase of B. 
subtilis might also be specific to PLP, forcing PNP 
to be retained inside the cell. The phosphatase 
PdxP from S. meliloti catalyzes hydrolysis of PLP 
and PNP but not of PMP, for example. Since E. 
coli and B. subtilis share no homologs of this 




specificities their phosphatases could have 
(EggNOG, Huerta-Cepas et al. 2016). The second 
possibility seems realistic because it is known 
that PdxH and Dxs are subject to feedback-
inhibition. PdxH from E. coli is inhibited by its 
product PLP and Dxs from several organisms 
including B. subtilis by isopentenyl 
pyrophosphate and dimethylallyl 
pyrophosphate (for B. subtilis this was only 
shown for the latter), which are both products of 
the isoprenoid synthesis pathway (Zhao, 
Winkler 1995; Banerjee et al. 2013; Kudoh et al. 
2017). For vitamin B6 synthesis intermediates 
and for other enzymes feedback inhibition has 
not been described so far but remains 
imaginable.  
Summarizing, the incapability of strains 
expressing partial DXP-dependent pathways to 
exchange intermediates of the pathway could be 
due to the unknown specificities and feedback-
inhibitory interactions of the synthesizing and 
modifying enzymes. It does not seem to be 
beneficial to the cell to produce a useless 
vitamer (PN) in huge quantities to feed it to 
another strain. Therefore, the ability to achieve 
a stable consortium would likely need to be 
engineered. 
4.7. An alternative route for 
threonine and isoleucine 
biosynthesis in B. subtilis 
As described in 3.2.2, a thrC deletion strain 
carrying the heterologous DXP-dependent 
vitamin B6 synthesis pathway formed 
suppressor mutants that could grow on C Glc 
minimal medium without external addition of 
threonine (Figure 21). This kind of suppressor 
mutant has not been described previously 
according to thorough literature research. The 
mechanism by which these mutants overcome 
the absence of the threonine synthase is so far 
unknown. It has previously and above been 
described that mutants lacking threonine 
dehydratase IlvA could overcome isoleucine 
auxotrophy by overexpression of the hom 
operon leading to higher amount of ThrC, which 
has a minor threonine dehydratase activity 
(Vapnek, Greer 1971a, 1971b). Furthermore, 
threonine synthase, threonine dehydratase and 
D-serine dehydratase have been shown to have 
a common ancestor and that they are carrying 
out their reaction by a conserved mechanism 
(Parsot 1986). It was hypothesized that the 
current suppressors would overcome lack of 
threonine synthase by overexpression of IlvA, 
possibly utilizing a minor threonine synthase 
activity. However, the promoter of ilvA (PilvA) 
was not mutated. Another possibility was that 
enzymes upstream of ThrC could take over the 
threonine synthase activity and that this would 
be achieved by deregulation of the hom operon. 
Therefore, the sequence encoding the described 
regulator of hom, ThrR and the sequence of the 
promoter of hom (Phom) were checked, but also 
turned out to be the wildtype alleles. 
Additionally, B. subtilis can catabolize threonine 
to glycine via threonine dehydrogenase Tdh and 
2-amino-3-ketobutyrate CoA ligase Kbl and both 
reactions of this catabolic pathway are 
theoretically reversible, which proposes a 
possible mechanism for a bypass of ThrC (Figure 
37 and Figure 40; Schmidt et al. 2001; Higashi et 
al. 2005; Raj et al. 2014).  The suppressor 
mutations might lead to an accumulation of 
glycine raising the reaction equilibrium 
concentration and/or a deregulation of the 
operon of tdh and kbl leading to an inversion of 
the metabolic flux and production of threonine. 
Future investigations should check these 
possibilities and also take into account the D-
serine deaminase SdsA, which could also show a 
minor threonine synthase activity due to its 
mechanistic similarity (Parsot 1986).  
Furthermore, other bacteria including E. coli 
possess the capability to degrade threonine 
directly to glycine by activity of threonine 
aldolase LtaE (which is also part of a 
serendipitous B6 synthesis pathway in E. coli) 
(Liu et al. 1998; Kim et al. 2010). This reaction is 
in theory also reversible. B. subtilis does not 
encode any homolog of this enzyme, although it 
is universally present in all domains of life and 
even other bacilli do encode it (Pfam, Finn et al. 
2016). It would however be imaginable that B. 
subtilis acquired this function by mutation. It 
was furthermore found that 2-isopropylmalate 
synthase LeuA is 40% identical and homologous 
to (R)-citramalate synthase CimA from 
Methanocaldococcus jannaschii (2.3.1.182) 
whose activity is not thought to be existent in B. 
subtilis (BLAST, Altschul et al. 1997). (R)-
citramalate synthase feeds into an alternative 
acetyl-CoA and pyruvate-derived isoleucine 
synthesis pathway and might thereby bypass 




from 2-OB to threonine is reversible in vivo, 
which might be the case when the given 
pathway is strongly deregulated and 2-OB 
accumulates (Charon et al. 1974; Howell et al. 
1999; Risso et al. 2008). Lastly, although it is 
unlikely that the enzymes of the DXP-dependent 
vitamin B6 synthesis pathway are able to 
convey threonine synthase activity, this 
possibility should be ruled out by knockouts of 
the heterologous constructs or crossing with the 
thrC deletion mutant BP920 (ΔpdxST ΔthrC) 
with selection for threonine prototrophy and 
checks for the absence of the heterologous 
constructs. 
 
Figure 37: Scheme showing possible ThrC 
bypasses in B. subtilis. Amino acids are three-
letter-code; ASA, L-aspartate-4-semialdehyde, H-
Ser(-P), homoserine (phosphate); DAP, 
diaminopimelate; 2-OB, 2-oxobutyrate; 2MM, (R)-
2-methylmalate; AOB, 2-amino-3-oxobutyrate. 
Protein shown in circles, dotted lines depict 
pathways carried out by more than one enzyme. 
Reactions that have not yet been shown to exist or 
be reversible in B. subtilis are depicted with 
question marks. 
Summarizing, there are several possible routes 
the isolated thrC suppressor mutants might take 
to bypass threonine synthase (Figure 37) and 
future experiments should elucidate this 
potential alternative route for synthesis of 
isoleucine and threonine. It is strongly advised 
to further investigate these suppressors and 
possibly determine the whole genome 
sequence. 
4.8. Vitamin B6 starvation is 
connected to amino acid limitation 
Vitamin B6 is a cofactor in many amino acid-
related reactions (see 1.2). It is therefore a 
logical consequence that lack of this essential 
cofactor is accompanied by disturbances in 
amino acid metabolism. However, only little is 
known about the effects of vitamin B6 starvation 
on the cellular level.  It has been shown decades 
ago that isoleucine and threonine prolong 
growth during PN starvation (Dempsey, Sims 
1972). Furthermore, B6 limitation in humans 
leads to accumulation of intermediates of 
cysteine and methionine homeostasis (Dalto, 
Matte 2017). The presented results show that 
vitamin B6 auxotrophic strains expressing the 
heterologous partial DXP-dependent pathway 
can grow at least for some hours in presence of 
CAA in combination with methionine or cysteine 
(Figure 28). It however remains unknown, 
whether this effect is due to feeding into the 
heterologous pathway or starvation for amino 
acids. Other work in this lab showed that 
addition of complex amino acids did not allow 
for growth of vitamin B6 auxotrophic strains 
suggesting that the growth promoting effect is 
indeed due to feeding into the pathway (Yeak 
2017). Future research should elucidate the 
connection between B6 starvation and amino 
acid limitation. 
4.9. Adaptation to the introduction 
of a heterologous pathway 
This work tried to find novel ways to ship 
around the current obstacles in the widely 
unknown waters of fermentative vitamin B6 
production (see 1.3). In many ways the 
heterologous introduction of production 
pathways into host organisms is equivalent to 
horizontal gene transfer (HGT). In both cases 
genes are acquired that did not coevolve with 
the host metabolism (at least in the recent past). 
This can mean that substrates, cofactors, export 
systems or detoxification mechanisms required 
for use of function encoded by the new genes are 
absent. To use the pathway encoded by the 
newly acquired genes, the host must adapt, and 
the adaptations can be categorized into (I) 
adaptation to interactions between acquired 
and host metabolism and (II) rewiring of the 





(I) Other reports previously highlighted the fact 
that horizontal transfer of elements (genes, 
mobile elements, plasmids) conveying a trait is 
not necessarily sufficient and needs further 
refinement because the new trait might be 
costly or interactions between host  metabolism 
and the heterologous or xenologous element can 
be detrimental (Carroll, Marx 2013; Michener et 
al. 2014; Rand et al. 2017). It can in fact be 
expected that many beneficial mutations that 
occur after acquisition are restoring the 
metabolic state before the event, rather than 
rewiring or optimizing the newly acquired 
element. This, among other adaptations, has 
been observed when the pathway for the use of 
methanol of Methylobacterium was replaced 
with a heterologous pathway (Carroll, Marx 
2013). The newly acquired pathway was 
functional but depleted the cellular NADPH 
which was countered by mutations deregulating 
the pntAB genes which encode 
transhydrogenases capable of replenishing the 
NADPH pool. In case the new element is not 
required for growth, the adaptation could also 
lead to inactivation, for example when the DXP-
dependent vitamin B6 pathway was introduced 
into B6 prototrophic B. subtilis the gene 
encoding the first enzyme of the pathway, epd, 
was inactivated by mutation in several cases 
(Commichau et al. 2014). This lead to 
inactivation of the unnecessary and obviously 
costly heterologous pathway. 
(II) The actual rewiring of the new pathway to 
the host metabolism can happen in several 
different ways, for example through regulatory 
rewiring, activation of pathways supporting the 
new function, or inactivation of pathways that 
inhibit it. This was observed, when the 
previously described beneficial but costly 
pathway for use of methanol as a carbon source 
was expressed from a plasmid in 
Methylobacterium lacking the endogenous 
methanol catabolic pathway (Chou, Marx 2012). 
The engineered cells initially grew worse than 
the wildtype on medium containing methanol 
but acquired mutations that optimized the gene 
dosage or expression of the recombinant 
pathway.  
 
Figure 38: Scheme showing some possible host-
heterologous interactions and possibilities to 
circumvent these. (A) Situation directly after 
introduction of the heterologous element (blue) 
conveying the trait of conversion of X to Y. 
Endogenous pathways shown in red, green and 
black. The host does not endogenously produce X, 
but a similar compound X’. One intermediate of the 
heterologous pathway interferes with synthesis of 
A and B. C allosterically inhibits one of the 
heterologous enzymes. (B) Situation after 
adaptation. The host acquired mutations 
unmasking underground metabolic activities 
leading to the conversion of X to X’ and an activity 
bypassing the inhibited enzyme in the pathway 
synthesizing A and B. The host furthermore 
inactivated the pathway synthesizing C, thus 
allowing production of Y. 
Furthermore, mutations optimizing and 
rewiring the new pathway have been observed 
in an E. coli strain that has been engineered to 
utilize levulinic acid as a carbon source (Rand et 
al. 2017). Laboratory evolution lead to 
deregulatory mutations in the heterologous 
construct and the functional deletion of fadE and 
atoC, rerouting metabolic flux to rewire the 
newly acquired pathway. 
In summary, overexpression of a heterologous 
pathway is regularly not sufficient to reach ideal 
function of the foreign enzymes in the new host 
and genetic optimization by engineering 
approaches or adaptive evolution are required 
to overcome detrimental effects and rewire the 
new pathway to host metabolism. 
4.10. Adaptation of B. subtilis to a 
partial DXP-dependent vitamin B6 
synthesis pathway 
As part of this work, the DXP-dependent vitamin 
B6 synthesis pathway from E. coli was reversely 
engineered in a B6 auxotrophic B. subtilis strain. 




last two enzymes of the heterologous pathway 
PdxJ and PdxH, allowed the isolation of 
suppressor mutants that could grow on minimal 
medium without external addition of vitamin B6 
(Figure 24). The precursors for the reaction 
catalyzed by PdxJ are DXP and APA. The first is 
also present in B. subtilis and produced by Dxs 
as a precursor for thiamine and isoprenoid 
synthesis. The latter is not known to be present 
in B. subtilis, although similar compounds exist 
(Figure 40, KEGG). However, the fact that the 
suppressors can grow means either that B. 
subtilis is able to produce this compound, or that 
the ability was acquired by the suppressor 
mutants. The following part of this discussion 
will evaluate the current knowledge and 
propose future strategies to determine how the 
suppressors are able to utilize the partial DXP-
dependent pathway. 
4.10.1. A mysterious connection 
All suppressor mutants inactivated biosynthesis 
of BSH (Table 9 and Table 10). BSH has been 
shown to be present in B. subtilis, S. aureus and 
D. radiodurans and is important for 
management of the redox potential of the cell, 
coping with oxidative stress and detoxification 
of formaldehyde (FA), fosfomycin as well as MG 
(Newton et al. 2009; Chandrangsu et al. 2014; 
Chandrangsu et al. 2017). According to its 
function as a protectant under oxidative stress 
conditions, the genes encoding its synthetic 
pathway are regulated by the oxidative stress 
regulator Spx (see 1.4.5). The isolated, BSH-
deficient suppressor mutants could grow on 
minimal medium but were much slower than 
the wildtype (Figure 25). It was speculated that 
absence of BSH would allow the cells to grow 
independently or at least in presence of 
extremely low amounts of vitamin B6. However, 
only cells encoding PdxJ and PdxH could profit 
from the absence of BSH, but not for example 
cells only encoding PdxH or B6 auxotrophs 
grown under B6 limitation (Figure 26 and 
Figure 27). That clearly indicates that the 
deletion of BSH synthetic genes was directly 
related to the partial heterologous DXP-
dependent B6 pathway and not to endogenous 
B6 metabolism. This raised the question how 
the mutation aided B6 synthesis. BSH is 
synthesized from UDP-GlcNAc in three steps by 
L-malic acid transferase BshA, GlcN-mal 
deacetylase BshB and the putative cysteine 
ligase BshC (Gaballa et al. 2010; Upton et al. 
2012; Fang et al. 2013; VanDuinen et al. 2015; 
Winchell et al. 2016). The synthesis consumes 
UDP-GlcNAc, malic acid and cysteine and cells 
deficient in BSH accumulate the GlcNAc-related 
precursors (Gaballa et al. 2010). It is therefore 
tempting to speculate that a GlcNAc derivative is 
feeding into the reaction catalyzed by PdxJ. 
However, addition of GlcNAc, which should 
readily be converted to UDP-GlcNAc and enter 
the BSH pathway by action of the GlcNAc 
phosphotransferase NagP and GlcNAc-1P 
uridyltransferase GlmU, was not beneficial for 
growth of strains expressing the DXP-
dependent pathway in presence of BSH (Figure 
33). GlcNAc should be taken up also in presence 
of glucose, because in contrast to the GlcNAc 
utilization enzymes NagAB, neither the 
transporter NagP, nor GlmU are under control of 
carbon catabolite repression, possibly because 
even in presence of glucose, recycling of cell wall 
components might be beneficial (Blencke et al. 
2003; Plumbridge 2015). Interestingly, GlcNAc 
had a beneficial effect for strains lacking BSH 
(Figure 33). BSH might have a regulatory effect 
on the peptidoglycan synthetic pathway, hinting 
at a feedback-regulatory mechanism 
distributing the UDP-GlcNAc precursor to 
peptidoglycan or BSH synthesis. In this case 
presence of BSH would inhibit the metabolic flux 
towards BSH synthesis and absence would 
cause too much of the produced or scavenged 
UDP-GlcNAc to be funneled away from 
peptidoglycan synthesis. External addition of 
GlcNAc could then alleviate the growth defect 
caused by lack of cell wall precursors through a 
higher equilibrium concentration. In fact, BshA 
is feedback inhibited by BSH, supporting this 
hypothesis (Upton et al. 2012). Another 
explanation is that UDP-GlcNAc indeed feeds 
into the partial DXP-dependent B6 synthesis 
pathway, but that the unknown GlcNAc-derived 
precursor cannot be utilized by PdxJ in presence 
of BSH because of the feedback inhibition of 
BshA. This would imply that not UDP-GlcNAc 
but one of the BSH synthesis intermediates 
feeds into the pathway. This however is not the 
case, because deletion of bshA has the same, 
beneficial effect as deletion of bshC (Figure 26). 
Taken together, the accumulating precursors of 
BSH do not seem to directly feed into the 




Cells deficient in low molecular weight (LMW) 
thiols like BSH are also thought to accumulate 
MG (Choi et al. 2008; Chandrangsu et al. 2014). 
The major detoxification mechanism of MG in B. 
subtilis involves a BSH-bound intermediate, 
which activates proton import leading to 
acidification of the cytosol and consequently 
prohibition of nucleophilic damage by MG 
(Chandrangsu et al. 2014). The precursor of MG 
dihydroxyacetone phosphate (DPA), has a very 
similar structure like the substrate of PdxJ APA 
(Figure 40), proposing a possible feeding into 
the pathway. In this case, the deletion of BSH 
could lead to accumulation of MG, either by 
induction of oxidative stress due to the absence 
of this redox buffer, or by lack of detoxification 
of MG.  However, for the conducted experiments 
C Glc was used which is a minimal medium 
containing high amounts (100 mM) of 
phosphate and moderate amounts of glucose. 
Under these conditions, MG synthesis by MgsA 
should be inhibited due to allosteric inhibition 
through phosphate (Martin-Verstraete et al. 
1990; Landmann et al. 2011; Falahati et al. 
2013). In comparison, the media used in the 
publications stating MG accumulation used 
either LB complex medium or HL5, which 
contain an unknown but low amount and 4 mM 
phosphate, respectively (Choi et al. 2008; 
Chandrangsu et al. 2014; Rich axenic medium 
(HL5) 2008). It can therefore be assumed that 
the accumulation of MG is not the mechanism by 
which the suppressors feed into the pathway 
under the given conditions. To be completely 
sure about this, MG feeding experiments should 
be performed with the B6 auxotrophic strains 
expressing pdxJ and pdxH to check whether they 
grow like the isogenic BSH deficient strains. 
It was also checked, whether the deletion of BSH 
would lead to an increased pool of sulfur 
containing amino acids (Figure 28). It is known, 
that under oxidative stress conditions, BSH is 
reversely inactivating the methionine synthase 
MetE protecting it from irreversible inactivation 
by oxidation of a vulnerable cysteine residue 
(Chi et al. 2011; Chi et al. 2013). This 
bacillithiylation leads to methionine 
auxotrophy, which is relieved when oxidative 
stress is removed. It was hypothesized that a B6 
auxotrophic strain expressing the partial DXP-
dependent pathway would suffer from vitamin 
B6 limitation, which might induce oxidative 
stress, because vitamin B6 is a reductant in 
eukaryotes (Bilski et al. 2000; Jain, Lim 2001). 
The lack of the putative bacterial antioxidant 
vitamin B6 would lead to activation of the Spx-
mediated oxidative stress response and 
activation of many genes including bshC and the 
operon encoding BshA, BshB1, MgsA, and BirA. 
In consequence, MetE would be inactivated, and 
the cells would starve for methionine and the 
inactivation of BSH synthesis by mutation of 
bshA or bshC would relieve this auxotrophy. 
However, experiments on medium with 
methionine showed that the addition of 
methionine does not allow growth and that the 
suppressor mutants arising on this medium also 
abolished BSH synthesis (Figure 28 and Table 
10). Furthermore, no evidence for oxidative 
stress induced bacillithiylation could be 
observed (Figure 28). An alternative hypothesis 
was that the limitation of vitamin B6 would lead 
to the limitation of cysteine and that the deletion 
of the gene encoding the putative cysteine ligase 
BshC could relieve this limitation. Indeed, it has 
been shown that in humans, vitamin B6 
limitation leads to accumulation of 
intermediates from cysteine metabolism, 
because most of these use PLP as a cofactor 
(Dalto, Matte 2017). However, a B6 auxotrophic 
strain expressing the partial DXP-dependent 
pathway could also not grow on plates with 
cysteine, also in combination with methionine. 
Therefore, the mutations abolishing BSH 
synthesis were not selected by limitation of 
sulfur-containing amino acids, which is in good 
agreement with data indicating that in bacteria 
threonine and isoleucine are the first amino 
acids to be limited under vitamin B6 starvation 
conditions (Dempsey, Sims 1972). 
Two other hypotheses are that the introduction 
of the recombinant genes leads to oxidative 
stress, because PdxH produces H2O2, explaining 
why the deletion of BSH synthesis genes only 
benefits strains expressing the recombinant 
genes (Zhao, Winkler 1995). Or the 
heterologous proteins PdxJ and PdxH, which 
both contain cysteines, could be inhibited by 
BSH directly. However, no bacillithiylated 
proteins of that size were found in an 
bacillithiylation assay (data not shown). 
Summarizing, there seems to be a connection 
between the expression of the partial 
heterologous DXP-dependent vitamin B6 




response in B. subtilis. The exact mechanism by 
which they are connected could not yet be 
elucidated, but it has been shown that the 
presence of BSH is detrimental for the function 
of the heterologous pathway in B. subtilis. Future 
experiments should elucidate, whether MG has 
a beneficial effect on the growth in presence of 
PdxJ and PdxH and whether the investigated 
strains are activating the Spx-mediated stress 
response. 
4.10.2. The unknown protein 
YtoQ 
The strains expressing the partial heterologous 
pathway and with deletion of bshC can grow in 
absence of externally added vitamin B6, but do 
so much slower than the wildtype (Figure 25). 
Therefore, the strains were evolved in minimal 
medium, which gave rise to two evolved strains 
capable to grow as fast as the wildtype (Figure 
30, Yeak 2017). These strains carried, among 
others, mutations leading to a deregulation or 
higher gene dosage of ytoQ. Reverse engineering 
of the suppressor mutants by overexpression of 
the encoded, unknown protein YtoQ showed 
that growth like wildtype can be ascribed to the 
ytoQ-related mutations and deletion of ytoQ lead 
to inability of these strains to grow in absence of 
vitamin B6 (Figure 30 and Figure 31). Thus, 
YtoQ is needed for growth of B6 auxotrophic 
strains with the partial heterologous pathway 
and its overexpression allows growth like 
wildtype.  
The gene ytoQ encodes an unknown protein of 
the YtoQ family (IPR019884) containing a 
nucleoside deoxyribosyl transferase domain 
(PF11071) and a weakly conserved helix-turn-
helix motif (KEGG, Pfam, Interpro, Table 11, Finn 
et al. 2016; Finn et al. 2017). This family of 
proteins has distant similarity to the nucleoside 
deoxyribosyl transferase family (COG3613), 
members of which are known to be able to add, 
release, and interchange bases of nucleosides 
and are thought to be a part of a pyrimidine 
salvage pathway (EC 2.4.2.6) (Macnutt 1952; 
Porter et al. 1995; Finn et al. 2017). It is to date 
unknown, what function members of the YtoQ 
family have but according to the features, YtoQ 
might be a regulatory protein, an enzyme, or 
both, allowing for a plethora of possible effects 
on the suppressor mutants. The following part 
of the discussion will deal with what is known 
about YtoQ and try to draw some conclusions. 
In Lactococcus lactis, a very distant ytoQ relative 
of the COG3613 family is regulated by a Spx 
homolog under envelope stress, suggesting a 
similar function of YtoQ family proteins, since 
ytoQ is regulated by Spx in B. subtilis (Veiga et al. 
2007; Zuber et al. 2011). Another member of 
this distantly related family from Rattus 
norvegicus has been implied to be involved in 
tumorigenesis (Ghiorghi et al. 2007). The closer 
relatives of YtoQ are even less characterized. 
Proteins containing domains of the same 
nucleoside deoxyribosyl transferase family as 
YtoQ (PF11071) are found in some eukaryotes 
and many bacteria, mostly in firmicutes (mainly 
bacillacae), α- and γ-proteobacteria (but not 
enterobacteria) but also some actinobacteria 
(Pfam, Finn et al. 2016). A STRING database 
search showed that its neighborhood with ytpQ 
and ytpR is conserved among bacillacae and the 
neighborhood with ytpR also in proteobacteria 
(STRING, Zuber et al. 2011). Importantly, both 
ytoQ (as earlier mentioned) and the divergently 
orientated tricistronic operon containing ytpP, 
ytpQ and ytpR are under control of the oxidative 
stress regulator Spx in B. subtilis (Zuber et al. 





Figure 39: (A) Scheme of the protein YtoQ, which 
is mainly made up by the nucleoside deoxyribosyl 
transferase domain (PF11071) containing a HTH 
motif. (B) The gene contains a cre element close to 
its stop codon. Capitalized letters are conserved 
among cre elements (Fujihara et al. 2002). (C) The 
intergenic region upstream of ytoQ contains an 
annotated Spx cis element and a region bearing 
high similarity to regions upstream of trxA and 
trxB (dotted line) (nBLAST, Zuber et al. 2011; 
Altschul et al. 1997). The mutations leading to 
deregulation of ytoQ are shown in red squares. 
Ribosomal binding sites (RBS) are underlined, 
promoter regions are highlighted in grey and bold 
letters (Zuber et al. 2011; Rosenberg et al. 2017b). 
(D) Chromosomal context of ytoQ. Green and red 
dots depict promoters and terminators, 
respectively. 
YtpP shows similarity to thioredoxins, YtpQ has 
been shown to be involved in iron homeostasis 
and YtpR is similar to a subunit of the 
phenylalanine-tRNA synthetase, suggesting an 
involvement in oxidative stress management 
(Subtiwiki, Zuber et al. 2011; Michna et al. 
2016). Interestingly, an additional deregulating 
mutation in the intergenic region has been 
isolated by others in this lab from a B6 
auxotrophic strain with the partial heterologous 
pathway evolved on solid minimal medium. This 
strain carries a base deletion upstream of the 
ytoQ promoter (nBLAST, Altschul et al. 1997; 
Yeak 2017). The fact that YtpP shows similarity 
to thioredoxin gave reason to compare the 
intergenic region between ytoP and ytoQ to the 
regions upstream of the two known 
thioredoxins from B. subtilis, trxA and trxB. 
Apparently, this new mutation is in a region 
with high similarity with the promoter regions 
of the Spx-regulated trxA (63%) and trxB (56%) 
genes, which gives a further hint that YtoQ is 
involved in the Spx-mediated oxidative stress 
response (Figure 39). Downstream of ytoQ a 
quite long 3’-UTR (729 bp) has been annotated, 
which overlaps with the convergently 
transcribed ytoP, encoding a protein similar to 
glutamyl aminopeptidase (Subtiwiki, Michna et 
al. 2016). This head-to-head orientation without 
an annotated terminator of the B. subtilis ytoQ 
transcript suggests a regulatory function of the 
3’-UTR and a possible regulatory tandem 
between ytoP and ytoQ. Indeed, the 
transcriptomics data of ytpP shows a little dip at 
the very 3’-end and the amount of the ytoQ 3’-
UTR transcripts decreases strongly when 
reaching the ytpP ORF (Nicolas et al. 2012). 
Interestingly, in a Rho-deficient mutant, the 
ytoQ transcript is not terminated at all and ytpP 
transcription is almost absent, showing that the 
transcription of ytoQ indeed has an influence on 
the convergently expressed gene ytpP. The 
hypothetical regulatory tandem between ytoQ 
and ytoP does not seem to be well conserved. 
YtoP cooccurs with YtpP and YtpR in most 
phylae of bacteria and even some eukaryotes, 
but the cooccurrence with YtoQ is limited to 
Halomonas, some Rhizobiales, Rhodobacteracae 
and Bacillacae according to STRING. There are 
also organisms encoding only YtoQ or YtoP (e.g. 
E. coli only encodes YtoP). However, STRING 
database and Pfam show contradictory results 





Figure 40: Examples for reactions 
with similarity to vitamin B6 
synthesis (at the top of A). Side 
products were omitted for clarity. 
(A) Reactions using similar 
substrates and/or performing 
similar cyclization. (B) Reactions 
using substrates or leading to 
products with similarity to 1-
amino-3-phosphohydroxy-acetone 
(APA). Amino acids are three-letter-
code; R5P, ribulose-5-phosphate; 
G3P, glyceraldehyde-3-phosphate; 
PLP, pyridoxal phosphate; DXP, 1-
deoxyxylulose-5-phosphate; PNP, 
pyridoxine phosphate; CMTEP, 2-
[(2R-5Z)-2-carbohyxy-4-





oxobutyrate; MG, methylglyoxal. 
For example, Pfam annotates a nucleoside 
deoxyribosyl transferase domain containing 
protein in S. aureus and a pBLAST search 
revealed a very similar and annotated YtoQ 
family protein in this genus, but STRING does 
not annotate a YtoQ homolog, thus I am 
recommending professional caution when using 
those databases and interpreting the presented 
results. However, the databases and BLAST 
agree on all other, arbitrarily tested organisms 
(Pfam, BLAST, STRING, Altschul et al. 1997; Finn 
et al. 2016). The ytoQ gene is furthermore 
subject to transfer-messenger RNA (tmRNA) -
dependent termination close to its STOP codon 
under physiological conditions (LB, 37°C) 
(Fujihara et al. 2002). B. subtilis uses tmRNA to 
rescue ribosomes from stalled transcription and 
this mechanism has been connected to CCR and 
CcpA-dependent transcriptional inhibition in 
previous studies (Fujihara et al. 2002; Ujiie et al. 
2009; Himeno et al. 2014). Interestingly, ytoQ 
also contains a cre site and it has been 
hypothesized that the tmRNA-dependent 
termination rescues the ribosomes from the 
CcpA roadblock at the cre site (see 1.4.3, 




whether the tmRNA-dependent termination 
leads to a functional protein, because the 
isolated, custom tmRNA-tagged peptide had a 
similar size as the full-length protein, but the cre 
element is located well in front of the stop codon 
at bases 392-406 of 444bp (Figure 39). 
Summarizing, the current knowledge about 
YtoQ connects it to the Spx-mediated oxidative 
stress response, pyrimidine salvage pathways, 
regulation of the unknown gene ytoP, and CCR. 
Distant relatives of YtoQ have been shown to be 
nucleoside deoxyribosyl transferases, but the 
enzymatic or regulatory nature of members of 
the YtoQ family of proteins is so far completely 
unknown. 
4.11. Comparison to similar studies 
in E. coli 
It has been shown in this work that growth of B6 
auxotrophic B. subtilis cells in minimal medium 
without externally added vitamin B6 could be 
reestablished to wildtype level by introduction 
of the last two enzymes of the heterologous 
DXP-dependent pathway from E. coli with only 
two genomic alterations abolishing BSH 
synthesis and deregulating ytoQ (Figure 24 and 
Figure 30). As shown in Figure 41, the strains 
have managed to efficiently feed into the DXP-
dependent pathway at the reaction of APA and 
DXP to PNP, mediated by PdxJ. The mechanism 
by which feeding occurs is still unknown, but 
previous studies have investigated a very 
similar situation with a truncated DXP-
dependent pathway in E. coli (Kim et al. 2010; 
Kim, Copley 2012; Oberhardt et al. 2016).  
In one study, the absence of the 4-
phosphoerytronate dehydrogenase PdxB was 
overcome by three serendipitous pathways, 
which were identified of a plasmid collection 
with overexpression constructs of ORFs from E. 
coli (Kim et al. 2010; Kim, Copley 2012). One of 
the pathways was described in detail, where 
metabolites from serine synthesis were diverted 
by activity of the enzymes SerA, YeaB, LtaE and 
ThrB, converting 3-Phosphoglycerate to 4HTP 
in four enzymatic and one non-enzymatic steps. 
This pathway includes the condensation of 
glycine and glycolaldehyde to 4HT by LtaE, 
which has no homolog in B. subtilis and the 
addition of glycine to the medium had no 
observably beneficial effect in the presented 
work (BLAST, Figure 33, Altschul et al. 1997). 
Some of the enzymes involved in this 
serendipitous pathway have homologs in B. 
subtilis however, suggesting a similar 
mechanism in the suppressors presented in this 
work (Table 14). Interestingly, the observed 
suppressor mutations (Table 9 and Table 11) 
show no apparent connection to this or the 
other pathways described in the study, although 
it must be said that the E. coli strains with the 
serendipitous pathways have not been 
sequenced according to the publications and 
therefore might have acquired undocumented 
similar mutations (Kim et al. 2010; Kim, Copley 
2012). Furthermore, this pathway feeds into the 
DXP-dependent pathway at the level of 4HTP 
and the presented B. subtilis formed suppressor 
mutants without PdxA, which would 
decarboxylate 4HTP. It could also be shown, that 
strains lacking PdxA could not utilize 4HTP also 
in presence of PdxJ and PdxH, indicating that B. 
subtilis has no endogenous 4HTP decarboxylase 
activity (data not shown). For the same reason, 
the remaining pathway consisting of HisB, Php 
and YjbQ feeding into B6 synthesis at the level of 
SerC, is no candidate for feeding in the 
presented mutants. 
Table 14: E. coli genes found by Kim et al. and 
homologs in B. subtilis SP1. 









*according to pBLAST and Pfam, (Altschul et al. 
1997; Finn et al. 2016) 
 
Another serendipitous pathway observed by 
Kim et al. was mediated by activity of AroB and 
it could be shown that overexpression of B. 
subtilis aroB gene from plasmid pBP632 could 
also enhance growth of the B6 auxotrophic 
strains expressing pdxJH and lacking BSH 
synthesis (and not the ones producing BSH) 
(data not shown). However, the growth 
promoting effect was much weaker than by 
overexpression of ytoQ, which is why this lead 
was not further followed. It shows however, that 




the pathway in B. subtilis and could be worth 
investigation in the future. 
In the other study, ThiG has been shown to 
bypass PdxB in E. coli. It is suspected to be able 
to catalyze a reaction like PdxS from B. subtilis 
and was found in a bioinformatic screen for 
enzymes that are predicted to catalyze reactions 
similar to PLP-synthetic enzymes with a tool 
predicting promiscuous activities (Oberhardt et 
al. 2016). The precursors and exact reaction 
mechanisms remain to be elucidated but 
interestingly, the reactions catalyzed by ThiG 
and PdxJ very similar and one substrate (DXP) is 
identical, making ThiG an interesting candidate 
for future investigations (Figure 40). However, 
the fact that B6 auxotrophic B. subtilis strains 
did not form suppressors in absence of the 
partial DXP-dependent pathway despite 
presence of ThiG suggests that this enzyme is 
not able to take over the function of PdxS in this 
organism (Figure 26). 
Other possible routes organisms could take to 
feed into the DXP-dependent pathway have 
been described by previous works. For example, 
proteins of 2-oxoglutarate and iron-dependent 
dioxygenases  family (PF10014) which are able 
to hydroxylate free amino acids, including 
threonine to 4HT, have been found in several 
organisms (Smirnov et al. 2012). 4HT could then 
be phosphorylated either by ThrB or enzymes of 
the novel DUF1537 containing enzyme family 
and enter the DXP-dependent pathway at the 
level of PdxA. However, proteins of the 2-
oxoglutarate and iron-dependent dioxygenases  
family are not present in B. subtilis SP1, although 
other species of B. subtilis supposedly have a 
protein containing such a domain (Pfam and 
BLAST, Altschul et al. 1997; Finn et al. 2016). 
Furthermore, as mentioned earlier, B. subtilis 
has no endogenous 4HTP decarboxylase activity 
and the strains in this work are lacking PdxA and 
could thus also not utilize the product of these 
interesting enzymes. Lastly, one point mutation 
leading to change of glycine to serine is enough 
to allow PdxJ to take over function of PdxH (Man 
et al. 1996). However, our strains were not able 
to form suppressors when only PdxJ was 
present (Figure S 6). 
Therefore, previous approaches in other 
organisms show some resemblance to the case 
presented in this work but the comparability is 
very limited. Connections could only be 
observed for AroB, overexpression of which 
however showed a much weaker growth 
promoting effect than overexpression of YtoQ. 
4.12. A model how feeding into the 
partial heterologous pathway 
occurs 
The presented and discussed work shows that 
vitamin B6 auxotrophic B. subtilis expressing a 
truncated DXP-dependent pathway can grow in 
absence of vitamin B6 by feeding into the 
heterologous pathway. It can only do so, when 
BSH is absent and the unknown protein YtoQ 
present. Furthermore, data suggests that the 
feeding occurs at the reaction of APA and DXP to 
PNP, which is catalyzed by PdxJ. As previously 
discussed, B. subtilis is not known to produce 
APA, but some acetone derivatives and similar 
two-carbon compounds do exist as 
intermediates of other reactions (Figure 40). 
Thus, B. subtilis either produces APA using its 
underground metabolism, or it utilizes different 
metabolites to produce PNP via PdxJ. PdxJ is 
provably involved in PLP synthesis by these 
strains, because those isogenic variants 
expressing only PdxH were not able to form 
suppressor mutants on minimal medium and 
did also not benefit from inactivation of BSH 
synthesis (Figure 26). It has furthermore been 
shown that the unknown activity of YtoQ is 
required for growth of these strains, because 
those variants lacking YtoQ were not able to 
grow on minimal medium despite the absence of 
BSH synthesis (Figure 31). It can therefore be 
inferred that a novel, non-native pathway 
involving YtoQ, PdxJ and PdxH has been 







Figure 41: Scheme illustrating how B. subtilis could 
feed into the heterologous pathway. The known 
reactions of the PLP producing pathway are 
catalyzed by Dxs, PdxJ and PdxH. The unknown 
reactions are shown in a red cycle. YtoQ could 
activate enzymes that catalyze to the synthesis of 
1-amino-3-phosphohydroxy-acetone (APA) from 
methylglyoxal (MG, as an example) or any other of 
the similar compounds. YtoQ and/or AroB could 
also directly catalyze a reaction producing APA. 
Bacillithiol (BSH) is by an unknown mechanism 
detrimental for feeding into the pathway. PNP, 
pyridoxine phosphate; PLP, pyridoxal phosphate; 
DXP, 1-deoxyxylulose-5-phosphate; G3P, 
glyceraldehyde-3-phosphate. 
It is thereby unknown, how YtoQ mediates the 
feeding into the pathway. It could well do so as 
an enzyme producing APA directly, or producing 
a precursor that feeds into an underground 
reaction producing the compound. YtoQ could 
also regulate other enzymes. Either it inhibits 
enzymes catalyzing reactions that compete for 
substrates of the heterologous pathway, or it 
activates enzymes feeding into it. What we 
know, is that YtoQ is required and beneficial for 
the pathway. Furthermore, BSH must by some 
mechanism interfere with the pathway, but all 
tested hypotheses were rejected, which is why it 
can only be said that BSH needs to be absent for 
the heterologous pathway to be rewired. 
Therefore, B. subtilis is most likely producing 
APA via an unknown pathway involving YtoQ 
or/and AroB, which is inhibited by BSH by an 
unknown mechanism and this way feeds into 
the heterologous vitamin B6 pathway consisting 
of PdxJ and PdxH (Figure 41). 
4.13. Unearthing underground 
metabolism 
The ability of organisms to carry out enzymatic 
functions they probably do not require under 
‘normal’ growth conditions has been described 
above and can be described as a second, 
invisible level of plasticity. It is called 
underground metabolism, because these 
reactions are usually very difficult to identify 
and are mostly found as accidentally 
observations. Underground metabolism 
consists of uncharacterized enzymes with 
unknown functions, reactions that need to be 
activated via mutation (of the specific enzyme or 
a regulatory sequence) and promiscuous 
enzyme activity. For several decades many 
groups in academia and industry have spent a 
lot of time and money to optimize synthetic 
pathways to produce valuable goods. In the 
process, heterologous expression systems and 
alternative routes for the utilization of carbon 
sources, the production of amino acid and fatty 
acid synthesis among others have been 
observed and most of these recombinant 
systems lead to adaptive mutations in the host 
genome, some of which have been discussed 
above (Chou, Marx 2012; Michener et al. 2014; 
Mizukami et al. 2014; Rand et al. 2017; Bracher 
et al. 2017; Jeschek et al. 2017). These findings 
were made independently and as parts of 
completely different projects. If all these efforts 
were orchestrated to unravel the underground 
potential of microbiological species, the 
understanding of host-heterologous pathway 
interactions would greatly profit from this; 
opening completely new horizons for strain 
design. It is hereby suggested to apply the 
approach presented in this work to other 
pathways. Several, non-homologous, 
convergent pathways  are known so far and it is 
likely that more will be discovered in the future 
(Dairi et al. 2011). This knowledge presents a 
huge potential for the design of ‘custom 
metabolisms’ for heterologous engineering. To 
utilize the pathways, one must understand the 
mechanisms by which they can be rewired in a 
heterologous environment and which functional 
redundancies exist in the underground 
metabolism.  
This work presents a ubiquitously applicable 
reverse engineering approach to achieve this. 




not only reveals the deleterious interactions 
between heterologous and host pathways but 
also the potential of the underground 
metabolism to rewire the partial pathways. This 
way completely new, hybrid pathways can be 
established that can have superior traits 
compared to the original ones. Due to the hybrid 
nature, the endogenous parts of the pathways 
have coevolved with the host metabolism, 
allowing detoxification mechanisms, export 
systems and cofactors to be properly regulated 
in concert with the production pathway. On the 
other hand, the heterologous parts of the 
pathway did not coevolve with the host and are 
therefore less likely to be feedback-inhibited by 
other pathways or pleiotropic regulators. 
Therefore, hybrid pathways would ideally 
combine the best of heterologous and host 
pathways. 
4.13.1. Known redundant and 
degenerate pathways 
As mentioned earlier, a recent review has dealt 
with the occurrence of non-homologous or 
homologous but mechanistically different 
pathways (Dairi et al. 2011). The following 
section will summarize these and some 
additional pathways and go into details for some 
of them. The most obvious and already 
explained example is vitamin B6 synthesis with 
the DXP-independent and the DXP-dependent 
pathways (see 1.2.1). Others are: 
 Isoleucine 
Different pathways in archaea and bacteria as 
described above (see 4.7 ,Risso et al. 2008). 
 Mevalonate 
Two pathways, one in most bacteria using G3P 
and pyruvate, which is also present in B. subtilis 
and E. coli (Rohmer et al. 1993), another in 
eukaryotes using Acetyl-CoA which is also 
present in some bacteria including the 
pathogens S. aureus and Streptococcus 
pneumoniae (Wilding et al. 2000; Goldstein, 
Brown 1990). Some organisms contain both 
pathways (Seto et al. 1996). The pathways have 
also already been subject to metabolic 
engineering for improved production of IPP as a 
precursor for biofuels (Kang et al. 2016). The 
endogenous MEP and the heterologous 
mevalonate (MVP) pathway have already been 
expressed for industrial application in E. coli 
(Martin et al. 2003; Yang, Guo 2014). 
 3-Dehydroquinate (DHQ) 
The shikimate (SHK) pathway has been subject 
to intense efforts to achieve more efficient 
production of aromatic compounds by 
fermentation, including the optimization of 
carbon flux from central carbon metabolism and 
the optimized expression of the enzymes of the 
pathway (Liu et al. 2014; Gu et al. 2017b; Yu et 
al. 2016; Liu et al. 2016; Gottlieb et al. 2014; 
Gosset 2009; Papagianni 2012). Therefore, the 
existence of two alternative synthetic routes 
and the chance for reverse engineering as 
proposed in this work might be worth realizing. 
DHQ is part of the SHK pathway, which is 
present only in microorganisms and plants and 
absent in animals (Herrmann, Weaver 1999). 
DHQ is metabolized to chorismite in five steps, 
which are universally conserved among the 
organisms containing this pathway. After 
chorismate (from Latin `fork`) the pathway 
branches into the tryptophan, folate, terpenoid, 
menaquinone, and phenylalanine pathways. In 
most organisms the SHK pathway is initialized 
by the synthesis of DHQ by the 3-deoxy-D-
arabino-heptulosonate 7-phosphate synthase 
AroA and the 3-dehydroquinate synthase AroB 
from E4P and PEP (Herrmann, Weaver 1999). 
The synthesis of DHQ follows a different path in 
a few archaea like the marine methanogenic 
Methanocaldococcus jannaschii and the marine 
halophilic Halobacterium salinarum who do not 
contain any homologs of the aroAB genes. 
Instead, these organisms produce DHQ from 
fructose-1-6-bisphposphate (F16P) or fructose-
1-phosphate (F1P). From either of these 
substrates they can form the compound 6-
Deoxy-5-ketofructose 1-phosphate by an unique 
activity of fructose-bisphosphate aldolase Fba 
(EC 2.2.1.11) which is then further metabolized 
by the 2-amino-3,7-dideoxy-D-threo-hept-6-
ulosonate synthase AroA’ and the 3-
dehydroquinate synthase II AroB’ (White 2004; 
Gulko et al. 2014). This alternative pathway 
gives the possibility to alter the initial step of the 
shikimate pathway and allows for a reverse 
engineering approach as proposed in this work. 
Indeed, previous researchers already proposed 
a reverse engineering approach to unravel the 
last mysteries of this industrially extremely 




phenylalanine branch (Báez-Viveros et al. 
2007). 
 Menaquinone 
Two pathways for synthesis of menaquinone are 
known, a CoA-dependent pathway and the 
futalosine pathway, both starting from 
chorismate (Nowicka, Kruk 2010). The CoA-
dependent pathway was found first in E. coli and 
has been summarized elsewhere (Meganathan, 
Kwon 2009). Briefly, it starts with the formation 
of isochorismate by isochorismate synthase 
MenF. Then the 2-succinyl-6-hydroxy-2,4-
cyclohexadiene-1-carboxylate synthase MenD 
and the O-succinyl-benzoate synthase MenC 
metabolize it further until MenE attaches CoA to 
yield succinyl-benzoyl-CoA. The naphthoate 
synthase MenB further forms 1,4-dihydroxy-2-
naphtoyl-CoA. The elimination of CoA is not well 
described but according to subtiwiki, MenB can 
also catalyze this reaction (Michna et al. 2016, 
subtiwiki). However, in E. coli, the hydrolysis of 
CoA is achieved by action of 1,4-dihydroxy-2-
naphthoyl-CoA hydrolase MenI, which happens 
to be 53% identical with B. subtilis YuxO (Chen 
et al. 2013; Altschul et al. 1997, BLASTp). 1,4-
dihydroxy-2-naphthoate octaprenyl transferase 
MenA and SAM-dependent menaquinone 
biosynthesis methyltransferase MenH then 
form menaquinone. The alternative futalosine 
pathway was found in Streptomyces coelicolor 
after bioinformatic studies revealed that several 
organisms, including Helicobacter pylori and 
Campylobacter jejuni were producing 
menaquinone but lacking the men genes 
(Hiratsuka et al. 2008). This pathway itself has 
two alternative routes, one including futalosine 
and the other skipping the name-giving 
compound. The initial step is carried out by the 
chorismate dehydratase MqnA forms 3-[(1-
carbocyvinyl)oxy]benzoate, which is further 
metabolized by aminodeoxyfutalosine synthase 
MqnE to form 6-amino-6-deoxy-futalosine 
(Mahanta et al. 2013).  From here either 
futalosine is formed by aminodeoxyfutalosine 
deaminases (Goble et al. 2013), which is then 
further metabolized to dehypoxanthine 
futalosine by MqnB, or futalosine is skipped by 
activity of methylthioadenosine nucleosidase 
(Kim et al. 2014). Dehypoxanthine futalosine is 
subsequently cyclized by action of the cyclic 
dehypoxanthinyl futalosine synthase MqnC 
(Cooper et al. 2013; Hiratsuka et al. 2008) and 
further metabolized to 1,4-dihydroxy-6-
naphtoate (different to R-2-naphtoate in the 
CoA-dependent pathway) by action of 1,4-
dihydroxy-6-naphthoate synthase MqnD 
(Hiratsuka et al. 2008). The final prenylation 
and methylation to form menaquinone has not 
been described in detail but is thought to be 
catalyzed by homologs of CtaO/B and MenG, 
respectively (Cooper et al. 2013; Altschul et al. 
1997, BLASTp). 
 Spermidine 
Also for spermidine, two non-homologous 
pathways are known, to both of which arginine 
is the initial substrate. The pathway discovered 
first, the SAM-dependent pathway is found in all 
eukaryotes, many archaea and many bacteria, 
including E. coli and B. subtilis. Here, Arginine is 
decarboxylated by arginine decarboxylase SpeA 
yielding agmatine, which is subsequently 
hydrolyzed by agmatinase SpeB forming 
putrescine (Wu, Morris 1973; Satishchandran, 
Boyle 1986; Carvajal et al. 1999). Then, an 
aminopropyl group from S-adenosyl-
methionamine is transferred by spermidine 
synthase SpeE (Bowman et al. 1973). The latter 
substrate of this reaction originates from SAM 
and is formed by decarboxylation through S-
adenosyl-methionine decarboxylase SpeD 
(Anton, Kutny 1987). E. coli furthermore has the 
ability to produce putrescene from ornithine by 
activity of ornithine decarboxylase SpeF, which 
is not present in B. subtilis (Applebaum et al. 
1975). It was observed that many organisms 
including the pathogen Vibrio cholerae, do not 
contain the spe genes but instead homologs of 
the genes encoding sym-norspermidine, but 
anyhow produced spermidine. It was found that 
these enzymes encoded by these genes are able 
to produce both sym-norspermidine and 
spermidine and were part of an alternative 
polyamine pathway in organisms of the genus 
Vibrio, which is however present in many 
species (Lee et al. 2009). This L-aspartate-4-
semialdehyde (ASA)-dependent pathway starts 
at putrescene, which is fused to ASA by 
carboxynorspermidine synthase CANSDH to 
form carboxyspermidine (Nakao et al. 1991) 
and then decarboxylated to spermidine by 
carboxynorspermidine decarboxylase CANSDC 





The lysine synthesis pathways (and analogously 
the ornithine pathways) are extremely diverse 
and several variants have been evolved to form 
the same compound. There are two major lysine 
synthesis routes, (I) the DAP and the 
aminoadipate (AA) route. The DAP route is 
again divided into 4 different pathways present 
in different organisms. All of these pathways 
originate in ASA, which is hydrolyzed and 
cyclized together with pyruvate by the 4-
hydroxy-tetrahydrodipicolinate synthase DapA 
(Yugari, Gilvarg 1965; Blickling et al. 1997).  In 
the next step, L-tetrahydrodipicolinate (TDC) is 
formed by 4-hydroxy-tetrahydrodipicolinate 
reductase DapB (Farkas, Gilvarg 1965; Devenish 
et al. 2010). From here, the different routes all 
originate. 
The one present in B. subtilis is mostly limited to 
Bacilli. TDC N-acetyltransferase YkuQ forms N-
acetyl-L-2-amino-6-oxopimelate, which is 
further metabolized to N-acetyl-DAP by 
tetrahydrodipicolinate N-acetyltransferase 
PatA. In the next step, DapI deacetylates its 
substrate to DAP, which is then transformed to 
m-DAP by the diaminopimelate epimerase DapF 
(Chatterjee, White 1982). 
The alternative pathway in most other bacteria, 
which was also identified first is very similar to 
the pathway from Bacilli, but utilizes 
succinylation instead of acetylation. Here 
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate 
N-succinyltransferase DapD forms N-succinyl-
L2-amino-6-oxopimelate from TDC, which is 
subsequently metabolized to N-succinyl-DAP by 
N-succinyldiaminopimelate aminotransferase 
ArgD (Simms et al. 1984; Ledwidge, Blanchard 
1999). In the last unique step, DAP is formed by 
succinyl-diaminopimelate desuccinylase DapE 
(Kindler, Gilvarg 1960). 
Two more alternatives exist in the DAP route, 
one is present in several bacteria including 
Bacilli and Corynebacteria and bypasses the 
need of any addition of acetyl or succinyl by use 
of the spontaneous decyclization of TDC to L2-
amino-6-oxopimelate and subsequent NADPH-
dependent amination to m-DAP by 
diaminopimelate dehydrogenase DAPDH 
(Misono et al. 1979). Another alternative is 
present in plants and cyanobacteria and forms 
DAP directly from TDC by action of the LL-
diaminopimelate aminotransferase (Hudson et 
al. 2006). 
The AA route originates from 2-oxoglutarate 
and Acetyl-CoA, which are metabolized to L-2-
Aminoadipate in several enzymatic steps. At this 
compound the route divides into two different 
pathways, the fungal LysW pathway and the 
bacterial pathway.  Fungi utilize LysW as a 
carrier protein for the reactions catalyzing the 
biosynthesis of lysine, which is also the case for 
ornithine synthesis, which will be described 
below. AA is bound to LysW by action of the 
ligase LysX and subsequently the substrate is 
phosphorylated by the LysW-gamma-L-alpha-
aminoadipate kinase LysZ. In the following the 
phosphorylated LysW-AA is reduced to LysW-
aminoadipate-6-semialdehyde by LysY and the 
transaminase LysJ converts it to LysW-lysine, 
which is cleaved from the carrier protein by 
LysK (Ouchi et al. 2013). 
 Ornithine 
There are two non-homologous synthesis 
pathways for ornithine, which are widely 
analogous to the lysine synthesis pathways. 
There is the acetylation pathway in bacteria and 
the LysW pathway in fungi and archaea, which 
both start with glutamate as the initial 
substrate. The pathway from bacteria starts by 
acetylation of glutamate by N-acetylglutamate 
synthase ArgA (Maas et al. 1953) with 
subsequent phosphorylation, reduction, 
amination and deacetylation to ornithine by 
ArgBCDE, respectively (Gil et al. 1999; Baich, 
Vogel 1962; Ledwidge, Blanchard 1999; Meinnel 
et al. 1992). The alternative pathway from fungi 
is homologous to the lysine pathway described 
above with the enzymes ArgXBCDE as homologs 
of LysXZYJ, respectively (Ouchi et al. 2013). 
The summarized pathways are all suitable for 
the suggested approach to reversely engineer 
them in a heterologous environment to unearth 
unknown host-heterologous interactions and 
underground metabolic activities as exemplified 





Fermentative production of valuable goods is an 
economically competitive and ecologically 
sustainable alternative to chemical synthesis. 
Several previous studies have been dedicated to 
the establishment of vitamin B6 production 
strains, but none was successful to compete with 
chemical synthesis. Fermentative production of 
vitamin B6 is hampered by toxic intermediates, a 
toxic end-product and insufficient knowledge 
about vitamin B6 homeostasis and related proteins 
and pathways. This work is dedicated to the 
identification of deleterious interactions between 
the heterologous production pathway and the host 
metabolism, and proposes and applies an 
approach to design novel, hybrid production 
pathways combining host underground 
metabolism and partial heterologous pathways. 
Mutant derivatives of the Gram-positive model 
bacterium Bacillus subtilis, which are able to grow 
in presence of toxic amounts of pyridoxal 5’-
phosphate are shown to carry mutations leading to 
deregulation of the biotin biosynthesis operon. 
Furthermore, the inhibitor of the threonine 
synthesis operon ThrR, which is also involved in 
resistance to the vitamin B6 synthesis 
intermediate 4-hydroxy-threonine phosphate, is 
characterized. In order to optimize an existing B6 
production strain, targeted evolution is applied 
leading to a novel, non-native biosynthesis 
pathway of endogenous underground and 
heterologous enzyme activities. This approach is 
regarded to be ubiquitously applicable in different 
species and for other products and the 
characterization of the host-heterologous 
interferences is of great value for future projects 
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Table 15: Chemicals used in this work 
Chemical Manufacturer 
2-oxobutanoate Roth, Germany 
Acrylamide Roth, Germany 
Agar Roth, Germany 
Agarose Peqlab, Germany 
Ammonium iron (III) citrate Sigma-Aldrich, Germany 
Ammonium Peroxydisulfate Roth, Germany 
Antibiotics Sigma, Germany 
Bromphenol blue Serva, Germany 
BSA MBI Fermentas, Germany 
Casamino acids BD, Germany 
Coomassie Brilliant Blue, G250 Roth, Germany 
Desthiobiotin IBA, Germany 
D-Glucose Merck, Germany 
dNTPs Roche Diagnostics, Germany 
EDTA Roth, Germany 
Ethidium bromide Roth, Germany 
Ethidium bromide Merck, Germany 
Formaldehyde (37%) Roth, Germany 
Glutardialdehyde Roth, Germany 
Glutardialdehyde Sigma Aldrich, USA 
Glycerol Merck, Germany 
HCl ChemSolute, Germany 
Iron- (III)-Chloride AppliChem, Germany 
Isopropyl ß-D-1- thiogalactopyranoside Peqlap, Germany 
L-amino acids Roth, Germany 





Methanol AppliChem, Germany 
Nutrient Broth Merck, Germany 
o-Nitrophenyl-β-D-Galactopyranosid Sigma-Aldrich, Germany 
Paraformaldehyde Roth, Germany 
Potassium chloride AppliChem, Germany 
RotiQuant Roth, Germany 
Silver nitrate Roth, Germany 
Skim milk powder   Oxoid, Germany 
Sodium chloride Roth, Germany 
Sodium Dodecyl Sulfate Roth, Germany 
ß-Mercaptoethanol Roth, Germany 
Strep-Tactin Sepharose IBA, Germany 
Tetramethylethylenediamine (TEMED) Roth, Germany 
Tris (hydroxymethyl)aminomethane Roth, Germany 
Tryptone    Oxoid, Germany 
Tween20 Sigma-Aldrich, Germany 
X-Gal Roth, Germany 
Yeast extract Oxoid, U.K. 
 
Table 16:Auxilalary materials used in this work 
Material Manufacturer 
96-Well-plates Sarstedt, Germany 
Centrifuge cups Beckmann, Germany 
Cuvettes (microlitre, plastic) Greiner, Germany 
Dialysis tube Roth, Germany 
Eppendorf tubes Greiner, Germany 
Erlenmeyer flasks (100 – 2000 ml) Duran, Germany 
Falcon tubes Sarstedt, Germany 





Glas pipette Brand, Germany 
Microlitre pipettes  
(1 µl, 2 μl, 20 μl, 200 μl, 1000 μl, 5 ml) 
Eppendorf, Germany 
Petri dishes Greiner, Germany 
Pipette tips Greiner, Germany 
Poly-Prep Chromatography columns Bio-Rad, Germany 
Polyvinylidendifluorid-Membran (PVDF) Bio-Rad, Germany 
Syringes Terumo, Belgium 
VivaSpin Turbo 15 concentrator Sartorius, Germany 
 
 
Table 17: Instruments used in this work 
Machine or component Manufacturer 
Äkta GE Healthcare 
Biofuge primo R Kendro, Germany 
CDP detection system Roche, Switzerland 
Fiberlite F9/F40 rotors Thermo Fischer Scientific, Germany 
Filter set 37 Zeiss, Germany 
Filter set F36-528 AHF Analysetechnik, Germany 
French pressure cell press Spectronic Instruments, G. Heinemann, Germany 
Gel electrophoresis apparatus PeqLab, Germany 
HXP 120 light source Zeiss, Germany 
Incubator Innova R44 New Brunswick, Germany 
ITC 200 microcalorimeter MicroCal Inc., USA 
LabCycler  SensorQuest, Germany 
miniDawn Treos multiangle light scattering 
system 
Wyatt Technology Europe, Germany 
Mini-Protean III System Bio-Rad, Germany 
Nanodrop ND-1000 Thermoscientific, Germany 




Machine or component Manufacturer 
pH meter Calimatic Knick, Germany 
Refrigerated centrifuge Kendro, Germany 
S75 Superdex 10/300GL GE Healthcare 
Scale Sartorius, Germany 
Special accuracy weighing machine Sartorius, Germany 
Spectral photometer Ultraspec 2100 pro Amersham, Germany 
Standard power pack Bio-Rad, Germany 
Sterile Bench Hera Safe Thermo Scientific, Germany 
Synergy MX Platereader BioTek Instruments, USA 
Thermocycler Biometra, Germany 
Thermomixer compact Eppendorf, Germany 
TS Sorvall WX ultraseries centrifuge/RC 6+ Beckmann Coulter, Germany 
Ultracentrifuge, Sorvall Ultra Pro 80 Thermo Scientific, Germany 
Ultrospec 2100 pro photometer Amersham, Germany 
UV Transilluminator 2000 Bio-Rad, Germany 
Water desalination plant Millepore, Germany 
Zeiss Axioskop 40 Zeiss, Germany 
 
Table 18: Kits used in this work 
Kit or component Manufacturer 
DNeasy Tissue Kit (250)   Qiagen, Germany 
GeneRuler DNA Ladder Mix MBI Fermentas, Germany 
Lambda DNA EcoRI + HindIII MBI Fermentas, Germany 
NucleoSpin Plasmid-Kit Macherey-Nagel, Germany 
Prestained Protein Marker (PageRuler) MBI Fermentas, Germany 







Table 19: Enzymes and antibodies 
Enzyme Manufacturer 
Anti-rabbit immunoglobulin G-alkaline 
phosphatase secondary antibody 
Promega, USA 
FastAP MBI Fermentas, Germany 
Lysozoyme Merck, Germany 
PfuS-DNA polymerase own purification 
Phusion DNA polymerase Finnzymes, Finland 
Restriction nucleases NEB Biolabs, Germany 
RNase A MBI Fermentas, Germany 
T4-DNA ligase MBI Fermentas, Germany 
Tag-DNA polymerase Roche Diagnostics, Germany 
 
Table 20: B. subtilis Strains used in this work 
Strain Genotype Reference 
168 trpC2 Laboratory Collection 
BKE27910 ΔthrR::ermC Rudner, unpubl. Boston 
Genetic Stock Center 
BKE29850 ΔytoQ::ermC Rudner, unpubl. Boston 
Genetic Stock Center 
BKE32250 ∆thrC::ermC Rudner, unpubl. Boston 
Genetic Stock Center 
BP494 trpC2 bglS::(hag-cfp kan) Diethmaier et al. 2011 
BP496 trpC2 amyE::(hag-yfp cat) Diethmaier et al. 2011 
BP555 trpC2 codY::spc amyE::(Phom-lacZ cat)  Rosenberg et al. 2016 
BP556 trpC2 ΔthrR::ermC codY::spc amyE::(Phom-lacZ cat) Rosenberg et al. 2016 
BP557 trpC2 ΔthrR::ermC amyE::(Phom-lacZ cat) Rosenberg et al. 2016 
BP558 trpC2 amyE::(Phom-lacZ cat) Rosenberg et al. 2016 
BP559 trpC2 amyE::(Phom(C26T)-lacZ cat) Rosenberg et al. 2016 
BP560 trpC2 amyE::(Phom(T9C)-lacZ cat) Rosenberg et al. 2016 
BP900 ∆pdxST::tet sacB::SC2* cat This work 
BP901 ∆pdxST::tet pBV415 This work 
BP902 ∆pdxST::tet sacB::SC2* cat pBV415 This work 
BP908 ∆pdxST::tet ∆thrR::ermC This work 




Strain Genotype Reference 
BP912 ∆pdxST::tet aprE::pdxH amyE::SC1 spc This work 
BP913 ∆pdxST::tet aprE::pdxH amyE::SC1 spc sacB::SC2* 
cat 
This work 
BP914 ∆comG::phleo This work 
BP915 ∆pdxST::tet ∆comG::phleo This work 
BP916 ∆pdxST::tet aprE::pdxH ∆comG::phleo This work 
BP917 ∆pdxST::tet amyE::SC1 spc ∆comG::phleo This work 
BP918 ∆pdxST::tet aprE::pdxH amyE::SC1 spc 
∆comG::phleo 
This work 
BP919 ∆pdxST::tet  sacB::SC2* cat ∆comG::phleo This work 
BP920 ∆pdxST::tet  ∆thrC::ermC This work 
BP921 ∆pdxST::tet aprE::pdxH amyE::SC1 spc sacB::SC2* 
cat ∆comG::phleo 
This work 
BP922 ∆pdxST::tet amyE::SC1 spc sacB::SC2* cat 
∆comG::phleo 
This work 
BP924 PbioW(A96G) sunT(ΔT449) This work 
BP925 PbioW(A96G) TtrmB(ΔT24) This work 
BP926 bshC(C343T) yqeT(A461T) This work 
BP927 bshC(C343T) yqeT(A461T) This work 
BP928 bshC(C343T) This work 
BP929 bshC(T881A) This work 
BP953 ∆pdxST::tet ΔbshC::cat This work 
BP956 ∆pdxST::tet aprE::pdxH ΔbshC::cat This work 
BP959 ∆pdxST::tet amyE::SC1 spc aprE::pdxH ΔbshC::cat This work 
BP962 ∆pdxST::tet aprE::pdxH amyE::SC1 spc sacB::SC2* 
cat ∆thrC::ermC 
This work 
BP965 ∆pdxST::tet aprE::pdxH amyE::pdxJ spc This work 
BP967 ∆pdxST::tet amyE::SC1 spc  aprE::pdxH bshA::pX2 
cat 
This work 
BP968 amyE::(PbioW-lacZ kan) This work 
BP969 amyE::(TtrmB-lacZ cat) This work 
BP970 amyE::(PbirA-lacZ kan) This work 
BP971 amyE::(PbioW(A96G)-lacZ kan) This work 




Strain Genotype Reference 
BP978 ∆pdxST::tet amyE::pdxJ spc aprE::pdxH ΔbshC::cat This work 
BP990 Suppressor of BP912 with methionine This work 
BP991 Suppressor of BP912 with methionine This work 
BP992 Suppressor of BP912 with methionine This work 
BP996 amyE::PytoQ(C55A)-lacZ This work 
BP997 amyE::PytoQ-lacZ This work 
BP999 lacA::PgudB-cfp ermC This work 
BP1000 amyE::PgudB-yfp cm This work 
BP1002 ∆pdxST::tet amyE::pdxJ spc This work 
BP1003 ∆pdxST::tet amyE::pdxJ spc ΔbshC::cat This work 
BP1005 Suppressor of BP962 without threonine This work 
BP1006 Suppressor of BP962 without threonine This work 
BP1007 Suppressor of BP962 without threonine This work 
BP1016 ΔytoQ::ermC This work 
BP1017 ∆pdxST::tet ΔytoQ::ermC ΔbshC::cat amyE::pdxJ spc 
aprE::pdxH 
This work 
BP1018 ∆pdxST::tet ΔytoQ::ermC amyE::pdxJ spc aprE::pdxH This work 
BP1032 glyQ(C76T) comEC(G1739T) bshC::cat [ytoQ-
ytzE]ampl. 
Rosenberg et al. 2017b 
BP1036 PytoQ(C55A) bshC(ΔA464) Rosenberg et al. 2017b 
BV411-1 amyE::SC1 spc  Commichau et al. 2014 
BV412-1 sacB::SC2* cat Commichau et al. 2014 
BV604 ∆pdxST::tet Commichau et al. 2014 
BV605 ΔpdxST::tet amyE::SC1 spc Commichau et al. 2014 
BV606 ΔpdxST::tet amyE::SC1 spc sacB::SC2* cat Commichau et al. 2014 
BV609 ∆pdxST::tet amyE::SC1 spc pBV415 Commichau et al. 2014 
BV708 HTR-1 (bcaP(A347G) ybxG(T907C)) Phom(T9C) Commichau et al. 2015a 
GP88 trpC2 bshA::pX2 cat Landmann 2011 
GP349 spr8 (trpC2 ilvA2 Phom(C26T)) Rosenberg et al. 2016 
SP1 trpC+ Commichau et al. 2014 






Table 21: E. coli strains used in this work 
Strain Genotype Reference 
DH5α recA1 endA1 gyrA96 thi hsdR17 rK- mK+ relA1 
supE44 Φ80 ΔlacZ ΔM15 Δ(lacZYA-arg)U169 
Sambrook et al. 1989 
BL21 (DE3) B(832)-derivate F- lon ompT hsdS(rB mB) gal 
dcm[DE3] 
Sambrook et al. 1989 
BTH101 F- cya-99’ araD139 galE15 galK16 rpsL1 (strR) 
hsdR2 mcrA1 mcrB1 
Karimova et al. 1998  
 
 
Table 22: Plasmids used in this work 
Plasmid Relevant feature Reference 
p25-N MCS-T25 Karimova et al. 1998 
pAC6 transcriptional fusion to lacZ cat Stülke et al. 1997 
pAC7 translational fusion to lacZ cat Weinrauch et al. 1991 
pBHA12 MCS kan Commichau et al. 2014 
pBP241 PgudB-cfp Gunka 2010 
pBP26 PgudB-yfp Gunka 2010 
pBP323 pGP172-thrR Rosenberg et al. 2016 
pBP600 pUT18C-codY This work 
pBP601 pUT18-codY This work 
pBP602 pKT25-codY This work 
pBP603 p25-N-codY This work 
pBP604 pUT18C-codYΔ This work 
pBP605 pUT18-codYΔ This work 
pBP606 pKT25-codYΔ This work 
pBP607 p25-N-codYΔ This work 
pBP608 pUT18C-thrR This work 
pBP609 pUT18-thrR This work 
pBP610 pKT25-thrR This work 
pBP611 p25-N-thrR This work 
pBP612 pUT18C-thrRΔ This work 
pBP613 pUT18-thrRΔ This work 
pBP614 pKT25-thrRΔ This work 
pBP615 p25-N-thrRΔ This work 
pBP616 pGP380-codY This work 
pBP617 pGP380-codYΔ This work 
pBP618 pGP382-codY This work 
pBP619 pGP382-codYΔ This work 
pBP620 pGP380-thrR This work 
pBP621 pGP380-thrRΔ This work 
pBP622 pGP382-thrR This work 




Plasmid Relevant feature Reference 
pBP624 pUT18-birA This work 
pBP625 p25-N-birA This work 
pBP627 pAC7-PbioW This work 
pBP628 pAC6-Palf2-TtrmB This work 
pBP629 pAC7-PbirA This work 
pBP630 pAC7-PbioW(A96G) This work 
pBP631 pAC6-Palf2-TtrmB(ΔT24) This work 
pBP637 pAC7-PytoQ(C55A) Rosenberg et al. 2017b  
pBP638 pAC7-PytoQ Rosenberg et al. 2017b  
pBP639 pBQ200-ytoQ Rosenberg et al. 2017b 
pBP640 pET-SUMOadapt-ytoQ This work 
pBP641 pGP172-ytoQ This work 
pBP642 pGP574-ytoQ This work 
pBQ200 Pdeg-MCS Martin-Verstraete et al. 1994 
pBV415 pdxH kan Commichau et al. 2014 
pET-
SUMOadapt 
SUMO-His-MCS Mossessova, Lima 2000 
pGP172 Strep-MCS Merzbacher et al. 2004 
pGP380 Strep-MCS Herzberg et al. 2007 
pGP382 MCS-Strep Herzberg et al. 2007 
pGP574 MCS-Strep Schilling et al. 2006 
pKT25 T25-MCS Karimova et al. 1998 
pUT18 MCS-T18 Karimova et al. 1998 
pUT18C T18-MCS Karimova et al. 1998 
 
Table 23: Primers used in this work 
Name Description Sequence 
cat-check fw cat check down-fragment CTAATGTCACTAACCTGCCC 
cat-check rev cat check up-fragment GTCTGCTTTCTTCATTAGAATCAATCC 











cat gene with kan tags and without 
terminator (Template: pGEM-cm) 
CGATACAAATTCCTCGTAGGCGCTCGGTTAT
AAAAGCCAGTCATTAGGCCTATC 
CD1 PnrgA fw AAAGAATTCTCCTTCCTTTCCATCCCTCG 
CD2 PnrgA rev CATAAAAACTGGATCCCCCATTTGCAT 
CZ68 ermC gene with kan tags and without 















Name Description Sequence 
HOMF131 Seq primer Phom fw CATCCATTTTCCTTCGCTTC 
HOMR1151 Seq primer Phom rev TCAGGAACGATATGCCATCA 
JR59 Seq primer SC1 pdxJ fw AGATCTATCCACGCTGTGTAAAAATTTT 
JR60 Seq primer SC1 pdxA rev TGTATTACTAGAAAATAACATAGTAAAACG
GACA 
JR61 Seq primer SC1 pdxA fw CACATCCCAGAACTTGCGGA 
JR62 Seq primer SC1 pdxJ rev ACACTGACAGTGTTATGTCCGG 
JR63 Seq primer SC2 serC fw GTGCCTGCAGGAATAAAATTCCC 
JR64 Seq primer SC2 serC rev GTTGTTCCTCGATAGAGTCCTCG 
JR65 Seq primer SC2 pdxR fw AAACTTCAGATATGGAAGCACTTATGC 
JR66 Seq primer SC2 pdxR fw CGGTGTTGGCTTACGGCA 
JR67 Seq primer SC2 serC rev ATGCGTCCGAACCCGTTT 
JR68 Seq primer SC2 epd fw ATGAGACGGATTAAACACGCATTC 
JR69 Seq primer SC2 epd rev TATAAAAAAATACCCTCCTAGTACAGGAGG 
JR74 aprE::pdxH UP fw CACTCCTTTTCATTTATATCGTAACCGAA 




JR76 aprE::pdxH DOWN fw TGATGATCTTTCTACTATGGAAAAGGGTTA 
JR77 aprE::pdxH DOWN rev GCTATCAAGTATCGCTTGACTATAACATTT 
JR78 aprE::pdxH pdxH rev TTGATTAACCCTTTTCCATAGTAGAAAGAT
CATCATCAGGGTGCAAGACGATCAAT 
JR79 aprE::pdxH UP rev GCCTTCACTTGACAATCATCATCAGATTAAC
GTTAACGCAAACAACAAGC 
JR80 Seq primer sacB locus fw CAGGTACCATTTGCCGTTCATTT 
JR81 Seq primer sacB locus rev GTCGGCGAAACTTCTATTGACAG 
JR82 Seq primer amyE locus rev CTATTTGGCTTTTCCCCGGGA 
JR83 Seq primer amyE locus fw CAATCATACCACCAGTGATTATGCC 
JR92 aprE::pdxH check fw GATATGGTTTTCACATGGACTGAAACA 
JR93 aprE::pdxH check rev GGTTTTGTGTTTGTGCTTTCGC 
JR94 Seq primer amyE locus fw 2 TATGAACAAAAAAGAAACCATCATTGATGG 
JR95 Seq primer amyE locus rev 2 AGGAAGCGGAAGAATGAAGTAAGA 
JR96 Seq primer tetB rev GAAAATATAAACTAATGTTTCATTTTGCCA
CTTG 
JR97 Seq primer tetB fw GGTTCCCTTGGGGAGAAGAAG 
JR98 Seq primer yqeT fw ATACGCTGTGACACCTACTAACTG 
JR99 Seq primer yqeT rev TGGTAGTTTTGAAATGGTCCGAATTAAG 
   
JR100 Seq primer yllA fw TTTTTATATGGCAGCATCAAAGCATTG 
JR101 Seq primer yllA rev CTTTCGCATCGATGGTATGCTG 
JR102 Seq primer yllA fw2 AAGACCACGATTTGGATGAGATTAATTT 
JR103 Seq primer yllA rv2 ATCACCGCCGTAAACTCTTCC 
JR108 Cody for B2H PstI fw AAACTGCAGGATGGCTTTATTACAAAAAAC
AAGAATTATTAACTC 





Name Description Sequence 
JR110 CodY for pGP380 BamHI fw AAAGGATCCATGGCTTTATTACAAAAAACA
AGAATTATTAACTC 
JR111 CodY for pGP382 SD BamHI fw AAAGGATCCAAAGGAGGAAACAATCATGGC
TTTATTACAAAAAACAAGAATTATTAACTC 
JR112 CodY for pGP380 PstI rev TTTCTGCAGTTAATGAGATTTTAGATTTTC
TAATTCAATTAGGAATT 
JR113 CodY for pGP382 PstI rev NO STOP TTTCTGCAGATGAGATTTTAGATTTTCTAA
TTCAATTAGGAATTTGT 
JR114 CodYΔ for pGP380 PstI rev STOP TTTCTGCAGTTAAATTAGGAATTTGTTGTT
TAGTACCTTGATATAAGT 
JR115 CodYΔ for pGP380 PstI rev NO STOP TTTCTGCAGGAATTAGGAATTTGTTGTTTA
GTACCTTGATATAAGT 
JR116 ThrR for pGP380 BamHI fw AAAGGATCCATGAAAGAGGAGACATTTTAT
CTTGTCC 
JR117 ThrR for pGP382 SD BamHI fw AAAGGATCCAAAGGAGGAAACAATCATGAA
AGAGGAGACATTTTATCTTGTCC 
JR118 ThrR for pGP380 PstI rev TTTCTGCAGTTATGCACCTGAACCTAATATT
TCAACC 
JR119 ThrR for pGP382 PstI rev NO STOP TTTCTGCAGTGCACCTGAACCTAATATTTCA
ACCT 
JR120 ThrRΔ for pGP380 BamHI fw AAAGGATCCAAATACAGGGATGCTGTTTTT
CCATT 
JR121 ThrRΔ for pGP382 SD BamHI fw AAAGGATCCAAAGGAGGAAACAATCAAATA
CAGGGATGCTGTTTTTCCATT 
JR122 ThrR for B2H XbaI fw AAATCTAGAGATGAAAGAGGAGACATTTTA
TCTTGTCC 
JR123 ThrRΔ for B2H XbaI fw AAATCTAGAGAAATACAGGGATGCTGTTTT
TCCATT 
JR124 ThrR for B2H KpnI rev NO STOP TTTGGTACCCGTGCACCTGAACCTAATATTT
CAACCT 
JR125 CodYΔ for B2H KpnI rev NO STOP TTTGGTACCCGAATTAGGAATTTGTTGTTT
AGTACCTTGATATAAGT 
JR126 comG::phleo UP fw AATCGCTCATTTTGTTCGTTTAAAAGAAT 
JR127 comG::phleo DOWN rev CGAATTTGAAGGGGAGCTTAACAAT 
JR128 comG::phleo check rev AGCGCTAAAAAAATTGAAATGGCG 
JR129 comG::phleo UP rev CCTATCACCTCAAATGGTTCGCTGCTATATG
GACGGGTTTCTTATTACATTCAT 
JR130 comG::phleo DOWN fw GCGCCTACGAGGAATTTGTATCGCGCCTTTC
ACCTATATCCATTGC 
JR131 yllA::cat UP fw GGAAGACGAATATATTATTTTTGCAAAACG
G 
JR132 yllA::cat UP rev CCTATCACCTCAAATGGTTCGCTGCTTTGCT
AAAACAATGATTGAAATGATTTTATGT 
JR133 yllA::cat DOWN fw CGAGCGCCTACGAGGAATTTGTATCGGCAA
GAACGGATTTGGAATATCATGT 
JR134 yllA::cat DOWN rev CAGAATGAGCTGTCCTTTATAATCGG 
JR135 yllA::cat check fw AGTCTGAAGGAATCCGGCTTTATAA 
JR142 cat::yllA check rev AATCAAATAAAATGCCGTCTACTTCTGT 
JR154 Seq primer thrR rev GCAAAATCAACTTCGCCTGCA 
JR155 Seq primer thrR fw CGATGGAAAATGAAGAAGTGCCAT 




Name Description Sequence 
JR185 Seq primer bioO rev TCCGCCGGATATATGCTTTCC 
JR186 Seq primer sunT fw CAAGAAAATAAGACATTCGAAGCCCTA 
JR187 Seq primer sunT rev CGAAGATGCACCTTATTAAGACCATAC 
JR188 Seq primer TtrmB fw GGATCGATTCATTTTAAAACGGACAAC 
JR189 Seq primer TtrmB rev ATGATGATATTGAGCCCATCCTTTTG 
JR192 amyE::pdxJ spc KI pdxJ fw ACCAGTGATTATGCCGCGATTTAAGCCGTTT
CTCCACAAGCT 
JR193 amyE::pdxJ spc KI pdxJ rev CCTGATCTTCAAATAAAGCACTCCCCAAGGG
TTTATTGTTTTCTAAAATCTGATTACCAATT
AGAATG 
JR194 amyE::pdxJ spc UP rev ATCGCGGCATAATCACTGGT 
JR195 amyE::pdxJ spc UP fw GCATTATGTTTGAATTTCCGTTTAAAGAAT
G 
JR196 amyE::pdxJ spc DOWN fw GGGAGTGCTTTATTTGAAGATCAGG 
JR197 amyE::pdxJ spc DOWN rev CTTTGATGTCTTTTTGTTTGTGAAGTATTTC 
JR198 amyE::pdxJ spc check fw GTAAAAGTGCGGGAGGAAGGT 
JR199 amyE::pdxJ spc check rev AACAAAACCCGCTCCGATTAAAG 













JR203 trmB terminator for lacZ rev BamHI TTTGGATCCCGTCAAGCCAGGTCAACGT 








JR206 Seq primer bshB2 fw CTTCAACTTTGTCTGGAATCCGTC 
JR207 Seq primer bshB2 rev TTGGCTTGAAAACAGAAGAAGGC 
JR208 Seq primer bshB2 with promoter rev AACGGCTGCCACTGTATCAA 
JR209 PgudB rev with perfect SD BamHI TTTGGATCCCTCCTCCTAATTCGAATCTTCT
GTTTCTCACATGCTCCCTTTC 
JR210 amyE::PgudB-cfp ermC cfp rev GCTTTCCAATACACGAAAGATATGTCATTA
CTTATAAAGTTCGTCCATGCCAAGTGTAAT
G 
JR211 amyE::PgudB-cfp ermC ermC fw CATATCTTTCGTGTATTGGAAAGCGATCCTT
TAACTCTGGCAACCC 
JR212 amyE::PgudB-cfp and aprE::PgudB-yfp 
ermC PgudB fw 
ACACGGGTAATGCCAAGTGTTTGCAAAAGT
CATTCAGCTTTCAGAAAGCTTACAGCGAATC 
JR213 amyE::PgudB-cfp ermC UP rev ACTTTTGCAAACACTTGGCATTACCCGTGTG
GGAGTGCTTTATTTGAAGATCAGG 
JR214 amyE::PgudB-cfp ermC  DOWN fw CGCCTACGAGGAATTTGTATCGATCGCGGCA
TAATCACTGGT 
JR215 aprE::PgudB-yfp cat UP rev ACTTTTGCAAACACTTGGCATTACCCGTGTT
CTTTCTACTATGGAAAAGGGTTAATCAAC 





Name Description Sequence 
JR217 aprE::PgudB-yfp cat cat fw CATATCTTTCGTGTATTGGAAAGCCGGCAAT
AGTTACCCTTATTATCAAGATAAG 
JR218 aprE::PgudB-yfp cat DOWN fw GCGAGCGCCTACGAGGAATTTGTATCGCGTT
AACGCAAACAACAAGCTG 
JR219 Seq primer bshC with promoter fw TGAAAGCTCCTGAATGCCGTAT 
JR252 metE for lacZ EcoRI fw AAAGAATTCTCGCAGAAAAAGCAGAGCAAT
C 
JR256 aroB for pBQ200 BamHI fw AAAGGATCCAGGAGGACAAACATGAAGACA
CTGCATGTTCAAACTG 
JR257 aroB for pBQ200 PstI rev TTTCTGCAGTCATGATGTCTCCTCCAATCGC 
JR260 ytoQ::kan UP fw TTGTCTCTGCGGTATGATCGTC 
JR261 ytoQ::kan UP rev CCTATCACCTCAAATGGTTCGCTGGTAATCG
GGAGCTTCAGTGATTTTG 
JR262 ytoQ::kan DOWN fw CGAGCGCCTACGAGGAATTTGTATCGCTCCA
CCATCCTTTAAAAGAGCTTT 
JR263 ytoQ::kan DOWN rev TGAAATTCAAACAGATAACGGGCC 
JR264 ytoQ::kan check fw GTTCAAAATCCGGCTTGCGT 
JR265 ytoQ::kan check rev AGCGCTTTTCCAAACACTGAC 
JR266 ytoQ for pBQ200 BamHI fw AAAGGATCCAGGAGGACAAACATGGAGTTT
ATCGTCTATTTAGCAGGA 
JR267 ytoQ for pBQ200 PstI rev TTTCTCCAGTTATTCTGTTTCAAATAGATAG
GAAAGGGC 
JR268 PytoQ for pAC7 EcoRI fw AAAGAATTCAGACCAATCATCCTTTACCGCT
T 
JR269 PytoQ in pAC7 BamHI rev TTTGGATCCATAATAAAAATCCCTCCTTATG
TATATCCATCTG 
JR276 Seq primer glyQ fw TTTTTTCTTTAAGCCAGCCTGTCAG 
JR277 Seq primer glyQ fw AAAGCGCTTTTTAGATCAAATGGAAAG 
JR278 Seq primer comEC fw AGCACGCGGATAGAATGTCTC 
JR279 Seq primer comEC rev TCTATCCTCTTCTATTTTTCAGCAGGTT 
JR280 Seq primer PytoQ fw GGGTGTCTTTTTCTCTGTCAAACA 
JR281 Seq primer PytoQ rev GCAGACAGTGGATGCGATTAAAG 
JR294 TtrmB for lacZ (pAC6) Palf2 BamHI fw AAAGAATTCATTCTTGTCAAGTGAAGGCGC
GCTATGCTATAATACAGCTTGGAATGCGTCC
AAAAAGTAAAAGACAGCG 
JR296 ytoQ for pET-SUMOadapt BsaI fw AAAGGTCTCATGGTATGGAGTTTATCGTCT
ATTTAGCAGGA 
JR297 ytoQ for pET-SUMOadapt XhoI rev TTTCTCGAGTTATTCTGTTTCAAATAGATA
GGAAAGGGC 
JR298 ytoQ for pGP172 SacI fw AAAGAGCTCGATGGAGTTTATCGTCTATTT
AGCAGGA 
JR299 ytoQ for pGP172 BamHI rev TTTGGATCCTTATTCTGTTTCAAATAGATA
GGAAAGGGC 
JR300 ytoQ for pGP574 SacI fw AAAgagctcATGGAGTTTATCGTCTATTTAGC
AGGA 
JR301 ytoQ for pGP574 BamHI NO STOP rev TTTGGATCCTTCTGTTTCAAATAGATAGGA
AAGGGC 





Name Description Sequence 
kan-check fw kan check down-fragment CATCCGCAACTGTCCATACTCTG 
kan-check rev kan check up-fragment CTGCCTCCTCATCCTCTTCATCC 
kan-fw kan gene (Template: pDG780) CAGCGAACCATTTGAGGTGATAGG 
kan-rev kan gene (Template: pDG780) CGATACAAATTCCTCGTAGGCGCTCGG 
kan-rev w/o 
Terminator 
kan gene without terminator 
(Template: pDG780) 
TTACTAAAACAATTCATCCAGTAAAATAT 
mls-check fw mls check down-fragment CCTTAAAACATGCAGGAATTGACG 
mls-check rev mls check up-fragment GTTTTGGTCGTAGAGCACACGG 
mls-fw (kan) ermC gene with kan tags (Template: 
pDG646 and pDG647) 
CAGCGAACCATTTGAGGTGATAGGGATCCT
TTAACTCTGGCAACCCTC 
mls-rev (kan) ermC gene with kan tags (Template: 
pDG646 and pDG647) 
CGATACAAATTCCTCGTAGGCGCTCGGGCCG
ACTGCGCAAAAGACATAATCG 
MT24 Phom fw AAAAGAATTCATGAATATGCGGGCGCAGAA
GCT 
MT25 Phom rev AAAAGGATCCTTCAAAAAAACTCCACCTTTC
TTTTGATTGTCC 
p25-N fw Seq primer p25-N fw GCTTCCGGCTCGTATGTTGTGTG 
p25-N rev Seq primer p25-N rev GCCATCGAGTACGGCTGCGG 
pKT25 fw Seq primer pKT25 fw CGACTCGGCGCGCAGTTCG 
pKT25 rev Seq primer pKT25 rev GCAAGGCGATTAAGTTGGGTAACGC 
pUT18 fw Seq primer pUT18 fw CTTCCGGCTCGTATGTTGTGTGG 
pUT18 rev Seq primer pUT18 rev GCCGGCGCGAGCGATTTTCC 
pUT18C fw Seq primer pUT18C fw GAAGTTCTCGCCGGATGTACTGG 
pUT18C rev Seq primer pUT18C rev CGGGTGTTGGCGGGTGTCG 
pWH844 fw Seq primer pWH844 MCS fw TATGAGAGGATCGCATCACCAT 
spec-check fw kan check down-fragment GTTATCTTGGAGAGAATATTGAATGGAC 
spec-check 
rev 
kan check up-fragment CGTATGTATTCAAATATATCCTCCTCAC 












T7-Prom. Seq primer out of the T7 promoter TAATACGACTCACTATAGGG 
T7-Term. Seq primer out of the T7 terminator GCTAGTTATTGCTCAGCGG 
tc-check-fw tet check down-fragment CGGCTACATTGGTGGGATACTTGTTG 
tc-check-rev tet check up-fragment CATCGGTCATAAAATCCGTAATGC 













7.2. Supplementary information 
7.2.1. Supplementary figures 
 





Figure S 2: (A) Maximal non-toxic concentrations for B. subtilis 168 of serine, threonine and tyrosine in CSE Glc 





Figure S 3: ITC of ThrR with cysteine in absence (A) and presence (B) of DTT. 10 µM ThrR with 150 µM Cysteine in 
reaction buffer (20 mM Tris, 150 mM NaCl, 1 mM MgCl2 with and without 1mM DTT). Injections of 14 µl of ligand 
solution with 1 µl s-1 and 300 seconds spacing at 20°C, a reference power of 12.5 µcal s-1 and 500 rpm stirring. 
 
Figure S 4: Analysis of growth of B. subtilis 168 in C Glc minimal medium in presence of different concentrations 





Figure S 5: Analysis of evolved BP921 from consortium C. Passaged BP921 does not produce more B6 or grow 
better. (A and B) 10 µl of a well-grown culture were dropped onto indicator plates containing strain BP905 and X-
Gal. Compared to wild type SP1, evolved BP921 and consortia produce less vitamin B6 and evolved BP921 do not 
produce considerably more B6 than the original strain. (C) The evolved BP921 strains do not grow considerably 
better than the original strain in C Glc minimal medium (2% glucose). 
 
Figure S 6: The introduction of pdxJ alone was not sufficient for the B6 auxotrophic strain to form suppressor 
mutants on C Glc minimal medium.  The deletion of bshC in this background also did not allow growth in absence 






Figure S 7: Structure of GlyQ (1J5W) with the highlighted residue D26. 
7.2.2. Supplementary tables 
Table S 1: YtoQ DP-bind DNA binding prediction. 
POS RES S_LBL S_PRB K_LBL K_PRB P_LBL P_PRB MAJ_CON STR_CON 
1 M 0 0,8055 0 0,7329 1 0,5137 0 NA 
2 E 0 0,6848 0 0,8028 0 0,6743 0 0 
3 F 0 0,7537 0 0,5745 0 0,5412 0 0 
4 I 1 0,7125 1 0,8085 1 0,8083 1 1 
5 V 0 0,5303 1 0,5804 1 0,7198 1 NA 
6 Y 1 0,8573 1 0,8128 1 0,8145 1 1 
7 L 1 0,535 0 0,7716 0 0,5471 0 NA 
8 A 0 0,6397 0 0,5711 0 0,5569 0 0 
9 G 1 0,6537 1 0,6279 1 0,5382 1 1 
10 E 1 0,6219 1 0,7174 0 0,7986 1 NA 
11 I 0 0,5236 0 0,6207 0 0,565 0 0 
12 H 1 0,8011 1 0,5798 1 0,7291 1 1 
13 S 0 0,576 1 0,5052 1 0,5598 1 NA 
14 N 1 0,7157 1 0,6068 1 0,5976 1 1 




POS RES S_LBL S_PRB K_LBL K_PRB P_LBL P_PRB MAJ_CON STR_CON 
16 R 1 0,5844 1 0,5731 1 0,5642 1 1 
17 E 0 0,858 0 0,8825 0 0,679 0 0 
18 E 0 0,6843 0 0,8267 0 0,7795 0 0 
19 I 0 0,7665 0 0,799 0 0,8574 0 0 
20 K 0 0,7938 0 0,8551 0 0,7866 0 0 
21 E 0 0,7976 0 0,9159 0 0,7913 0 0 
22 K 0 0,6896 0 0,794 0 0,5957 0 0 
23 T 0 0,7595 0 0,7554 0 0,7509 0 0 
24 K 0 0,6853 0 0,8846 0 0,6688 0 0 
25 S 0 0,6782 0 0,5673 0 0,8576 0 0 
26 L 0 0,8014 0 0,776 0 0,9319 0 0 
27 K 0 0,8925 0 0,8563 0 0,8709 0 0 
28 L 0 0,948 0 0,9584 0 0,9177 0 0 
29 P 0 0,8792 0 0,8107 0 0,8606 0 0 
30 I 0 0,7375 0 0,8419 0 0,7282 0 0 
31 T 0 0,7052 0 0,5921 0 0,6279 0 0 
32 F 0 0,6398 0 0,655 0 0,6263 0 0 
33 V 1 0,5619 1 0,5663 1 0,6527 1 1 
34 G 0 0,6222 0 0,5069 0 0,5828 0 0 
35 P 0 0,7357 0 0,7459 0 0,6567 0 0 
36 M 1 0,56 1 0,5997 1 0,5716 1 1 
37 E 1 0,5414 0 0,6924 1 0,5565 1 NA 
38 N 0 0,7898 0 0,6354 0 0,5529 0 0 
39 H 0 0,5642 0 0,5107 0 0,5184 0 0 
40 D 0 0,8625 0 0,824 0 0,9382 0 0 
41 R 0 0,5158 0 0,5008 0 0,5285 0 0 
42 S 0 0,7402 0 0,7473 0 0,7026 0 0 
43 D 0 0,8293 0 0,8288 0 0,8046 0 0 
44 N 0 0,8004 0 0,8344 0 0,9145 0 0 
45 I 0 0,9607 0 0,9759 0 0,9717 0 0 
46 G 0 0,9014 0 0,8004 0 0,8836 0 0 
47 E 0 0,9509 0 0,9352 0 0,9455 0 0 
48 E 0 0,9558 0 0,9754 0 0,9771 0 0 
49 I 0 0,9588 0 0,9645 0 0,9524 0 0 
50 M 0 0,9428 0 0,936 0 0,9182 0 0 
51 G 0 0,9177 0 0,9323 0 0,8578 0 0 
52 V 0 0,9757 0 0,9876 0 0,888 0 0 
53 Q 0 0,889 0 0,8705 0 0,8391 0 0 
54 P 0 0,8293 0 0,8458 0 0,8667 0 0 
55 N 0 0,8448 0 0,9484 0 0,839 0 0 
56 A 0 0,6082 0 0,5767 1 0,5422 0 NA 
57 V 0 0,773 0 0,7662 0 0,6558 0 0 
58 L 0 0,5255 0 0,551 1 0,5666 0 NA 
59 K 1 0,7463 1 0,8442 1 0,8615 1 1 




POS RES S_LBL S_PRB K_LBL K_PRB P_LBL P_PRB MAJ_CON STR_CON 
61 D 1 0,5511 0 0,528 1 0,7631 1 NA 
62 K 1 0,8204 1 0,59 1 0,8021 1 1 
63 A 1 0,5485 1 0,6072 0 0,5628 1 NA 
64 S 1 0,648 1 0,6318 1 0,6467 1 1 
65 D 1 0,9133 1 0,8902 1 0,7797 1 1 
66 I 0 0,5667 1 0,6823 1 0,5039 1 NA 
67 N 1 0,8726 1 0,7594 1 0,6684 1 1 
68 N 1 0,7827 1 0,837 1 0,6738 1 1 
69 F 0 0,7117 0 0,6907 0 0,534 0 0 
70 R 1 0,9405 1 0,98 1 0,8554 1 1 
71 T 1 0,8683 1 0,8802 1 0,8194 1 1 
72 A 1 0,8006 1 0,7164 1 0,7161 1 1 
73 V 1 0,6487 1 0,7011 1 0,579 1 1 
74 L 0 0,777 0 0,8149 0 0,7799 0 0 
75 M 0 0,8738 0 0,9083 0 0,7069 0 0 
76 N 0 0,7265 0 0,8144 0 0,8155 0 0 
77 K 0 0,8663 0 0,8564 0 0,7291 0 0 
78 A 0 0,8734 0 0,8982 0 0,8856 0 0 
79 D 0 0,9265 0 0,8349 0 0,9078 0 0 
80 F 0 0,9263 0 0,8929 0 0,8731 0 0 
81 V 0 0,8991 0 0,9058 0 0,8754 0 0 
82 I 0 0,611 0 0,5641 0 0,6699 0 0 
83 A 0 0,6902 0 0,5545 0 0,7634 0 0 
84 L 1 0,7333 1 0,6213 1 0,5486 1 1 
85 F 1 0,5809 0 0,5234 1 0,577 1 NA 
86 G 1 0,5234 1 0,5225 1 0,5006 1 1 
87 E 0 0,8222 0 0,8037 0 0,6757 0 0 
88 K 1 0,915 1 0,9422 1 0,7908 1 1 
89 Y 1 0,5915 1 0,6806 1 0,6839 1 1 
90 K 1 0,8549 1 0,8065 1 0,8073 1 1 
91 Q 1 0,8926 1 0,9332 1 0,7772 1 1 
92 W 1 0,8498 1 0,906 1 0,8529 1 1 
93 N 1 0,9456 1 0,8975 1 0,8683 1 1 
94 T 1 0,732 1 0,7217 1 0,5418 1 1 
95 A 1 0,632 1 0,7391 1 0,5745 1 1 
96 M 0 0,5126 1 0,5031 1 0,6727 1 NA 
97 D 1 0,7336 1 0,7317 1 0,5863 1 1 
98 A 1 0,6217 0 0,6535 0 0,5298 0 NA 
99 S 1 0,5326 1 0,5735 1 0,6376 1 1 
100 Y 0 0,6292 0 0,602 1 0,6042 0 NA 
101 A 1 0,5407 0 0,5372 0 0,7088 0 NA 
102 I 0 0,6975 0 0,7385 0 0,6235 0 0 
103 A 1 0,5348 0 0,5114 0 0,608 0 NA 
104 K 1 0,5252 0 0,563 0 0,6021 0 NA 




POS RES S_LBL S_PRB K_LBL K_PRB P_LBL P_PRB MAJ_CON STR_CON 
106 K 1 0,6172 1 0,6799 1 0,7453 1 1 
107 P 0 0,7802 0 0,719 0 0,5065 0 0 
108 L 0 0,5553 0 0,6494 0 0,5114 0 0 
109 I 0 0,8781 0 0,8428 0 0,8247 0 0 
110 I 0 0,7554 0 0,908 0 0,8048 0 0 
111 I 0 0,9434 0 0,9617 0 0,9009 0 0 
112 R 0 0,6968 0 0,5702 0 0,6479 0 0 
113 P 0 0,9617 0 0,954 0 0,9268 0 0 
114 E 0 0,8748 0 0,9279 0 0,9228 0 0 
115 S 0 0,7988 0 0,8312 0 0,8756 0 0 
116 L 0 0,8578 0 0,8409 0 0,8364 0 0 
117 H 0 0,8899 0 0,8608 0 0,8701 0 0 
118 H 0 0,6618 0 0,6533 0 0,5225 0 0 
119 P 0 0,6765 0 0,7172 0 0,7118 0 0 
120 L 0 0,8015 0 0,5711 0 0,8443 0 0 
121 K 1 0,799 1 0,705 1 0,5282 1 1 
122 E 1 0,6528 1 0,6221 0 0,6241 1 NA 
123 L 0 0,8666 0 0,8515 0 0,8183 0 0 
124 S 0 0,549 0 0,6091 0 0,7198 0 0 
125 N 0 0,5345 0 0,7904 0 0,6812 0 0 
126 K 1 0,6902 1 0,6475 1 0,5575 1 1 
127 A 0 0,7296 0 0,5836 0 0,6026 0 0 
128 N 0 0,6803 0 0,8241 0 0,5659 0 0 
129 I 0 0,7173 0 0,8686 0 0,7313 0 0 
130 T 0 0,667 0 0,7016 0 0,5417 0 0 
131 V 0 0,88 0 0,9408 0 0,7858 0 0 
132 E 0 0,842 0 0,8842 0 0,6727 0 0 
133 T 0 0,9297 0 0,9738 0 0,8731 0 0 
134 V 0 0,9321 0 0,9392 0 0,8113 0 0 
135 N 0 0,88 0 0,7893 0 0,8415 0 0 
136 Q 0 0,9067 0 0,9516 0 0,9153 0 0 
137 A 0 0,9875 0 0,9838 0 0,9526 0 0 
138 I 0 0,9669 0 0,9313 0 0,9491 0 0 
139 K 0 0,797 0 0,8896 0 0,827 0 0 
140 A 0 0,9508 0 0,8407 0 0,9005 0 0 
141 L 0 0,8902 0 0,922 0 0,8052 0 0 
142 S 0 0,8124 0 0,6801 0 0,6246 0 0 
143 Y 0 0,9006 0 0,918 0 0,6337 0 0 
144 L 0 0,8977 0 0,8613 0 0,7558 0 0 
145 F 0 0,9036 0 0,9548 0 0,791 0 0 
146 E 0 0,8514 0 0,8815 0 0,6599 0 0 
147 T 0 0,9505 0 0,9461 0 0,8635 0 0 





Table S 2: Sequences of the rationally designed constructs. 















7.2.3. Supplementary code 
Code S 1: R script for the determination of the amplification. 
#read data 
data1 <- read.csv(choose.files(), header=T) 
#extract amplification 
amp <- data1[3093515:3112936, ] 
#extract rest 
rst <- data1[c(1:3093514,3112937:4277542), ] 
#remove zeros 
nz <- rst[rst$Coverage!=0, ] 
#check whether zeros are correct 
zero <- rst[rst$Coverage==0, ] 
summary(zero) #only zeros 
summary(nz) #no zeros 
#calculate means 
meanrest <- mean(nz$Coverage) 
meanamp <- mean(amp$Coverage) 
#calculate fold change 
foldamp <- meanamp/meanrest 
#make dataset for plot 
amp.plot <- data1[3083515:3122936, ] 
#make plot 
xaxis <- seq(length=39422, from=3044174, by=1) 
plot(xaxis, amp.plot$Coverage, type="l", ylab="Coverage", xlab="Genome position") 
plot 
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